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Abstract
Rats were maintained on aqueous extracts (2.5%, w/v) of green tea, black tea, and 
decaffeinated black tea, and after 4 weeks, received a single, oral dose of the food 
carcinogen 2-amino-3-methylimidazo[4,5-/]quinoline (IQ). Urine was collected for 
48 h, and the excretion of urinary mutagens determined. Consumption of green tea 
and black tea, but not of decaffeinated black tea, markedly decreased the excretion 
of urinary mutagens and promutagens. In a further study, supplementing 
decaffeinated black tea with caffeine also suppressed the urinary excretion of 
mutagenic material in rats treated with IQ.
Rats were maintained on similar preparations of tea for 4 weeks and hepatic and 
extrahepatic DNA adduct formation determined 16 h after administration of a 
single, oral dose of IQ, utilising the ^^P-postlabelling-HPLC assay. Decaffeinated 
black tea caused a statistically-significant increase in hepatic IQ-DNA adduct 
formation.
Rats were maintained on similar aqueous extracts (2.5%, w/v) of tea or on a solution 
of caffeine of similar concentration to that found in black tea (700 mg 1"^ ) for 4 
weeks. Two further groups of animals were administered solutions of black tea 
theaflavins or theafulvins for 4 weeks. Determination of intestinal phase I and II 
xenobiotic-metabolising enzyme activities and immunoblot analyses failed to reveal 
any significant differences between any of the treatments and the control.
Green tea (2.5%, w/v) was fractionated by HPLC and the fractions evaluated for 
antimutagenic potential. One fraction, that corresponding to (-)-epigallocatechin 
gallate (EGCG), exhibited the greatest suppression of IQ-induced mutagenicity, 
primarily by inhibiting the bioactivation of the mutagen. Inhibition of 
methoxyresorufin 0-demethylase by the fraction, used as a marker for CYP1A2 
activity, was abolished following treatment with degallase.
It is concluded that tea modulates the metabolism of IQ, and that the antigenotoxic 
effect of tea is mediated largely by caffeine and EGCG.
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''We come here to he philosophers, and I hope you will always 
remember that whenever a result happens, especially if  it be 
new, you should say, 'What is the cause? Why does it occur?' 
and you will, in the course o f  time, find  out the reason. "
Michael Faraday (1791-1867), The Chemical H istory o f  a 
Candle, pp 21-2.
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1.1 Chemical carcinogenesis
Cancer is the unrestrained, malignant proliferation of a somatic cell that results in a 
neoplasm, a progressively-growing mass of abnormal tissue. The accompanying 
loss of growth control means that the proliferation is uncontrolled, the clonal 
expansion indicating that a heritable, permanent transformation has taken place 
within the cell. Cancer is now regarded as a disease caused by the accumulation of 
genetic alterations in somatic cells, particularly where such genes regulate cell death 
or cell proliferation, and represents the multistage conversion from the normal to the 
malignant. In addition to exposure to carcinogens, genetic predisposition is an 
important factor. A further important feature of carcinogenesis is that it is a 
multistage process of at least three stages, initiation, promotion, and progression 
(Sugimura et al, 1996; Timbrell, 1994).
1.1.1 Initiation and promotion o f cancer
There are certain common features of this multistage process, for example, exposure 
to the initiator must precede exposure to the promoter. The initiator is usually 
chemically reactive and interacts with DNA, often resulting in an irreversible 
change; exposure to the promoter is usually repetitive, and may be reversible 
(Timbrell, 1994).
A striking, and well-documented, association is that between mutations in somatic 
cells and cancer — initiation of cancer is probably synonymous with mutation (De 
Flora, 1988; Hayatsu et al, 1988). Mechanistic studies of carcinogenesis indicate an 
important role of oxidative damage to DNA that is balanced by elaborate defence 
and repair processes (Ames et al, 1995). This damage may be produced either by 
xenobiotic or autobiotic genotoxic substances (Sugimura et al, 1996). An 
exogenous mutagen produces an increment in lesions above the background rate of 
endogenous lesions, and when the cell divides, a DNA lesion can give rise to a point 
mutation, deletion, or translocation (Ames et al, 1995). Many ultimate mutagens 
are reactive electrophiles, often able to alkylate or arylate DNA bases, especially at 
the N  ^ and positions of guanine, and the N  ^ and N  ^positions of adenine. Cells 
destined to become cancerous acquire a growth advantage because of these genetic
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alterations, which result in accelerated passage through the cell cycle. However, 
mutation alone is insufficient for tumorigenesis, and further coincident changes are 
necessary in the form of epigenetic mechanisms (Sugimura et a l, 1996; Timbrell, 
1994). Significantly, mutations in the p53 tumour suppressor gene are found in 
about half of all human tumours, and since p53 is involved in apoptosis, mutation of 
this gene may result in failure of apoptotic signalling, leading to inappropriate cell 
survival (Ames et al, 1995).
Promotion is the second stage of carcinogenesis. Following initiation, transformed 
cells may lie dormant, but through the action of promoters, neoplastic proliferation 
is facilitated. This may be via a number of mechanisms, e.g. inhibition of cellular 
communication, or suppression of growth control (Timbrell, 1994). Progression 
involves the neoplastic cells becoming a malignant tumour, characterised by 
increased growth rate, invasive growth, and metastasis. Further mechanisms in 
carcinogenesis, outside the scope of this discussion, include interference with DNA 
repair, activation of proto-oncogenes, and other epigenetic mechanisms (Timbrell, 
1994).
1,1.2 Environmental carcinogens
The majority of human cancers result from exposure to environmental carcinogens, 
although the fraction of human cancer attributable to xenobiotics is unknown and 
controversial (Guengerich & Shimada, 1998). There is a vast number of chemicals 
known to cause cancer in animal models, and these chemical carcinogens show a 
striking diversity in structure and potency. Such environmental carcinogens include 
man-made and natural chemicals, viruses, and ionising radiation. Examples of these 
carcinogens include polycyclic aromatic hydrocarbons (PAH), produced by 
incomplete combustion of organic matter, microbial toxins, such as the aflatoxins, 
which may be contaminants of food and water, UV radiation, various metal ions, 
asbestos, plastics, and even hormones (Timbrell, 1994). In the context of the present 
discussion in particular, a significant and important source of many such chemicals 
is the diet (Guengerich & Shimada, 1998).
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1.1.3 Significance o f  the diet in carcinogenesis  —  dietary carcinogens
The diet is a complex mixture of chemical entities and is known to be an important 
factor in determining the risk of cancer; it is estimated that diet may relate to the 
cause of around one third of all human cancers (Ferguson, 1994; Hayatsu et al, 
1988; Sugimura et a l, 1996). For example, studies on the incidence of breast cancer 
among migrant populations strongly suggest dietary and/or environmental factors in 
the aetiology of the disease, as opposed to other factors, such as genetic 
predisposition (Carmichael et al, 1996). Such cancers are caused by food-borne 
carcinogens, produced, for example, during food preservation (such as smoking or 
pickling) or, more importantly, by cooking (Adamson et al, 1995 — see 
Apostolides et a l, 1996). In contrast, the diet also contributes numerous 
antimutagenic and anticarcinogenic factors, inhibiting either the initiation or the 
promotion (or even both) of carcinogenesis. Hence, the risk of diet-related cancer in 
man is difficult to assess, but it is safe to conclude that any exposure to carcinogens 
in the diet should be decreased as far as possible (Ferguson, 1994; Sugimura et al, 
1996).
1.2 An overview of the xenobiotic-metabolising enzyme systems
The routes by which xenobiotics may be metabolised are many and varied, and 
include the chemical reactions of oxidation, reduction, hydrolysis, hydration, and 
conjugation, among others. Many dietary carcinogens must first undergo some 
degree of metabolism before becoming ‘activated’, and the diverse range of 
enzymes responsible for such activation are discussed below.
1.2.1 Phase I  xenobiotic-metabolising enzymes
Phase I reactions are generally believed to act as a ‘functionalising’ step to prepare 
the substance for phase II metabolism, generally conjugation, thus preparing the 
substance for excretion, and usually regarded as the ‘true’ detoxication pathways 
(Gibson & Skett, 1994). It should be noted at this point that many of the enzymes 
involved in xenobiotic metabolism are, in fact, principally involved in the 
metabolism of endogenous compounds, but such a role will not be considered here.
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1.2.1.1 The microsomal mixed-function oxidase— cytochromes P450
The microsomal mixed-function oxidase (MFO), found mainly in the liver, but also 
in the kidneys, lungs, intestine, and many other tissues, performs numerous diverse 
reactions {vide supra), all of which require the presence of molecular oxygen and 
NADPH, as well as the complete MFO system (cytochrome P450, NADPH- 
cytochrome P450 reductase, and lipid). All reactions involve the initial insertion of 
a single oxygen atom into the xenobiotic molecule, which may then be followed by 
rearrangement and/or decomposition of this product (Gibson & Skett, 1994). The 
mechanism of this reaction is, however, outside the scope of the present discussion. 
The metabolism of foreign compounds, including mutagens and carcinogens, can 
produce toxic metabolites, many of which are responsible for tumour initiation, 
promotion, and progression, as well as other toxic responses (Guengerich & 
Shimada, 1998; Nelson et a l, 1993). The diverse reactions catalysed by the MFO 
include aliphatic and aromatic hydroxylation, epoxidation, N-, 0-, and S- 
dealkylation, N- and 0-oxidation, oxidative deamination, alcohol oxidation, and 
dehalogenation (Gibson & Skett, 1994).
The cytochrome P450 (P450) mono-oxygenase system is actually a collection of 
isoforms, all of which possess an iron protoporphyrin IX as the prosthetic group, 
with the enzyme monomer having a molecular mass of 45-55 kDa (Timbrell, 1994). 
The P450 superfamily is very ancient, the ancestral gene having existed more than
3.5 billion years ago (Nelson et a l, 1993). With fewer than a dozen known amino 
acid sequences of these enzymes, it became apparent that the sequences could be 
aligned and classified on the basis of divergent evolutionary relationships of the 
corresponding genes. The systematic nomenclature of P450 enzymes is based upon 
this relationship; the abbreviation ‘CYP’ denoting cytochrome P450, an Arabic 
number designating the P450 family, a letter indicating the subfamily (when two or 
more subfamilies are known to exist within that family), and an Arabic number 
representing the individual protein. For example, the enzyme CYPlAl is a P450 of 
family ‘1’, subfamily ‘A’, designated isoform ‘1’ (Nelson et a l, 1993). An amino 
acid sequence from one family is defined as having < 40% sequence identity with a 
P450 from another family.
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The first three gene families (CYP 1-3) are primarily hepatic microsomal enzymes 
involved in the metabolism of xenobiotics, and, as for P450 enzymes in general, 
there is often an overlap in terms of substrate specificity and type of reaction 
catalysed (Timbrell, 1994). Variations in the proportions and presence of particular 
isoforms may underlie differences in metabolism due to species, sex, age, 
nutritional status, and inter-individual variability. The presence or absence of a 
particular isoform may be the cause of toxicity in an organ or tissue, and a striking 
feature of some P450 enzymes is their dramatic inducibility, especially in the liver. 
Some forms are expressed at a very low or undetectable levels unless the organism 
is exposed to an inducing chemical, such as PAH, barbiturates, synthetic steroids, 
etc. (Oinonen & Lindros, 1998). The inducing substance commonly affects the P450 
catalysing its own metabolism, thereby accelerating this metabolism, as well as that 
of other chemicals metabolised by the same isoform, and thus having important 
implications in the toxic response(s) to such chemicals.
7.27.2 Phase I  reactions other than those catalysed by the mixed-function oxidase
Although the MFO is the most important system, there are a variety of other 
enzymes unrelated to the MFO involved in the phase I metabolism of xenobiotics. 
Such enzymes may also be involved in oxidation reactions, such as alcohol and 
aldehyde dehydrogenase, xanthine oxidase, and amine oxidases. Microsomal 
enzymes, including P450 enzymes, may also catalyse reductive reactions, such as 
azo- and nitro-reduction, or epoxide reduction, and require the presence of NADPH, 
although they are generally inhibited by oxygen. Further reactions include 
hydrolysis (e.g. esters, amides, carbamates), hydration (e.g. epoxides), and a variety 
of more specific reactions, such as ring cyclisation, dimérisation, and isomérisation 
(Gibson & Skett, 1994).
7.2.2 Phase IIxenobiotic-metabolising enzymes
As already alluded to, it is accepted that phase II metabolism results in the true 
detoxication of xenobiotics, generally yielding water-soluble products readily- 
excretable in the urine or bile. Primarily, phase II metabolism involves the
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conjugation of the ‘primed’ phase I product with another (endogenous) compound, 
such as a sugar, sulphate, or GSH, for example.
1.2.2.1 UDP-Glucuronyltransferases
The major route of sugar conjugation is glucuronidation (conjugation with a -D - 
glucuronic acid, GlcA), and is quantitatively the most important form of 
conjugation for xenobiotics, although conjugation with glucose, xylose, or ribose is 
also possible. This is, perhaps, due to the relative abundance of the cofactor for the 
reaction, the energy-rich intermediate UDP-glucuronic acid (UDP-GlcA). Such 
conjugations may result in 0-, N-, or 5'-glucuronides, or even C-glucuronides, and in 
each case, the enzymes catalysing the reactions are the microsomal UDP- 
glucuronyltransferases (UGT) (Bock, 2002; Gibson & Skett, 1994).
In analogy to the P450 superfamily, the nomenclature of the UGT superfamily is 
also based upon evolutionary divergence, designated ‘UGT’ followed by a number, 
letter, and a number to represent the family, subfamily, and isoform, respectively 
(Mackenzie et a l, 1997). As with the P450 enzymes, there is a relatively low 
substrate specificity, but many of the UGT enzymes do have substrate preferences. 
In the context of the present study, the UGTl family is perhaps the most 
noteworthy. UGTlAl catalyses the conjugation of many dietary phenolic plant 
constituents, such as fiavonoids and anthraquinones, whereas UGT1A6 and 1A7 
catalyse the conjugation of simple, planar phenols, and both planar and bulky 
phenols, respectively. Interestingly, UGT1A8 and lAlO, both expressed in the 
intestine, but not in the liver, have been shown to conjugate metabolites of the food 
mutagen 2-amino-1 -methyl-6-phenylimidazo[4,5-6]pyridine (PhIP, vide infra), a 
colon carcinogen (Bock, 2002).
1.2.2.2 Sulphotransferases
Sulphation is a major pathway of conjugation for phenols, but may also occur with 
alcohols, amines, and thiols. As with glucuronidation, an energy-rich donor is 
required, in this case 3'-phosphoadenosine-5'-phosphosulphate (PAPS). Sulphation 
reactions are catalysed by a family of cytosolic enzymes, the sulphotransferases
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(SULT). Previously, these enzymes were named according to their substrate 
selectivities (Gibson & Skett, 1994; Glatt, 2002), but it is now recognised that, like 
the P450 and UGT enzymes, SULT enzymes form their own superfamily, and as 
such are named according to their sequence identity. However, not all isoforms 
belonging to the SULT superfamily possess recognised sulphotransferase activity, 
nor do all enzymes with sulphotransferase activity belong to the SULT superfamily 
(Glatt, 2002).
1.2.2.3 Glutathione ^-transferases
GSH is recognised as a protective compound within the body for the removal of 
potentially toxic electrophilic compounds, and GSH conjugates may be directly 
excreted in the urine, or more usually, the bile, but may also undergo further 
metabolism. (Gibson & Skett, 1994). Catalysing the conjugation of such 
electrophiles with GSH is another enzyme superfamily, the glutathione S- 
transferases (GST), cytosolic enzymes found mainly in the liver, kidney, and gut 
(Sherrat & Hayes, 2002). These soluble, cytosolic enzymes are assigned to one of 
eight mammalian families, or classes, based upon their sequence identity, namely. 
Alpha, Mu, Pi, Sigma, Theta, Omega, and Kappa. There is a second, more recently- 
defined superfamily of microsomal GST enzymes, designated the membrane- 
associated proteins in eicosanoid glutathione metabolism, or MAPEG for short 
(Sherrat & Hayes, 2002). However, it is the soluble enzymes that are involved 
primarily in the metabolism of xenobiotics.
1.2.2.4 Epoxide hydrolase
Hydration may be regarded as a form of hydrolysis where water is added to the 
molecules without causing the compound to dissociate. Epoxides are particularly 
prone to hydration, by the enzyme epoxide hydrolase, yielding the dihydrodiol 
(Gibson & Skett, 1994). If the parent compound is an epoxide, then this reaction 
may be considered to be a phase I reaction, but many epoxides are derived from 
phase I metabolism of PAH, and in the context of the present discussion, will be 
classed as a phase II reaction.
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1.2.2.5 Summary
There are many other phase II reactions not covered in the present discussion, 
notably, méthylation, acétylation, and amino acid conjugation, as well as fatty acid 
conjugation and condensation reactions. In addition, phase II products may undergo 
further metabolism, often referred to as ‘phase IIP metabolism. Hov^ever, such 
pathways are also beyond the scope of this discussion, and attention has been 
focused on those systems considered for investigation and discussion elsewhere in 
the present study.
1.3 Carcinogenic compounds present in the diet
1,3,1 Formation o f  dietary carcinogens
Cooking of food is not only desirable, but is also often necessary, yet it can be 
accompanied by a number of negative changes. It was discovered in the 1970s that a 
wide variety of mutagenic and carcinogenic compounds are formed as a result of the 
cooking process, and is therefore an example of such an undesirable change. In 
particular, the cooking of proteinaceous foods has been shown to cause the 
formation of carcinogenic heterocyclic aromatic amines (HAA), a novel class of 
compounds, which, because of their high bacterial mutagenicity, are referred to as 
the ‘food mutagens’. These highly mutagenic compounds are found in foods such as 
meat and fish cooked at normal household cooking temperatures (Ames et a l, 1995; 
Kleman & Ôvervik, 1995; Weisburger et a l, 1994). All HAA tested have been 
shown to be carcinogenic, with the exception of 2-amino-3,4,8- 
trimethylimidazo[4,5-7]quinoxaline (DiMelQx, vide infra) (Schut & Snyderwine, 
1999), and have caused malignant tumours in one or more organs in rats and mice, 
and in primates (Ferguson, 1994).
Although the mechanisms by which the HAA are formed are not clear, conditions 
that influence mutagenic activity are well known, with cooking temperature being 
one of the most important factors in mutagen formation (Keating et a l, 1999). Meat 
cooked at 150°C contains low levels of mutagens, while meat cooked at 250°C 
contains high levels of mutagens (Kleman & Ôvervik, 1995), Such mutagenicity 
increases markedly if the temperature is raised to 300°C (Murkovic et a l, 1997).
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Cooking time is perhaps of least influence, with virtually all mutagenicity being 
produced within the first 5 minutes or so of cooking, and only very small further 
amounts being produced following even prolonged cooking. The method of cooking 
is also of importance; while fried and barbecued meat contain high levels of 
mutagenicity, meat that has been either boiled, stewed, or roasted contains lower 
levels of mutagenicity. In addition, the presence of fat, either as a frying medium or 
as fat content within the meat, increases mutagen formation, possibly due to 
increased efficiency of heat transfer (Kleman & Ôvervik, 1995).
Creatine (and protein) content is possibly the most important determinant of 
mutagenicity production, mutagenicity having been shown to parallel creatine level 
more so than any other factor (Felton et a l, 1994). Cooking of low-creatine, high- 
protein foods, such as milk, cheese, or beans, yields only low mutagenic activity. 
The importance of free amino acid levels has been demonstrated by enzymatic 
proteolysis prior to cooking, resulting in increased mutagen formation (Kleman & 
Ôvervik, 1995). In Maillard reaction systems, whereby amino groups react with 
carbonyl groups during storage, heating, etc. (Jenq et a l, 1994), monosaccharides 
may also yield HAA when combined with creatine and certain amino acids (Kleman 
& Ôvervik, 1995).
Another class of carcinogenic compounds may be formed during the cooking of 
nitrite- or nitrate-rich foods, such as bacon, and such compounds are known as the 
nitrosamines. Nitrosamines (A-nitroso compounds), also formed in the stomach, are 
created through a reaction between nitrite and secondary or tertiary amines 
(Ferguson, 1994). In addition, further examples of dietary carcinogens are the PAH, 
produced as a result of incomplete combustion and pyrolysis of organic matter, e.g. 
in charcoal-grilled beef (Kleman & Ôvervik, 1995). Human exposure to such 
carcinogens in food, and from the environment, is likely to involve a complex 
mixture of HAA, PAH, and nitro-PAH, and the potential for such agents to 
demonstrate synergism in terms of their carcinogenicity must also be considered 
(Carmichael et a l, 1996).
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1.3,2, Structure o f  heterocyclic aromatic amines
HAA are characterised by the fact that most have an exocyclic amino group and an 
ortho-methyl group (Weisburger et al, 1994). The presence of HAA was revealed 
by isolation and characterisation of the mutagenic fraction of amino acid pyrolysates 
and of meat and fish products. More than 20 HAA have been isolated and identified 
in cooked food, and are divided into five groups based on their structure. The 
indoles and pyrido-imidazoles have a 2-aminopyridine moiety in common, and are 
formed from the amino acids tryptophan and glutamate respectively, whereas the 
quinolines, quinoxalines, and pyridines have a 2-aminoimidazole moiety in 
common. HAA are also referred to as TQ’ and ‘non-IQ’ types, after the HAA 2- 
amino-3-methylimidazo[4,5-y]quinoline (IQ). IQ types are formed from heating 
mixtures of creatine, amino acids, and sugars, whereas the non-IQ types are those 
formed by heating tryptophan or glutamate (Kleman & Overvik, 1995; Sugimura et 
al, 1996). Some examples of HAA structures are presented in Figure 1.1.
N— CHs N— CH3
1. 2. 3.
CH
NH2
CH. CH
4. 5.
F igure 1 .1  Examples of heterocyclic arom atic am ine structures. 1. 2-amino-3- 
methylimidazo[4,5-f]quinoline (IQ); 2. 2-amino-4,5-dimethylimidazo[4,5%/]quinoline (MelQ); 3. 2- 
amino-l-methyl-6-phenylimidazo[4,5-6]pyridine (PhIP); 4. 3-amino-l,4-dimethyl-5//-pyrido[4,3- 
6 ]indole (Trp-P-1); 5. 2 -amino-6 -methyldipyrido[l,2 -a:3 ',2 '-<5(]imidazole (Glu-P-1). (From Sugimura 
et at., 1996).
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1.3.3 Quantitation o f  heterocyclic aromatic amines
The very high potency of the food mutagens in the Ames test means that they are 
easily detectable with this system. Actual quantities of HAA in cooked food are 
very low, and therefore, sensitive techniques are required for their analysis, such as 
GC/MS and HPLC. Approximately 80% of the mutagenicity in cooked meat is 
derived from only four HAA, namely PhIP, IQ, DiMelQx, and 2-amino-3,8- 
dimethylimidazo[4,5-/]quinoxaline (MelQx). PhIP is the most abundant of the HAA 
in cooked meat or fish, and the most commonly-occurring HAA in the Western diet, 
but only accounts for approximately 10% of the mutagenic activity. Unknown 
compounds with low Salmonella mutagenicity, like PhIP, but which may have high 
mammalian mutagenicity, may account for unidentified mutagenic activity in 
cooked meat (Carmichael et ah, 1996; Kleman & Overvik, 1995).
1.3.4 Metabolism o f  heterocyclic aromatic amines
1.3.4.1 The role o f cytochrome P450 enzymes
Many genotoxic carcinogens, including HAA, are promutagens, and as such require 
metabolic activation to an electrophilic form in order to interact with 
macromolecules such as DNA (Guengerich & Shimada, 1998). This activation 
commonly occurs in the liver, but may also occur in extrahepatic tissues, especially 
in the gastrointestinal (GI) tract. The cytochrome P450 system is the major enzyme 
system involved in the metabolism of HAA, the CYPIA subfamily being the most 
important, and CYP1A2 the predominant isoform involved in the activation of HAA 
(Ferguson, 1994; Sugimura et al, 1996). The CYPIA subfamily is highly inducible 
by environmental procarcinogens such as benzo[a]pyrene (B[a]P), but are also 
inducible by the HAA (Rodrigues et a l, 1989). Induction may also occur in 
extrahepatic tissues, depending upon which food mutagen is used, suggesting that 
the capacity to induce specific isoforms varies with the different HAA (Overvik & 
Gustafsson, 1990). It is not clear whether HAA induce CYP1A2 more efficiently 
than CYPlAl, but their capacity to induce CYPIA activity is relatively low, as 
determined by assays which do not distinguish between CYPlAl and CYP1A2, and 
are therefore unlikely to contribute to their own activation in vivo (Rodrigues et a l, 
1989).
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Although CYP1A2, closely followed by CYPlAl, is the most effective isoform in 
the activation of HAA, other isoforms capable of activating the HAA include 
CYP2C11 (rat liver), 2C9 (human liver), 3 A4 (human colon), and 2A3 (rat lung). 
Although these have a rather low activity, they may be of greater significance in 
extrahepatic tissues where CYPIA levels are not predominant. Hence, the presence 
of certain P450 enzymes within a tissue may predispose that tissue to DNA damage 
by reactive metabolites (Guengerich & Shimada, 1998; Kleman & Overvik, 1995).
1.3.4.2 Activation o f heterocyclic aromatic amines
HAA are activated to reactive A-hydroxy metabolites; hydroxylation of the 
exocyclic amino group leads to activation, whereas ring hydroxylation, usually 
followed by conjugation, is a deactivation pathway. Therefore, inhibition of the 
activation pathways, and enhanced C-hydroxylation and phase II conjugation, 
would increase detoxication by increasing excretion and reducing the levels of N- 
hydroxy metabolites essential to mutagenic activity (Weisburger, 1994). As with 
other arylamines, W-oxidation of the exocyclic amino group is an important step in 
activation of HAA. In human liver microsomal fractions, for example, W-hydroxy- 
MelQx has been unequivocally identified as being responsible for almost 90% of 
the mutagenic activity. Pathways of IQ metabolism, as a model for HAA 
metabolism, are illustrated in Figure 1.2.
A number of chemicals, to which there is widespread human exposure, are known 
to cause mammary tumours in laboratory animals, and include the food mutagens. 
PhIP, the most abundant heterocyclic amine food mutagen (Layton et a l, 1995), is a 
mammary carcinogen in rodent models, and may be involved in human breast 
cancer, since it can be metabolised by the epithelial cells of human breast tissue to 
DNA-reactive metabolites (Stone et al, 1998). These agents exert their effects 
following metabolic activation to electrophilic species, which then interact 
covalently with DNA, resulting in DNA adducts. Following W-hydroxylation by 
CYP1A2, most likely in the liver, the A-hydroxy derivative may undergo transport 
to an extrahepatic tissue, such as mammary tissue, where phase II estérification 
results in the formation of a reactive ester, and where 0 -acetyltransferase may be 
the primary phase II enzyme (Carmichael et a l, 1996).
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Nitrenium ion
H+
N-OSO; N -O H
3? .N-CH3 4?
/V-Sulphatoxy IQ W-Hydroxy IQ W-Acetoxy IQ
OH
N-GIcANHz
A/ Hydroxy IQ /V-glucuronlde
NH;
N-GIcA
.N-CH3 ,N-CH;
OH
5-Hydroxy IQ IQ A/-Glucuronlde
5-0-conjugation with sulphate 
or glucuronic acid
Figure 1.2 Pathw ays of IQ metabolism. The various routes illustrated above are catalysed 
primarily by the following enzymes: 1. Cytochrome P450 1A2; 2. UDP-Glucuronyltransferase; 3. 
Sulphotransferase; 4. 0-Acetyltransferase; 5. A-Acetyltransferase. (From Kleman & Overvik, 1995).
The formation of such DNA adducts is a critical event in the multistage process of 
chemical carcinogenesis, and sensitive methods for the detection and measurement
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of these lesions are required for the identification of human carcinogens and their 
mechanisms of action (Carmichael et a l, 1996).
1.3.4.3 Detoxication and excretion o f heterocyclic aromatic amines 
Excretion of the parent food mutagen and its metabolites, via the urine, bile, and 
faeces, is efficient in rodents as well as in humans, approximately 90% of the 
administered mutagen being excreted within 24 hours. Following ring 
hydroxylation, HAA are usually conjugated with either sulphate or GlcA, though 
direct conjugation to the exocyclic amino group may also occur, yielding N- 
glucuronides or sulphamates. Glutathione conjugates of HAA have also been 
produced in vitro (Wallin et a l, 1989). The mutagenicity of A-acetylated derivatives 
is generally lower than A-hydroxylated derivatives, hence W-acetylation also 
appears to represent a detoxication step, though this seems to be a minor pathway in 
vivo (Kleman & Overvik, 1995).
L3,5 Genotoxicity o f  heterocyclic aromatic amines
1.3.5.1 Mutagenicity o f heterocyclic aromatic amines
Despite the fact that HAA are potent bacterial mutagens, most only exhibit weak 
effects in mammalian genotoxicity test systems (Overvik & Gustafsson, 1990). In 
frame shift-sensitive strains of S. typhimurium, only nanogram amounts are required 
to produce a mutagenic response (in the presence of an activation system), and in 
comparison with other bacterial mutagens, such as B[a]P and aflatoxin Bi (AFBi), 
the majority of HAA are extremely potent. HAA show almost exclusively frame 
shift mutations at the GC site in both bacterial and mammalian cells, and in 
agreement with this, analysis of HAA-induced rodent tumours shows that almost all 
mutations occur at the GC locus. However, two of the weakest HAA bacterial 
mutagens, PhIP and Trp-P-2, are the most potent mammalian mutagens. This may 
be due to the active metabolites reaching the target DNA more effectively in 
mammalian compared with bacterial cells (Felton et a l, 1994; Kleman & Overvik, 
1995). In the unscheduled DNA synthesis (UDS) assay, IQ, MelQ, MelQx, Trp-P-I, 
Glu-P-1, Glu-P-2, and other HAA have been shown to induce DNA repair in rodent
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cells, although the potent mammalian mutagen Trp-P-2 failed to induce UDS in rat 
hepatocytes. IQ, MelQ, and PhIP have also been shown to induce DNA damage (i.e. 
strand breaks) in vitro (Kleman & Overvik, 1995).
1.3.5.2 Formation o f DNA adducts with heterocyclic aromatic amines
Covalent binding of HAA to DNA, conceivably resulting in mutations, is believed 
to be a crucial step in carcinogenesis, and DNA adducts are produced in the tissues 
of many organs in rats and monkeys following oral administration of HAA. The 
highest levels of adduct formation are in the liver for most HAA, although adducts 
have been observed in organs where tumours have not (i.e. non-target organs) 
(Schut & Snyderwine, 1999; Snyderwine et a l, 1993b). In addition, the DNA 
adduct profiles appear to be identical across different species (bacteria, mouse, rat, 
and monkey), which would seem to suggest that the same ultimate metabolites of 
HAA are reacting with DNA in vivo in the different species. One of the most 
prevalent adducts formed is at the C- 8  position of guanine following the reaction 
with the A-hydroxylamine or esterified forms of the hydroxylated HAA. Formation 
of adducts increases linearly with increasing doses of MelQx, indicating there may 
be no threshold for adduct formation (Yamashita et a l, 1990), and in view of their 
mutagenic properties, HAA are likely to act as initiators in the carcinogenic process. 
Although HAA have been shown to induce enzyme-altered rat liver foci in vivo, 
their carcinogenic potency is generally low compared with other known liver 
carcinogens (Tsuda et a l, 1980).
1.4 Antigenotoxic compounds in the diet
1,4,1 Diet and anticarcinogenesis
There are many substances in the diet that can counteract mutagenic and 
carcinogenic processes. The potential protective roles of specific antioxidants and 
certain other constituents of fhiit and vegetables requires further attention, and 
consumption of adequate fruit and vegetables is associated with a lower incidence 
of cancer (Ames et a l, 1995). However, it is unlikely that all compounds sharing 
antioxidant properties would have similar effects against all types of cancer, since
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each antioxidant has a unique function and distribution within the body (Sugimura 
e ta l, 1996).
Such compounds include flavonoids, inducers of detoxifying enzymes such as 
indoles, and weak oestrogens that act as anti-oestrogens (Ames et a l, 1995). 
Flavonoids (and isoflavonoids) account for a large part of this activity, the most 
commonly found flavonoids being quercetin and its glycoside, rutin. Many other 
polyphenolic compounds exhibit similar anticarcinogenic activity, including other 
components of tea leaves, in particular, the flavanols, such as (-)-epigallocatechin 
gallate (EGCG) (Sugimura et a l, 1996).
L4,2 Modulation o f  mutagenicity by dietary components
There are several possible ways in which inhibitors of mutagenesis may act. These 
include inhibition of the interaction between DNA and mutagen, and inhibition of 
activation of indirect-acting mutagens. This may occur either by inhibition of the 
activating enzymes, or by interacting with the promutagen, rendering it unavailable 
for activation (Hayatsu et a l, 1988). There is evidence that the reaction resulting in 
nitrosamine formation may be inhibited by certain dietary components, including 
some phenolics (e.g. caffeic and ferulic acids) and flavonoids (Ferguson, 1994).
L4,3 Contribution o f  tea to dietary chemoprevention
Green tea and black tea contain many hundreds of components (Weisburger, 1994), 
the more important in this context being the polyphenols, for example, flavanols, 
thearubigins, and theaflavins (vide infra). These compounds have been shown to 
lower appreciably the mutagenicity of IQ and PhIP in the Ames test, and in the 
DNA repair test in liver cells (Apostolides et a l, 1997; Catterall et a l, 1998; 
Weisburger, 1994). For example, PhIP is metabolised to the reactive W-hydroxy 
PhIP that induces concentration-dependent mutations in S. typhimurium strain 
TA98, and aqueous extracts of green tea or black tea can inhibit the activation of 
PhIP, as determined by the Ames test (Apostolides et a l, 1996). In cultured 
mammalian cells, the frequencies of mitomycin C- or UV-induced chromosomal
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aberrations were also suppressed by subsequent treatment with tea polyphenols in 
the presence of an S9 activation system (Yang & Wang, 1993).
1.5 Tea
Tea, from the tea plant Camellia sinensis, originating in China, is one of the oldest 
and most popular prepared beverages worldwide, its consumption being commonly 
linked with beneficial health effects. Various processing methods have been 
developed, each producing a unique composition and characteristic flavour, and 
there are three general classes of tea, namely green tea, oolong (semi-fermented) 
tea, and black (fermented) tea, depending on the extent of fermentation during the 
manufacturing process (Mukhtar & Ahmad, 1999a, 1999b, 2000; Yen & Chen, 
1994). Green tea is widely consumed in Japan, China, and other Asian countries, 
but not extensively in the Western world, where black tea is favoured, and 
increasingly, decaffeinated black tea. Oolong tea production is confined to China 
and Taiwan (Wang et a l, 1994; Yen & Chen, 1996). It is estimated that in excess of
2.5 million tonnes of tea are manufactured every year, approximately 78% of which 
is black tea (Mukhtar & Ahmad, 2000; Yang & Wang, 1993). The manufacturing 
process gives rise to the major differences between the teas, the monomeric 
polyphenols in fresh green tea leaves being preserved in the final dried product, 
whereas approximately 80% are oxidised in the manufacture of black tea. These 
oxidation reactions, catalysed by polyphenol oxidase and peroxidase, result in 
larger, polymeric polyphenols (Mukhtar & Ahmad, 2000). Until recently, most of 
the research on the effects of tea has concentrated on green tea, rather than black or 
oolong teas (Stavric et a l, 1996).
1.5.1 Components o f  tea
1.5.1.1 Flavonoids
Flavonoids are phenol derivatives synthesised in substantial amounts and widely 
distributed in plants. They are well known to possess antioxidant and free radical 
scavenging activity (Lunder, 1992), and there is a significant dietary intake of 
flavonoids from tea, these in particular being among the most powerful of the
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antioxidant flavonoids (Vinson et a l, 1995). Flavonoids, and related compounds, 
can be divided into six classes, namely flavones, flavanones, isoflavones, flavonols, 
flavanols, and anthocyanins, and antioxidant activity appears to increase with the 
number of o-dihydroxy groups, the most potent being epigallocatechin gallate, with 
four such groups. Antioxidant phenolic acids, while not flavonoids, are often 
esterified with flavonoids (Constable et a l, 1996; Vinson et a l, 1995). Flavanols 
are easily oxidised to the corresponding quinones, and both are able to function as 
hydrogen acceptors or donors. Tea polyphenols are also effective scavengers of 
ROS, and have high complexation affinities for metal ions, alkaloids, and other 
biomolecules (Vinson et a l, 1995).
1.5.1.2 Flavanols
Green tea contains many fiavonoid polyphenols, which include the flavanols, 
flavandiols, and phenolic acids, and may account for up to 30% of the dry weight of 
the leaves. Most of the polyphenols are flavanols, commonly known as catechins. 
The probable active component of green tea has been identified as EGCG, although 
many other components, including chlorophyll, possess established antimutagenic 
activity (Mukhtar & Ahmad, 1999a; Yen & Chen, 1996). Green tea contains the 
highest amounts of catechins, the major ones being (-)-epicatechin, (-)-epicatechin 
gallate, (-)-epigallocatechin, and EGCG (Mukhtar & Ahmad, 2000). Catechins are 
the most abundant group of compounds in fresh leaves, and it is these compounds 
that are oxidised by polyphenol oxidase during the fermentation process to black tea 
(Yen & Chen, 1996). The fiavanol content of green, black, and decaffeinated black 
teas are summarised in Table 1.1.
During the processing of green tea, the catechin monomers dimerise and polymerise 
to form bisfiavonols, theaflavins, and thearubigins, a heterogeneous mixture of 
polyphenols. Since a reduction in catechin content does not correlate with a 
reduction in antimutagenicity, as demonstrated by black tea, and still further by 
freeze-dried ‘instant’ tea, it would seem that catechins are not the only compounds 
responsible for the protective and antioxidant effects of tea, or that the compounds 
produced by the processing of tea in some way compensate for the decrease in 
catechin content (Constable et al, 1996).
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The composition of oolong tea would be expected to be intermediate between green 
and black tea. Indeed, a large number of flavonoids, such as theasinensins, 
oolongtheanin, and oolonghomobisflavins, are transitory products of catechin 
oxidation that have not been found in fermented and non-fermented teas (Yen & 
Chen, 1996).
Table 1.1 Caffeine and polyphenolic content o f aqueous infusions o f green tea, black tea, and 
decaffeinated black tea.
Compound Concentration in 2.5% (w/v) aqueous infusions (pg ml )^*
green tea 
(Gunpowder)
black tea 
(Keemun)
decaff, black tea 
(Ceylon)
(+)-catechin 2 1 29 30
(-)-epicatechin 203 225 83
(-)-epigallocatechin 205 69 46
(-)-epicatechin-3 - 
gallate
1 1 2 69 25
(-)-epigallocatechin- 
3-gallate
980 135 109
total flavanols 1521 527 293
gallic acid 36 134 58
caffeine 489 701 15
’Aqueous extracts (2.5%, w/v) o f each tea were prepared by adding boiling water (400 ml) to the tea 
leaves (10 g) in a pre-warmed Thermos flask, allowing to brew for 10 minutes whilst inverting every 
30 seconds, and then filtering through cotton wool to remove the leaves. (From Bu-Abbas et a l, 
1999b).
In the manufacture of black tea, the monomeric flavanols undergo oxidative 
polymerisation, leading to the formation of bisflavanols, theaflavins, thearubigins, 
and other polymers in a process known as fermentation. It is the theaflavin content 
that gives black teas their characteristic colour and taste, accounting for 
approximately 1-2% of the dry weight of black tea (Yang & Wang, 1993). The term 
‘tannins’, often used to describe certain tea components, refers to a group of
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polyphenolic chemicals usually with large molecular weights and very diverse 
structures. However, it is more appropriate to use the term ‘tea polyphenols’, as they 
should be regarded as distinct from commercial tannins and tannic acid (Pingzhang 
et a l, 1994; Yang & Wang, 1993). The structures of some examples of 
polyphenolics found in both green tea and black tea are presented in Figure 1.3.
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HO. o OH OH
HO. HO.
OH
HO OH OH
GALLATE
3,
OH OH
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COOH
COOH
HOHO
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HO.HO.
OHOH
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Figure 1.3. Examples of polyphenolic structures present in tea. 1. Gallic acid; 2. Catechin; 3. 
Epigallocatechin gallate (EGCG); 4. Theaflavins; 5. Thearubigins. R and R' may be H, gallate, 
digallate, or galloyl. (From Balentine, 1992, and Huang & Ferraro, 1992).
1.5.1.2 Caffeine
Also present in tea is caffeine, one of the most extensively-consumed dietary 
constituents. The principal alkaloids in tea, theophylline, theobromine, and caffeine, 
account for approximately 4% of the dry weight of the leaf (Yang & Wang, 1993), 
the major determinants of caffeine content being the variety of tea or the cultivation 
conditions, rather than the manufacturing process (Yen & Chen, 1996).
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Caffeine itself is extensively metabolised to various demethylated and hydroxylated 
products by the P450 system and xanthine oxidase. Caffeine has also demonstrated 
various modulatory effects on chemical carcinogenesis, possibly by modifying the 
generation of reactive carcinogens due to its effect on the enzyme systems 
catalysing such activation (Alldrick & Rowland, 1988). The major P450 enzyme 
involved is CYP1A2, and caffeine has been shown to induce this enzyme (Ayalogu 
et a l, 1995). Induction of CYP1A2 is normally via interaction with the Ah receptor. 
However, caffeine does not interact with this receptor, nor does the induction of 
CYP1A2 by caffeine involve transcriptional activation, and so may occur by 
another mechanism, such as mRNA or protein stabilisation. Prior ingestion of 
caffeine, by increasing CYP1A2 activity, may stimulate activation of chemical 
carcinogens. However, if given simultaneously with the carcinogen, competitive 
inhibition may result in decreased activation, and since caffeine intake is orders of 
magnitude higher than food mutagens, simultaneous consumption is likely to afford 
protection (Ayalogu et a l, 1995).
1.5.1.3 Other components o f tea
Carotenoids and tocopherols, also present in tea may play an antioxidant and 
antimutagenic role in the lipid fraction of tea leaves (Uehara et a l, 1996; Yen & 
Chen, 1996). Also of interest in this context are the chlorophylls, and their water- 
soluble derivatives, the chlorophyllins. These compounds have shown significant 
antimutagenicity in the Ames test against a variety of dietary extracts and 
environmental carcinogens, including PAH, HAA, and AFBi (Hemaez et a l, 1997; 
Okai et a l, 1996; Te et a l, 1997). These magnesium-based porphyrin compounds 
(chlorophyllins being hydrophilic due to loss of the phytol chain) are the major 
antimutagenic factor in a variety of vegetable extracts. They too appear to possess 
antioxidant activity and the ability to interact with the P450 system, thereby 
inhibiting the metabolism of promutagens. The scavenging properties appear to be 
due, at least in part, to the ‘face-to-face’ complexing of this molecule with planar 
promutagen molecules, thus inhibiting their absorption, although this also appears to 
depend upon the water-solubility of the mutagen. These data suggest that 
chlorophyll has the potential to decrease the carcinogenic potential of food 
mutagens (Ferguson, 1994; Hartman and Shankel, 1990; Hayatsu et a l, 1988).
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L5,2 Anticarcinogenic and antimutagenic properties o f  tea
1.5.2.1 Anticancer properties o f tea
The relationship between cancer and tea consumption is related to the type of 
cancer, geography, diet, and quantity and temperature of tea drunk (Pingzhang et 
al, 1994). However, there is inadequate evidence from which to draw general 
conclusions regarding the relationship between human cancers and tea drinking, and 
available epidemiological evidence does not indicate that tea is a significant factor 
in this respect. For instance, a Dutch epidemiological study (Hertog et a l, 1993) 
found that dietary fiavonoid intake, mainly from tea, significantly reduced heart 
disease mortality, as well as being beneficial with respect to prevention of 
atherosclerosis, yet a similar study by the same group (Goldbohm et a l, 1996) 
failed to demonstrate a protective effect of black tea against major human cancers.
However, based on laboratory investigations demonstrating the inhibitory effects of 
tea against tumorigenesis, it is believed that tea consumption is likely to have 
beneficial effects (Yang & Wang, 1993), since green tea, green tea extracts, and 
major tea components have been shown to antagonise the carcinogenicity of 
chemicals in a number of animal models (Fujiki et a l, 1998; Suganuma et al, 
1999).
The roles of tea and tea polyphenols in cancer chemoprevention have been widely 
reviewed (Ahmad & Mukhtar, 1999; Kuroda & Hara, 1999; Suganuma et a l, 1999), 
and studies on the effects of tea on a variety of different cancers have been carried 
out. For example, the involvement of tea consumption in oesophageal cancer has 
been widely discussed, early observations suggesting that tea consumption might be 
associated with increased incidence of oesophageal cancer, although it now seems 
clear that this is due to hot beverages in general and the temperature of the tea 
consumed, rather than the chemicals present in tea itself (Stavric et a l, 1996; Yang 
& Wang, 1993). The association of lower incidence of stomach cancer with green 
tea drinking is variable, and may be interrelated to other factors, such as 
nitrosocompounds present in the diet. For instance, tea polyphenols have been 
demonstrated to effectively trap nitrite, and therefore lower the formation of 
carcinogenic nitrosamines (Weisburger et a l, 1994; Yang & Wang, 1993).
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Green tea extract has also been demonstrated to inhibit protein kinase C activation 
in vitro, possibly by interacting with membrane receptors, thus blocking interaction 
of tumour promoters, hormones, and growth factors (Narisawa & Fukaura, 1993). 
The mechanism of action of green tea could also be due to its influence on the post­
initiation phase by suppressing cell proliferation (Chen et a l, 1998; Fujiki, 1999). 
Numerous studies have demonstrated the anticancer effects of tea, or of tea 
components, with regard to the post-initiation phase of carcinogenesis, including the 
induction of apoptosis by tea polyphenols (Ahmad et a l, 1997; Saeki et a l, 1999), 
differential inhibition of growth of cancerous cells by EGCG (Chen et a l, 1998), 
suppression of cell proliferation through inhibition of cellular signalling and 
scavenging of reactive oxygen species (ROS) (Lin et a l, 1999), inhibition of 
tumour-promoting activity by flavonoids (Shih et a l, 2000), and inhibition by tea of 
pulmonary adenoma progression to adenocarcinoma (Yang et a l, 1998). It is also 
interesting to note that most polyphenols in green tea escape digestion, being mostly 
excreted in the faeces. However, intraluminal polyphenols above a given minimum 
dosage may act directly on the colonic mucosa to effect antitumorigenic activity 
(Narisawa & Fukaura, 1993).
Epidemiological studies on the incidence of cancer have suggested an inhibitory 
effect of tea on stomach and colorectal cancers, and tea polyphenols have 
demonstrated inhibition of azoxymethane- and MNU-induced colon cancer in rats 
(Narisawa & Fukaura, 1993). In addition, tea had an inhibitory effect on 
micronuclei and apoptosis induced by DMH in colonic crypts of mice, as well as 
reducing tumour size and tumour formation (Pingzhang et a l, 1994). However, a 
recent study by Hirose et al (2001) has contested this evidence, demonstrating that 
exposure of rats to a mixture of green tea catechins in the diet actually enhanced 
DMH-induced colon carcinogenesis.
1.5.2.2 Antimutagenicity o f tea
Tea and tea polyphenols have been widely reported to show antimutagenic activity 
against a range of different types of mutagen, including B[a]P, AFBi, 1,2- 
dibromoethane, 2-nitropropane, and several HAA (Weisburger et a l, 1994, 1996). 
Much of the research regarding the antimutagenic and anticarcinogenic effects of
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tea has been carried out on green tea, but since the components of tea products may 
alter during manufacture, especially during fermentation, the bioactivity could also 
be influenced (Yen & Chen, 1994).
A study on the antimutagenic effect of various teas to investigate the effect of the 
fermentation process concluded that the antimutagenic effect of semi-fermented tea 
was stronger than that of green and black teas (Yen & Chen, 1994). Mutagenicity of 
IQ and Trp-P-1 was markedly reduced by all the tea extracts, antimutagenic activity 
increasing with concentration of tea. Most tea extracts, when tested against a range 
of mutagens, generally exhibited antimutagenic activity in the following decreasing 
order, oolong > green > black tea. The content of the various tea components can 
vary with the variety, harvesting season, and processing method, which may also 
partially explain the varying antimutagenic activities. Although catechin content 
decreases with the degree of fermentation, it has been suggested that other 
compounds with antimutagenic activity are formed during processing to compensate 
for the loss of catechins (Constable et a l, 1996; Yen & Chen, 1994). However, 
black and oolong tea extracts showed no inhibitory effect, and green tea showed 
only a small inhibitory effect against the direct-acting mutagen nitroquinoline-iV- 
oxide (NQNO), suggesting that the antimutagenic mechanism of action of tea is 
likely to be via the inhibition of activating enzymes. It is quite likely that the 
constituents of aqueous extracts of green tea may modulate xenobiotic enzyme 
systems (Bu-Abbas et al, 1994b). Therefore, tea consumption would appear to be 
useful in reducing the risk of some types of human cancer (Apostolides et a l, 1996; 
Yen & Chen, 1994).
An unexpected result against the mutagenicity of HAA was observed by Stavric et 
al, (1996). They showed that the use of different tea concentrations showed a 
duality in activity, demonstrating inhibition at a higher concentration, and 
potentiation of mutagenicity at a lower dose, although why this occurred was not 
clear. The varying modifying effects of tea extracts on HAA mutagenicity strongly 
suggest that the various components in different teas may act differently towards 
each HAA, although this may, in part, be explained by the diverse structures of the 
HAA. The potentiation of mutagenic activity by dilute tea may be eliminated at
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higher concentrations due to the presence of ‘inhibitory factors’ in the tea. However, 
low doses of tea have never been associated with cancer (Stavric et a l, 1996).
Combined administration of GTE with a carcinogenic agent in animal models 
demonstrated inhibition of 8 -hydroxydeoxyguanosine formation, a product of DNA 
damage that induces mutagenesis (Matsumoto et a l, 1996). GTE also possesses 
antioxidant properties, such as inhibition of lipid peroxidation, an event that appears 
to correlate with oxidative DNA damage. Hence, such evidence suggests that the 
anticarcinogenic activity of GTE may be manifested by inhibiting the initiation of 
carcinogenesis (Matsumoto et a l, 1996). Tea polyphenols, and to a slightly lesser 
extent tea, have been shown to inhibit the formation of MelQx and related HAA in 
model systems (Weisburger et a l, 1994). Although this may be due to the 
antioxidant properties of the polyphenols, they may also act as traps for Maillard 
reaction intermediates that result in HAA formation, with creatine as the main target 
(Weisburger et a l, 1994).
1.6 Effects of tea and the components of tea on xenobiotic- 
metabolising enzymes
1.6.1 Effects o f tea on phase I  enzyme systems
Aqueous green tea extracts have displayed potent antimutagenic activity against an 
array of chemical carcinogens. Previous studies indicate that green tea may exert its 
anticarcinogenic effect, at least in part, by acting at the initiation stage (Bu-Abbas et 
al, 1994a). In addition, both black tea and decaffeinated black tea, as well as black 
tea theaflavins have demonstrated similar antimutagenic activity (Bu-Abbas et al, 
1996; Catterall et a l, 1998). The principal mechanism of the antimutagenicity of tea 
in the aforementioned studies appears to be inhibition of the metabolic activation of 
chemical carcinogens.
In carcinogenicity studies involving tea, the tea is usually given continuously as the 
sole source of fluid, so it may be that induced CYP1A2 is catalytically unavailable, 
being occupied by the tea components responsible for its induction (Bu-Abbas et 
al, 1996). In a recent study by Bu-Abbas et al (1996), green, black, and
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decaffeinated black teas were compared, all causing a concentration-dependent 
decrease in the mutagenicity of Glu-P-1 and B[a]P, although the black teas were 
slightly less effective against A-nitrosopyrrolidine. However, against the direct- 
acting carcinogen 9-aminoacridine, green tea was the least effective. All three teas 
inhibited dealkylation of methoxy-, ethoxy-, and pentoxyresorufin, and NADPH- 
cytochrome c reductase (Bu-Abbas et al, 1996). The emphasis in this study was 
placed on black tea, the most commonly consumed in Europe. All three teas 
markedly inhibited CYPIA activity, and although statistically significant, the 
decaffeinated black tea was the least effective. This may be partly due to the 
absence of caffeine, a potent inducer and substrate of CYP1A2 in particular, and 
may therefore act as a competitive inhibitor in green tea and whole black tea. At 
relatively high concentrations, caffeine is able to induce CYP2B activity, and 
therefore may have a low-affinity interaction with this protein. Thus, the absence of 
caffeine may explain the slightly lower inhibitory potency toward CYP2B of 
decaffeinated black tea. It was suggested that the inhibition of NADPH-cytochrome 
c reductase was due to the presence of flavanols (Bu-Abbas et a l, 1996), which are 
able to act as electron acceptors (Steele et al, 1985).
Since both green tea and black tea show a similar degree of antimutagenicity, either 
flavanols are not the major components in this activity, or the oxidation products of 
flavanols are similarly active (Bu-Abbas et al, 1996). These authors also concluded 
that caffeine does not play a major role in this function. The theafulvin fraction 
isolated from aqueous black tea extract has also demonstrated antimutagenic 
activity toward a variety of promutagens, and such an effect was shown to be 
manifested by inhibition of the bioactivation of these mutagens (Catterall et al, 
1998). These data suggest that black tea and decaffeinated black tea may be as 
efficient in vivo as green tea, but whether either black tea can act at the promotion 
stage of carcinogenesis, similar to green tea, remains to be established (Bu-Abbas et 
al, 1996).
From studies on the antimutagenicity of aqueous extracts of tea, the mechanism of 
action against HAA has been proposed to be at the level of the metabolising 
enzymes. In vitro studies have shown that the addition of tea extracts to rat hepatic 
microsomal preparations can inhibit the activities of arylhydrocarbon hydroxylase.
27
Chapter 1 : Introduction
7-ethoxycoumarin-O-deethylase, and cause a decrease in the O-dealkylation of 
methoxy-, ethoxy-, and pentoxyresorufins. Similar inhibition of the reduction of 
cytochrome c has also been observed, and may be due, in part, to the impairment of 
electron flow from NADPH to the cytochrome (Constable et ah, 1996). When tested 
against a direct-acting mutagen, 2-nitrofluorene (2-NF), no antimutagenic activity 
was observed with the tea extracts, which seems to support the suggestion that the 
antimutagenicity is due to interference with the activation enzymes in the S9 mix 
(Constable et a l, 1996). Studies on the protective effects of tea against the 
mutagenicity of A-nitrosocompounds have indicated that the tea extract interferes 
with the nitrosation reaction itself, although in vitro studies indicate that such an 
effect may also be due to inhibition of the bioactivation of nitrosamines (Bu-Abbas 
et a l, 1994a, 1996).
The antimutagenic activity of tea has been shown to be largely due to the inhibition 
of P450 enzymes in vitro (Bu-Abbas et a l, 1994a), yet further work has established 
that intake of green tea by rats, at levels comparable with human consumption, 
perturbed P450 enzymes (Bu-Abbas et a l, 1994b). Indeed, many inhibitors of the 
P450 system in vitro, may actually induce these enzymes upon in vivo 
administration. In a study by Bu-Abbas et al (1994b), the changes in rat hepatic 
CYPIA and CYP4A, following administration of green tea extract, were monitored 
by the use of diagnostic probes and polyclonal antibodies. An increase in the 
déméthylation of methoxyresorufin, a probe for CYP1A2, and immunoblot analysis, 
showed that this enzyme had been induced.
Laurie acid hydroxylase activity, an indicator of CYP4A, was also stimulated by 
green tea. Since CYPIA enzymes are associated with the activation of food 
mutagens, it is possible that green tea may actually enhance the activation of these 
compounds. Green tea also enhanced the mutagenicity of 2-aminoanthracene (2- 
AA), activated by a cytosolic oxidase. The increase in CYP4A activity suggested 
induction of peroxisome proliferation, an observation confirmed by chemical and 
immunological probes. In addition, these findings would seem to contradict 
previous findings on the anticarcinogenic potential of green tea, especially against 
the food mutagens, activated by CYPIA enzymes (Bu-Abbas et al , 1994b).
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1.6.2 Effects o f  tea on phase II  enzyme systems and antioxidant properties o f  tea
The antioxidant properties of tea polyphenols are due to three mechanisms: [1] they 
are strong metal chelators, and so can bind to and decrease the levels of ferrous and 
ferric ions which are required for the generation of ROS; [2] they are strong 
scavengers of ROS; and [3] they can react with peroxy- or free radicals, rendering 
them more stable, thereby terminating lipid peroxidation chain reactions. The 
inhibition of carcinogenesis by polyphenols due to antioxidant activity is supported 
by recent findings, such as the inhibition of 8 -hydroxyguanosine formation, a 
marker for oxidative damage to DNA (Constable et a l, 1996; Yang & Wang, 1993). 
Marked inhibition of NADPH-dependent reduction of cytochrome P45Ô by green 
tea has been observed, presumably due to the high catechin content. These catechins 
may serve as electron acceptors, directing the flow of electrons from NADPH away 
from the P450. However, since green tea exerted differential effects on P450- 
dependent activity, it is unlikely that this is the only site of action (Bu-Abbas et al, 
1994a).
Oral administration of GTE to mice has been reported to enhance GSH peroxidase, 
catalase, NADPH-quinone oxidoreductase, and GST activities. Elevation of these 
conjugative and detoxicating enzymes may be expected to have protective effects 
against cancer, and mutagenicity of tea components in the Ames test was inhibited 
by catalase, implying the involvement of H2O2 (Yang & Wang, 1993). Catechins 
inhibit the NADPH-cytochrome-c reductase enzyme, but intake of tea also enhances 
levels of phase I and II xenobiotic enzymes, and glutathione, so that detoxication 
reactions occur more efficiently (Apostolides et a l, 1996). In addition, superoxide 
dismutase (SOD) activity in mice that received green tea polyphenols was much 
higher than that in mice treated with DMH, which may also attribute 
anticarcinogenic activity to antioxidant properties of green tea polyphenols 
(Pingzhang et a l, 1994).
A study by Bu-Abbas et al (1995) to investigate the influence of green tea 
treatment in rats on phase II metabolism found that the activities of SULT, epoxide 
hydrolase, and GST were not influenced. However, the activity of UGT was 
increased by 1 0 0 %, though not with all substrates of this enzyme investigated.
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Being a multigene enzyme family, these results may reflect differential induction of 
various isoforms of UGT by the tea or its components. In a separate study, treatment 
with black tea, but not decaffeinated black tea, enhanced both hepatic UGT and 
GST activities (Bu-Abbas et al, 1998). Such enhanced phase II conjugation may 
contribute to the beneficial effects of tea by facilitating inactivation of mutagens and 
their subsequent excretion.
1.7 Aims of the project
The aims of this project are to better define the mechanism of action of the observed 
anticarcinogenic properties of tea, with respect to the antigenotoxic effects of green 
tea, black tea, and decaffeinated black tea, and thus gain further insight into the 
nature of the compound(s) that are responsible for such effects.
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2.1 Materials
Purchased chemicals and reagents were obtained from the following suppliers: 
Amersham Life Science, Little Chalfont, Bucks., UK
Hybond ECL nitrocellulose membrane, ECL and ECL Plus Western blotting 
detection systems, ECL mini-camera, "^*C-lauric acid (1.85 MBq, 10 mCi ml"^)
Becton-Dickinson, Cowley, Oxon., UK
Vogel-Bonner E plates
Cambridge Bioscience (Gentest Chemicals), Cambridge, Cambs., UK
Goat anti-rat CYP2E1, 3A4, and 4A1
London Analytical Bioscience, UK/International Diagnostics Group pic. Bury, 
Lancs., UK
LAB M agar No. 1, MC2
Melford Laboratories Ltd, Ipswich, Suffolk, UK
NADP (tetrasodium salt) and NADPH (sodium salt)
Midwest Research Institute, Kansas City, Missouri, USA
Benzo Mpyrene-4,5 -epoxide and benzo [a]pyrene-4,5 -trans-dihydrodiol
National Diagnostics, Aylesbury, Bucks., UK
Ultra-pure ‘AcrylageP (30% acrylamide solution) and ‘Bis-acrylageP (2% N f l -  
methylene bisacrylamide solution)
Oxoid Ltd, Basingstoke, Hants., UK
Oxoid nutrient broth No. 2
Sigma Chemical Co., Poole, Dorset, UK
2-Aminoanthracene, ammonium persulphate, ampicillin, ascorbic acid,
benzo [ajpyrene, D-biotin, BSA (fraction V), 1 -chloro-2,4-dinitrobenzene.
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dexamethasone, 3,4-dichloronitrobenzene, erythromycin, ethoxyresorufin, Folin and 
Ciocalteu's phenol reagent, D-glucose-6 -phosphate (disodium salt), glucose-6 - 
phosphate dehydrogenase, GSH, L-histidine (hydrochloride salt), isoniazid, lauric 
acid, 2 -mercaptoethanol, methoxyresorufin, methylene blue, 1 -naphthol-a- 
glucuronide, 1-naphthyl sulphate, PAPS, pentoxyresorufin, peroxidase-linked 
donkey anti-sheep secondary antibody, peroxidase-linked monoclonal anti­
sheep/goat secondary antibody, pyronin-Y, resorufin, SDS, 
tetramethylethylenediamine (TEMED), Tris (Sigma 7-9®), Triton X-100, UDP- 
glucuronic acid
AstraZeneca (formerly ICI Pharmaceuticals), Macclesfield, Cheshire, UK
Sodium clofibrate
All other commercial reagents were of analytical grade or specified laboratory 
reagents.
Sheep anti-rat CYPIA antiserum was kindly provided by Dr Costas loannides. The 
antibody did not distinguish between CYPlAl and CYP1A2, but did not cross-react 
with proteins from other cytochrome P450 families (Rodrigues et al., 1987). 
Aroclor 1254 was also provided by Dr Costas loannides.
2.2 Methods
2.2.1 Pre-treatment o f  animals
Male Wistar albino rats were purchased from either B&K Universal Ltd (Hull, East 
Yorks., UK) or from the Experimental Biology Unit (EBU), University of Surrey 
(Guildford, Surrey, UK). Animals were housed in the EBU in cages with sawdust 
bedding, and were allowed food (B&K rat and mouse standard expanded diet) and 
water ad libitum unless indicated otherwise. Animals were kept in a 12-hour light- 
dark cycle (0630 to 1830 light) at 20°C ± 1°C and 50% humidity.
For the preparation of the activation systems used in the Ames test, rats were treated 
with the appropriate cytochrome P450-inducing agent. For mixed CYP1A/CYP2B
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induction, animals were treated with a single intraperitoneal (i.p.) injection of 
Aroclor 1254 (500 mg ml“  ^ in com oil) at a dose of 500 mg kg"  ^ body weight. 
Animals were killed by cervical dislocation on the fifth day following treatment. 
For the induction of CYP2E1, animals were dosed for 3 consecutive days by gavage 
with isoniazid (100 mg kg“* body weight, dissolved in distilled water). Animals 
were fasted for 24 hours after the final treatment, and killed by cervical dislocation. 
Induction of CYP3A was achieved by treatment with dexamethasone (in distilled 
water) for 3 consecutive days by gavage at 100 mg kg“  ^ bodyweight. Induction of 
CYP4A was achieved by treatment with clofibrate (in 0.9% saline) for 3 
consecutive days by i.p. injection at 80 mg kg“  ^bodyweight.
2.2.2 Preparation o f  subcellular fractions
Hepatic subcellular fi*actions were prepared essentially as described by loannides & 
Parke (1975). All equipment and solutions were sterilised by autoclaving at 120°C 
for 20 minutes prior to use. Animals were killed by cervical dislocation, the livers 
excised and immediately washed in chilled, sterile KCl (1.15%, w/v) on ice to 
remove excess blood. Livers were blotted dry and weighed before scissor-mincing 
in 1-2 volumes of chilled KCl. The minced livers were then homogenised on a bed 
of ice using a motor-driven Potter-Elvehjem-type homogeniser (size ‘C’ glass 
vessel, Philip Thomas, Philadelphia, PA., USA) with Teflon™ pestle. The 
homogenate was adjusted to 25% (w/v) by further addition of chilled KCl. Finally, 
the homogenate was briefly homogenised again to ensure homogeneity before 
centrifugation at 9,000g for 20 minutes at 4°C (Beckman J2-21 high-speed 
centrifuge, JA-17 angle-head aluminium rotor). The supernatant (post- 
mitochondrial or S9 fraction) was decanted off, aliquots (2 ml) of which were stored 
at -20°C until required.
Microsomal and cytosolic fractions were prepared from the S9 fraction by 
ultracentrifugation at 105,000g for 60 minutes at 4°C (Beckman L7 Ultracentrifuge, 
TI 70.1 angle-head titanium rotor). The cytosolic fraction (supernatant) was 
aspirated and stored at -20°C until required. The microsomal fraction (pellet) was
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resuspended in an equal volume of chilled KCl using a motor-driven Potter- 
Elvehjem-type Teflon™ homogeniser.
2.2,3 The Ames Salmonella mutagenicity assay
Mutagenicity was determined by the Ames Salmonella mutagenicity assay, 
essentially as described by Maron & Ames (1983). All consumables and heat-stable 
solutions were previously autoclaved at 120°C for 20 minutes, and all procedures 
were performed in a class 2 safety cabinet (BioMAT, Medical Air Technology, 
Manchester, UK). Bacterial cultures were grown overnight in Oxoid nutrient broth 
No. 2 (25 mg ml"*).
2.2.3.1 Bacterial tester strains
Salmonella typhimurium strains were stored as permanent frozen cultures at -80°C, 
incorporating DMSG as a cryopreservative (90 pi in 1 ml of bacterial overnight 
culture). Working cultures were prepared by inoculating nutrient broth, for TA1530, 
or nutrient broth containing ampicillin (25 pg ml"*) for all other, plasmid-containing 
strains, with a bacterial colony picked from master plates using a flame-sterilised 
nickel-chromium wire loop. Inoculated broth was incubated in a shaking water bath 
at 37°C for 12 hours overnight.
2.2.3.2 Testing for strain characteristics
Each frozen permanent culture was routinely tested for viability and spontaneous 
reversion rate to ensure that all strain characteristics were maintained. All tests were 
performed in triplicate.
Histidine requirement
Tester strains have lesions in the his operon, rendering them unable to synthesise 
histidine, thus requiring histidine in the culture medium to grow. High histidine- 
biotin solution (100 pi, O.I M histidine/0.5 mM biotin) was spread over the surface 
of a Vogel-Bonner E plate using a sterile disposable plastic spreader. Bacterial 
culture ( 1 0 0  pi) was then streaked over the plate using a flame-sterilised nickel-
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chromium wire loop. Bacterial culture was also streaked over histidine-free plates. 
Plates were incubated at 37°C for 24 hours. The presence of bacterial colonies/lawn 
on the histidine plates only indicated that the his mutation was intact.
The rfa mutation and the R-factor
Bacterial culture (100 pi) was added to high-histidine top agar (2 ml, 0.6% 
agar/0.5% NaCl containing 5 mM histidine and 25 pM biotin), briefly vortexed, and 
poured onto a Vogel-Bonner E plate. Once the top agar had solidified, a sterile filter 
paper disc (1 cm diameter) was placed in the centre of the plate. To test for the rfa 
mutation, crystal violet (50 pi, 1 mg ml“* solution) was dispensed onto the filter 
disc. To test for the R-factor (by ampicillin resistance), ampicillin (50 pi, 8  mg ml“  ^
solution in 20 mM NaOH) was dispensed onto the filter disc. Plates were incubated 
at 37°C for 24 hours. The presence or the absence of a clear zone of inhibition 
around the filter disc (i.e. no bacterial growth) indicated the presence of the rfa 
mutation or the R-factor respectively.
Bacterial viabilitv
To ensure sufficient viable bacteria, overnight culture was serially diluted to 1 in 
10^  with nutrient broth. Diluted culture (100 pi) was then added to high-histidine 
top agar (2 ml), mixed, and poured onto Vogel-Bonner E plates. Plates were 
incubated at 37°C for 24 hours, and the total number of colonies counted so that the 
viability (number of bacteria per ml) of the original culture could be calculated.
Spontaneous reversion rate
The spontaneous reversion rate, the frequency of reversion of the histidine mutation 
which occurs spontaneously, i.e. in the absence of any mutagen, is characteristic for 
each tester strain. This was determined by incorporating bacterial culture (100 pi) 
into low-histidine top agar (2 ml, 0.6% agar/0.5% NaCl containing 50 pM histidine 
and 50 pM biotin), mixing and pouring as above, then incubating at 37°C for 48 
hours. The spontaneous reversion rate is independent of the initial number of 
bacterial cells plated, within the approximate limits of 1 0  ^to 1 0  ^cells.
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2.2.3.3 Determination o f mutagenic activity using the plate incorporation method
Fresh overnight bacterial culture (100 pi) was added to sterile, capped 10 ml 
polystyrene tubes containing low-histidine top agar ( 2  ml) and the test mutagen ( 1 0 0  
pi). To assess direct mutagenicity, the tubes were then mixed and poured onto 
Vogel-Bonner E plates. To assess indirect mutagenicity, an activation system (500 
pi, see below), usually derived from rat hepatic S9 fraction, was added immediately 
before mixing and pouring. Tubes were held at 45°C until pouring in order to 
maintain the fluidity of the top agar. Plates were then incubated at 37°C for 48 
hours, and revertant colonies counted manually using a Gallenkamp colony counter. 
All experiments were carried out in triplicate unless indicated otherwise.
2.2.3.4 Determination o f mutagenic activity using the pre-incubation method
Fresh overnight bacterial culture (100 pi) was added to tubes containing activation 
system (500 pi) and test mutagen (100 pi), mixed and then incubated in a shaking 
water bath at 37°C for various time intervals, as required. Once the pre-incubation 
period had ended, low-histidine top agar ( 2  ml) was added, the contents of the tube 
mixed, then poured onto Vogel-Bonner E plates. Plates were incubated at 37°C for 
48 hours, and revertant colonies counted manually using a Gallenkamp colony 
counter. All experiments were carried out in triplicate unless indicated otherwise.
2.2.3.5 The activation system
Subcellular fractions were prepared as described above (section 2.2.2), and the 
activation system (1 0 %, v/v) prepared as follows:
subcellular fraction (25%, w/v) 10%
KCl/MgCb solution (0.33 M/0.08 M) 20%
phosphate buffer (0.2 M, pH 7.4) 50%
co-factor solution 2 0 %
The standard co-factor solution contained glucose-6 -phosphate (5 mM) and NADP 
(4 mM) in phosphate buffer (0.2 M, pH 7.4), and was filter-sterilised before use.
37
Chapter 2 : Materials and methods
Note that when microsomal fraction was used in place of S9 fraction in the mixture, 
the system was supplemented with glucose-6 -phosphate dehydrogenase (lU per 
plate), this being a cytosolic enzyme.
2.2,4 Protein determination
Protein concentrations in subcellular fractions were measured relative to bovine 
serum albumin standard (fraction V) by the spectrophotometric method of Lowry et 
al (1951).
Protein standards were prepared, by diluting the BSA stock solution (500 pg ml”*, 
in 0.5 M NaOH) with NaOH (0.5 M), to give a range from 0 to 200 pg protein. 
Suitable dilutions of the samples were also prepared by diluting with NaOH (0.5 
M). Freshly-prepared copper reagent (5 ml) was added to all tubes, and after 
mixing, the tubes were left to stand at room temperature for 10 minutes. The copper 
reagent comprised sodium carbonate (2 %, w/v), sodium potassium tartrate (2 %, 
w/v), and copper sulphate (1 %, w/v) solutions, mixed in a ratio of 1 0 0 :1:1  
respectively.
Folin and Ciocalteu’s phenol reagent was diluted 1 in 2 with distilled water before 
an aliquot (0.5 ml) was added to each tube, followed by immediate mixing. 
Standards and samples were then left to stand at room temperature for 30 minutes 
before measuring A720. All measurements were performed in triplicate (Shimadzu 
1201 UV-VIS spectrophotometer or Kontron Instruments Uvikon 932 dual-beam 
spectrophotometer), and the protein concentrations determined from the standard 
curve.
2.2.5 Determination o f  phase Ixenobiotic-metabolising enzyme activity
2.2.5.1 Fluorimetric determination o f alkoxy-0-resorufin dealkylase activity
The 0-dealkylation of methoxy-, ethoxy-, and pentoxyresoruftns was determined 
fluorimetrically by monitoring the generation of resorufrn. These methods were 
based on those described by Burke & Mayer (1974), and Lubet et al (1985). These
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chemical probes can be used as selective markers of CYP1A2, CYPlAl, and 
CYP2B activities respectively (Lubet et a l, 1985; Namkung et a l, 1988).
The following reagents were added to a polystyrene fluorimeter cuvette and mixed 
by inversion:
Tris-HCl buffer (0.1 M, pH 7.8) at 37°C 2 ml
7-ethoxyresorufin (0.5 mM in 70% EtOH) 10 pi
microsomal suspension (25%, w/v) 50 pi
After establishing a baseline, the microsomal reaction was initiated by the addition 
of NADPH (10 pi, 50 mM in 1% NaHCOs), and the increase in fluorescence 
monitored at 510 nm (^%) and 586 nm (A,em)- A calibration curve was constructed by 
serially adding aliquots (10 pi) of resorufrn (0.1 mM in 70% EtOH) to an incubation 
mixture comprising all components, except substrate, and recording the 
fluorescence. The initial rate of resorufrn generation was calculated from the 
standard curve by measuring the rate of change in fluorescence produced by the 
sample incubation (i.e. the slope of the trace).
Fluorimetry was carried out on a Perkin Elmer LS5 Luminescence Spectrometer 
(slit settings were 10 nm and 2.5 nm, excitation and emission, respectively) 
connected to a Perkin-Elmer 561 chart recorder. Concentrations of alternative 
substrates were 0.5 mM (methoxyresorufrn) and 0.1 mM (pentoxyresorufrn).
2.2.5.2 Aniline 4-hydroxylase activity
The 4-hydroxylation of aniline, which results in the formation of 4-aminophenol, 
estimated colourimetrically by the indophenol reaction, is used as a marker for 
CYP2E1 activity. The procedure was based on that described by Nakanishi et al 
(1971).
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Incubations contained the following:
Tris-HCl buffer (50 mM, pH 7.8) 0.9 ml
aniline hydrochloride (50 mM, pH 7.0) 0.5 ml
cofactor solution* 0 .1 ml
microsomal suspension (25%, w/v) 0.5 ml
*Cofactor solution comprised NADP (20 mM), glucose-6 -phosphate (200 mM), and 
glucose-6 -phosphate dehydrogenase (10 U ml"^) in MgCb (0.1 M).
Samples were incubated at 37°C in a shaking water bath for 15 minutes, then the 
reactions stopped by placing the tubes on ice, followed by the addition of solid 
NaCl (approx. 1 g). Diethyl ether (10 ml) was added to each tube, and the 4- 
aminophenol extracted for 10 minutes on a rotary mixer. Aliquots of the ether phase 
(5 ml) were added to alkali phenol reagent (4 ml, 0.5 M tripotassium 
orthophosphate containing 1%, w/v, phenol) and extracted for a further 1 0  minutes. 
Samples were allowed to stand at room temperature for 1 hour to allow the colour to 
develop, before reading Agio of the ether phase. Suitable 4-aminophenol standards 
(0 - 2 0 0  nmol) and blanks were also carried through the procedure.
2.2.5.3 Erythromycin Fi-demethylase activity
The A-demethylation of erythromycin results in the production of formaldehyde, 
which can be estimated colourimetrically, and this reaction is catalysed 
predominantly by the CYP3A sub-family. The method was essentially that of 
Wrighton et al (1985).
Incubation mixtures contained the following:
phosphate buffer (50 mM, pH 7.25) 600 pi
MgCl2 (0.15 M) 100 pi
erythromycin (10 mM in phosphate buffer) 100 pi
microsomal suspension (25%, w/v) 100 pi
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Mixtures were pre-incubated at 37°C in a shaking water bath for 3 minutes. The 
reaction was initiated by the addition of NADPH (10 mM in 1% NaHCOs), 
followed by further incubation for 10 minutes. The reaction was terminated by the 
addition of ice-cold TCA (0.5 ml, 12.5%, w/v), and the tubes placed on ice for 5 
minutes. The tubes were then centrifuged at 2,000g for 10 minutes at 4°C (Beckman 
J6  centrifuge, JS 4.2 swinging bucket rotor) to remove protein.
Aliquots of the deproteinised supernatant (1 ml) were added to freshly-prepared 
Nash reagent (1 ml), and after mixing, incubated at 37°C in a shaking water bath for 
40 minutes to allow the colour to develop. Nash reagent comprised ammonium 
acetate (4 M) containing acetylacetone (4 ml“ )^. After allowing to cool to room 
temperature, A412 was measured (Kontron Instruments Uvikon 860 dual-beam 
spectrophotometer). Suitable blanks and formaldehyde standards (0-100 nmol) 
were carried through the procedure, without the addition of NADPH.
2.2.5.4 Laurie acid hydroxylase activity
Laurie acid hydroxylase activity is an indicator of CYP4A1 activity (Tamburini et 
al, 1984), and this assay was based on that described by Parker & Orton (1980).
Incubation mixtures contained the following:
Tris-HCl buffer (50 mM, pH 7.4) 1.5 ml
lauric acid (1 mM in MeOH) 200 pi
"^^ C-lauric acid (10 mCi ml” )^ 10 pi
microsomal suspension (25%, w/v) 200 pi
Tubes were pre-incubated at 37°C in a shaking water bath for 3 minutes. The 
reaction was initiated by the addition of NADPH (10 mM in 1% NaHCO]), 
followed by further incubation for 10 minutes. The reaction was terminated by the 
addition of HCl (200 pi, 3 M), followed by the addition of diethyl ether (10 ml). 
The contents were vortex-mixed then extracted for 10 minutes on a rotary mixer.
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Following centrifugation at 2,000g for 10 minutes at 4°C (Beckman J6 ) to separate 
the phases, the ether phase was aspirated into a fresh glass test tube and evaporated 
to dryness under nitrogen. The residue was dissolved in methanol (50 pi), an aliquot 
of which (30-40 pi) was spotted onto a glass silica TLC plate. Plates were 
developed in a 70:28:1.5 mixture of hexane, diethyl ether, and acetic acid, 
respectively. Radioactivity was measured by scanning each lane of the TLC plate 
for 5 minutes (Berthold LB 2842 Automatic TLC Linear Analyser, Berthold 
Chroma analytical software). Suitable blanks (without the addition of NADPH) and 
an hepatic microsomal sample (clofibrate-induced) as a positive control were 
carried through the same procedure.
2,2,6 Determination o f  phase IIxenobiotic-metabolising enzyme activity
2.2.6.1 UDP-Glucuronyl transferase activity using 2-aminophenol as substrate
The UDP-glucuronyl transferase enzymes catalyse the glucuronidation of functional 
groups, such as hydroxyl groups, in the presence of UDP-glucuronic acid (UDP- 
GlcA). This procedure was adapted from that described by Gibson & Skett (1994), 
based on the method of Winsnes (1969).
An aliquot of cofactor solution (1 ml) was added to 2-aminophenol solution (0.5 ml, 
1 mM), and the reaction initiated by the addition of microsomal suspension (0.5 ml, 
25%, w/v). Samples were incubated at 37°C in a shaking water bath for 30 minutes. 
Cofactor solution comprised 0.1 M Tris-HCl buffer, pH 8.0 ( 8  ml), 0.15 M MgCli 
(1 ml), 1% (w/v) Triton X-100 (0.5 ml), 20 mM ascorbic acid (1 ml), and UDP- 
GlcA (10 mg). The reaction was terminated by the addition of ice-cold 
trichloroacetic acid (1 ml, 20%, w/v, in 0.1 M phosphate buffer, pH 2.7). After 
allowing to stand on ice for 5 minutes, samples were centrifuged at 2,000g for 10 
minutes at 4°C (Beckman J6 ) to remove protein. Fresh sodium nitrite (0.5 ml, 0.1%, 
w/v) was added to the supernatant ( 1  ml), mixed well, and allowed to stand for 2  
minutes at room temperature. Ammonium sulphamate (0.5 ml, 0.5%, w/v) was 
added, mixed, and allowed to stand at room temperature for a further 3 minutes. N- 
Naphthylethylene diamine (0.5 ml, 0.1%, w/v) was then added, and after mixing.
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the samples were allowed to stand in the dark at room temperature for 60 minutes to 
allow the colour to develop.
Absorbance was read at 540 nm against the substrate blank, and the concentration of 
the glucuronide product estimated by reference to a standard curve constructed 
using aniline (0.1 mM in 6 %, w/v, TCA) as the standard (0-100 nmol), a 
chromophore with similar properties to the glucuronide, which was not readily 
available. Absorbance was measured using a Uvikon 932 dual-beam 
spectrophotometer (Kontron Instruments).
2.2.6.2 UDP-Glucuronyl transferase activity using 1-naphthol as substrate
This assay was based on those described by Bock & White (1974), MacKenzie & 
Hânninen (1980), and Snegaroff & Jamet (1985). The isoform (UGT1A6) that 
catalyses the glucuronidation of 1 -naphthol is responsible for the glucuronidation of 
small, planar phenolics (Bock, 2002).
Incubation mixtures contained the following:
phosphate buffer (50 mM, pH 7.25, in 5 mM EDTA) 750 pi
MgClz (100 mM) 50 pi
1-naphthol (0.5 mM) 100 pi
microsomal suspension (25%, w/v) 50 pi
Tubes were pre-incubated at 37°C in a shaking water bath for 5 minutes. The 
reaction was initiated by the addition of UDP-GlcA (50 pi, 20 mM), followed by 
further incubation for 5 minutes. The reaction was terminated by the addition of 0.4 
M TCA/0.6 M glycine, pH 2.2 (1 ml), and placed on ice for 5 minutes. Samples 
were then extracted with chloroform ( 1 0  ml) for 1 0  minutes on a rotary mixer, and 
centrifuged at 2,000g for 10 minutes at 4°C (Beckman J6 ) to separate the phases 
and remove protein.
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An aliquot (1 ml) of the aqueous phase was added to NaOH (2 ml, 0.45 M) in a 
quartz fluorimeter cuvette, mixed by inversion, and the fluorescence read at 293 nm 
(A<ex) and 335 nm (A.em)- Blanks were prepared by stopping the reaction at time zero. 
A standard curve was constructed using 1 -naphthol-a-glucuronide from 0 to 20 
nmol m r \  Fluorimetry was carried out using a Perkin-Elmer LS5 Luminescence 
Spectrometer (slit settings were 10 nm and 5 nm, excitation and emission, 
respectively) connected to a Perkin-Elmer 561 chart recorder.
2.2.6.3 Sulphotransferase activity using 2-naphthol as substrate 
This assay was based on the method of Sekura & Jakoby (1979).
Incubation mixtures contained the following:
phosphate buffer (0.1 M, pH 7.4) 100 pi
2-naphthol (1 mM in acetone, 5%, v/v) 100 pi
2-mercaptoethanol (0.1 M in phosphate buffer) 20 pi
PAPS (2 mM in phosphate buffer) 40 pi
The reaction was initiated by the addition of cytosolic fraction (100 pi, 25%, w/v), 
and the mixtures incubated at 37°C in a shaking water bath for 30 minutes. The 
reaction was terminated by the addition of methylene blue (0.5 ml, 0.025%, w/v, 
containing concentrated H2SO4, 1%, v/v) and chloroform (2 ml). Samples were 
extracted for 1 0  minutes on a rotary mixer before centrifuging at 2 ,0 0 0 g for 1 0  
minutes at 4°C (Beckman J6 ) to separate the phases and remove protein.
The (lower) chloroform layer was transferred to a fresh tube containing anhydrous 
sodium sulphate (50-100 mg). The absorbance of the chloroform layer was then 
read at 651 nm using a glass or quartz cuvette (Kontron Instruments Uvikon 860 
dual-beam spectrophotometer). The concentration of the sulphate product was 
calculated relative to a standard curve constructed using 1 -naphthol sulphate, or 
alternatively, by assuming that 1 0  nmol of 1 -naphthol sulphate carried through the 
procedure yield an Agsi of 0.3 (Sekura & Jakoby, 1979).
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2.2.6.4 Determination o f glutathione ^-transferase activity
This was determined as described by Habig et al. (1974), employing 2 substrates, 
3,4-dichloronitrobenzene (DCNB) and 1 -chloro-2,4-dinitrobenzene (CDNB). The 
activities observed in these assays are composite results of the activity of each GST 
isozyme present in the tissue preparation (Gibson & Skett, 1994).
(a) Using DCNB as substrate
Cytosol (25%, w/v) was diluted 1 in 4 with KOI (1.15%). The following were mixed 
in 2  cuvettes:
test reference
phosphate buffer 1 . 8  ml 1.9 ml
DCNB 0 . 1  ml 0 . 1  ml
GSH (25 mM) 0.5 ml 0.5 ml
After establishing a baseline, the reaction was initiated by the addition of diluted 
cytosol (0 . 1  ml) to the test cuvette, mixed thoroughly by inversion, and the 
absorbance change at 345 nm followed over a 5-minute time period. Enzyme
activity was calculated using 8  = 8.5 mM"  ^ cm“  ^ for the nitrophenyl-glutathione 
conjugate.
(b) Using CDNB as substrate
Cytosol (25%, w/v) was further diluted to 1 in 100 with KCl (1.15%), and the 
following mixed in 2  cuvettes:
test reference
phosphate buffer 1 . 8  ml 1.9 ml
CDNB 0 . 1  ml 0 . 1  ml
GSH (5 mM) 0.5 ml 0.5 ml
After establishing a baseline, the reaction was initiated by the addition of diluted 
cytosol (0 . 1  ml) to the test cuvette, mixed thoroughly by inversion, and the 
absorbance change at 340 nm followed over a 5-minute time period. Enzyme
activity was calculated using 8  = 9.6 mM“  ^ cm“* for the dinitrophenyl-glutathione 
conjugate.
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In each case, activity was monitored using a Uvikon 932 dual-beam 
spectrophotometer (Kontron Instruments). The dilutions described above are 
applicable to hepatic cytosolic fraction, and may require adjusting for extrahepatic 
cytosolic fractions.
2.2.6.4 Epoxide hydrolase activity
The fluorimetric determination of the hydrolysis of benzo[a]pyrene-4,5-epoxide to 
benzo[a]pyrene-4,5-dihydrodiol, mediated by microsomal epoxide hydrolase, was 
based on the procedure described by Dansette et al (1979).
The following reaction mixture was prepared in a fluorimeter cuvette:
Tris-HCl buffer (15 mM, pH 8.7) at 37°C 2 ml
microsomal suspension (25%, w/v) 50 pi
benzo[fl]pyrene-4,5-epoxide (2 mM in acetonitrile) 10 pi
The contents were mixed by inversion, and the increase in fluorescence with time 
monitored at 310 nm (lex) and 385 nm (lem) (Perkin Elmer LS5 Luminescence 
Spectrophotometer, slit settings at 5 nm and 2.5 nm, excitation and emission, 
respectively, connected to a Perkin-Elmer 561 chart recorder). A calibration curve 
was constructed by serially adding aliquots (10 pi) of benzo[a]pyrene-4,5- 
dihydrodiol (2 mM in acetonitrile) to an incubation mixture comprising all 
components, except substrate, and recording the fluorescence. The initial rate of 
reaction was calculated from the standard curve by measuring the rate of change in 
fluorescence produced by the sample incubation (i.e. the slope of the trace).
2,2,7 Electrophoresis and Western blotting o f  microsomal proteins
2.2.7.1 SDS-PAGE
The separation of microsomal proteins was achieved by SDS-PAGE, based on the 
method described by Laemmli (1970). Vertical slab gel apparatus (Mini-Protean II, 
Bio-Rad) was used for electrophoresis. Gels were cast between glass plates clamped
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in place, separated by plastic spacers. Dimensions of the gels were 73 mm x 80 mm 
X 1 mm. Prior to use, the glass plates were washed with detergent, thoroughly rinsed 
with RO water, then cleaned with 70% ethanol and left to dry. The cassettes were 
assembled and clamped vertically.
The resolving (lower) gel (12%, w/v) was prepared by mixing the following:
Milli-Q water 3.55 ml
resolving gel buffer 4.5 ml
acrylamide (30%) 7.5 ml
bis-acrylamide (2 %) 2.95 ml
TEMED* 18 pi
*TEMED, N N N  'N  -tetramethy lethy lenediamine
Resolving gel buffer comprised Tris-HCl (1.5 M, pH 8 .8 ) containing SDS (0.4%, 
w/v). Polymerisation was initiated by the addition of freshly-prepared ammonium 
persulphate solution (180 pi, 10%, w/v). After mixing, the gel was pipetted into the 
apparatus up to the indicator line, and a layer of water added to ensure a flat 
interface between the upper and lower gels. After the gel had set, the water was 
poured off, and excess removed with filter paper, taking care not to touch the 
surface of the gel.
The stacking (upper) gel (4%, w/v) was prepared by mixing the following:
Milli-Q water 6.9 ml
stacking gel buffer 2.5 ml
acrylamide (30%) 1 ml
bis-acrylamide (2 %) 0.4 ml
TEMED 1 0  pi
Stacking gel buffer comprised Tris-HCl (0.5 M, pH 6 .8 ) containing SDS (0.4%, 
w/v). Again, polymerisation was initiated by the addition of ammonium persulphate 
(50 pi), and after mixing, pipetted onto the lower gel. A Teflon™ comb was inserted
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into the upper gel in order to form the sample wells. After the gel had set, the 
apparatus was placed into the tank full of electrode buffer and the comb removed. 
Electrode buffer comprised Tris-HCl (25 mM, pH 8.3) containing glycine (192 
mM) and SDS (0.1%, w/v).
Samples were diluted with an equal volume of loading buffer and heated for 5 
minutes at 95-100°C in a water bath or kettle, briefly centrifuged (8,000g in a 
benchtop centrifuge), then loaded into the wells using long-ended pipette tips. 
Loading buffer consisted of 0.5 M Tris-HCl, pH 6 . 8  (1.2 ml), glycerol (960 pi), 
10% (w/v) SDS (1.92 ml), p-mercaptoethanol (480 pi), and 0.05% (w/v) pyronin Y 
(600 pi) in Milli-Q water (4.8 ml). Electrophoresis was carried out immediately 
after loading the samples using a Bio-Rad Power Pac 300 power pack at a constant 
current of 40 mA and a voltage of 120 V. When the pink band of the loading buffer 
had nearly reached the bottom of the gel, the power was switched off. The cassette 
was removed from the electrophoresis tank, the glass plates separated, and the 
stacking gel discarded.
Proteins were transferred electrophoretically to nitrocellulose paper according to the 
method of Towbin et al (1979). The resolving gel was transferred to the blotting 
apparatus and soaked in transfer buffer for at least 1 0  minutes to allow equilibration. 
The gel was then placed in the transfer cassette facing a nitrocellulose sheet 
(Hybond ECL), and sandwiched between sheets of filter paper and Scotchbrite’'' ,^ 
all of which had also been pre-soaked in transfer buffer. Assembly of the cassette 
was performed in transfer buffer, ensuring air bubbles were excluded from the 
assembly (see Figure 2.1). Transfer buffer comprised Tris-HCl (16 mM, pH 8.3) 
containing glycine (120 mM) and methanol (20%, v/v).
The cassette was placed into transfer buffer in the electrophoresis tank. Transfer was 
carried out at a constant current of 100 mA and a voltage of 120 V for 16 hours 
overnight. Following transfer, the cassette was dismantled and the nitrocellulose 
membrane allowed to dry. The membrane was either wrapped in cling-film and 
stored at 4°C until detection (for up to 2 weeks), or used for detection immediately.
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Scotchbrite pad
2 x 3  mm filter paper 
gel
nitrocellulose membrane 
2 x 3  mm filter paper
Scotchbrite pad
Figure 2.1 Schematic representation of transfer cassette construction. Direction of protein 
migration is indicated by the arrow, fi*om the cathode to the anode.
2.2.7.2 Immunodetection and visualisation
Following incubation in blocking reagent (5%, w/v, non-fat dried milk powder, 
purchased locally, in TBS-T) for 1 Vi hours and subsequent washing, the membrane 
was incubated with the primary antibody (at the appropriate dilution) for 1 hour. 
TBS-T contained Tween 20 (0.1%, v/v) in TBS, pH 7.6 (20 mM Tris, 137 mM 
NaCl). Following a second wash, the membrane was incubated with diluted 
secondary antibody for a further hour. Primary and secondary antibodies were 
diluted with 1% (w/v) non-fat dried milk powder in TBS-T. Excess antibody was 
removed by further washing, before incubation with the detection reagents. The 
membrane was then exposed to Polaroid film to visualise the protein bands (ECL 
mini-camera). Membranes were re-exposed for various time periods as required to 
improve the image obtained.
Images were captured and quantitated using LlSCap image capture utility software 
and ImageMaster® TotalLab image analysis software via an ImageMaster® VDS 
imaging system (Pharmacia Biotech).
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CHAPTER 3
THE EFFECTS OF TEA CONSUMPTION ON PHASE I 
AND PHASE II XENOBIOTIC-METABOLISING 
ENZYMES IN THE SMALL INTESTINE OF THE RAT
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3.1 Introduction
The cytochrome P450 superfamily has the predominant role in the phase I 
metabolism of xenobiotics, with over 40 isoforms being expressed in the rat, the 
highest levels of expression and greatest number of forms occurring in the liver 
(Nelson et a l, 1993). However, extrahepatic P450 expression is also important 
because of the potential to regulate organ-specific effects such as toxicity (Zhang et 
al, 1996), P450 enzymes being present in a variety of other tissues (e.g. liver, 
kidney, gut, brain, lung) in which several isozymes may be expressed 
simultaneously (Gushchin et a l, 1999). Recently, the small intestine has been 
increasingly recognised as a potential site for drug metabolism, the intestine being a 
major route of absorption of orally-dosed xenobiotics, and contributes substantially 
to the first-pass metabolism effect (Emoto et a l, 2000a).
3.1.1 Xenobiotic-metabolising enzymes in the small intestine
The intestinal wall acts as a biological barrier and protects, at least in part, against 
xenobiotics, as it limits the uptake and bioavailability of chemicals such as drugs 
(Lampen et a l, 1998). The gastrointestinal (GI) epithelium represents a primary 
route of entry into the systemic circulation, and as a consequence, the epithelial cells 
(enterocytes) are directly subject to xenobiotic and dietary influences (Rosenberg, 
1991a, 1991b). These cells have thus developed a highly active system for 
metabolising such xenobiotics, and the principal hepatic phase I and II enzymes are 
also present in the intestinal mucosa, including various P450 isoforms, UGT and 
GST enzymes, and epoxide hydrolase (Rosenberg, 1991b). Therefore, intestinal 
biotransformation of xenobiotics can influence the systemic uptake and resultant 
metabolic profile of ingested chemicals, and this is sometimes referred to as 
‘intestinal extraction’ (Lampen et a l, 1998). The complement of intestinal P450s is, 
however, more restricted than hepatic forms, reflecting different regulation of P450s 
between the two tissues (Zhang et a l, 1996). In addition, expression and 
inducibility of both phase I and phase II enzymes vary with age in the rat, thus 
contributing to patterns of genotoxic injury observed in the small intestine (Patel et 
al, 1998).
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3.1.1.1 Intestinal phase I  enzymes
Since the intestinal mucosa is exposed to a diversity of xenobiotics, including plant 
toxins, food additives, drugs, and carcinogens, it is reasonable to suspect that the 
intestinal xenobiotic-metabolising system plays an important role in the pathways of 
detoxication (Kobayashi et al, 1998).
The P450s of the small intestinal epithelial cells are particularly important because 
these cells provide the first exposure of many orally-ingested xenobiotics to phase I 
metabolism. There is growing evidence that P450s in enterocytes, particularly the 
CYP3A sub-family, contribute significantly to first-pass metabolism and oral 
bioavailability of many drugs and chemicals, though the total amount of P450s in 
enterocytes is much lower than in the liver (Gushchin et a l, 1999). The extended 
length of the small intestine, and the villi of the mucosal surface both serve to 
enhance greatly the metabolic capacity of the relatively low levels of small 
intestinal P450s (Zhang et a l, 1996). Also, in addition to dietary constituents, the 
short life-span of villous enterocytes ( 2  days in the rat) may affect the capacity of 
intestinal P450s (Kaminsky & Fasco, 1992).
A role for colonic P450 has been suggested in bowel cancer (Rosenberg, 1991a), 
and differences in P450 isozyme composition can affect the ultimate fate of ingested 
chemicals, including procarcinogens and mutagens. Thus there exists a balance 
between bioactivation/detoxication and subsequent elimination of xenobiotics, a 
balance that may be affected by such xenobiotics. For example, 2-naphthoflavone 
(BNF) has been shown to induce CYPlAl in the small intestine, while 
phénobarbital has been shown to increase selectively CYP2B1 levels, including 
mRNA levels (Bonkovsky et a l, 1985; Foster et a l, 1986).
Several CYP isozymes, including lA l, 2B1, 2B2, 2A1, 3A1, and 3A2, among 
others, have been detected in rat enterocytes by measurements of enzyme activity. 
Western and Northern blotting, and by RT-PCR (Gushchin et a l, 1999), whereas 
CYP4A and 2E1 have been probed for, but not detected. CYP1A2 has been detected 
at the mRNA level by RT-PCR, but the low level of transcription did not result in 
its detectable translation. CYP2C6 and 2C11 have also been detected, previously
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reported as undetectable, the discrepancy probably due to the availability of more 
sensitive detection techniques (Zhang et a l, 1996). However, the low level of 
CYP2C11 is particularly noteworthy, this being the major form present in the livers 
of untreated rats (Guengerich et a l, 1982). CYP2J4, a member of the recently- 
identified CYP2J sub-family, is expressed predominantly in enterocytes in the rat. 
In addition, CYP2J1 mRNA and 2J6 mRNA are specifically and primarily 
expressed in the small intestine, respectively (Zhang et a l, 1999a).
Immunoblotting has also confirmed the inducibility of intestinal P450s (Fasco et al, 
1993), and several activities associated with CYPlAl, 2B1, and 3A have been 
demonstrated to be inducible in rat enterocytes by a variety of xenobiotics 
(Kaminsky & Fasco, 1992). In addition, CYP2E1 has also been shown to be 
inducible in enterocytes by ethanol, possibly a post-translational effect (Zhang et 
al, 1996), and CYP2J4 by pyrazole (also an inducer of CYP2E1), an effect also 
observed in the liver and the olfactory mucosa (Xie et a l, 2000). Despite typical 
P450 inducers failing to modulate CYP2J levels (BNF, dexamethasone, and 
phénobarbital), pyrazole did significantly induce CYP2J4, probably by mRNA 
stabilisation, and to a lesser extent, protein stabilisation (Zhang et a l, 1999a). 
However, Western blotting and probing by warfarin metabolism failed to 
demonstrate the presence of CYP1A2 in enterocytes following treatment with BNF 
(Fasco et a l, 1993). This chemical appeared to be the most potent in enhancing total 
small intestinal P450 concentrations, including in rats fed standard diets, hence such 
induction probably represents changes from diet-induced levels, rather than from 
constitutive levels (Fasco et a l, 1993).
Unlike the majority of P450s, the regulation of CYP2E1 appears to involve several 
different mechanisms. Starvation, high-fat feeding, and diabetes induce CYP2E1 at 
the post-transcriptional level, the latter by stabilising mRNA. In contrast, cheniical 
inducers have been suggested to stabilise the enzyme itself (Roberts et a l, 1994). 
An investigation into the hepatic and extrahepatic induction of CYP2E1 by ethanol 
(Roberts et a l, 1994) suggested that the enzyme has a very short half-life (< 6  
hours), with levels returning to control from as little as 1 2  hours after cessation of
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ethanol exposure. No changes in hepatic mRNA were observed at any time, 
suggesting a post-translational mechanism of induction.
The induction of intestinal P450s could be expected to be influenced by the route of 
administration of the inducing agent — orally-administered inducers are directly 
taken up by the enterocytes, as opposed to i.p.-administered inducers, though this is 
a contentious issue. For example, CYPlAl activity in the small intestine was shown 
to decrease markedly (i.e. decay of induction) in the 24- to 48-hour period following 
i.p. administration of BNF, far less so when BNF was administered orally (Zhang et 
al, 1996).
The most prominent inducible isoform in rat small intestine is CYPlAl (Fasco et 
al, 1993). This enzyme has the potential to play a protective role against orally- 
ingested PAH carcinogens for several reasons, namely, inducibility by dietary 
components, that the gut is the first metabolic site to which such chemicals are 
exposed, and that metabolism of PAH in the gut may result in the excretion of 
metabolites back into the intestinal lumen, thus preventing their systemic uptake. 
Finally, bioactivation of PAH, and subsequent covalent binding to macromolecules, 
would result in their rapid excretion as the cells are sloughed off (Zhang et a l, 
1996); the short life-span of enterocytes confers a correspondingly short life upon 
intestinal P450-activated adducts with DNA and other enterocyte macromolecules. 
A potential benefit of this is to diminish the carcinogenic consequences of ingested 
procarcinogens. Also, stable metabolites may be absorbed systemically, and hence 
be unlikely to undergo further metabolic activation in what would otherwise be 
target organs (Zhang et a l, 1997). Inducibility of CYPlAl in the small intestine 
also diminishes longitudinally from the duodenum to the ileum (Zhang et a l, 1996).
3.1.1.2 Intestinal phase II enzymes
As previously described in Chapter 1, UGT are divided into two families, UGTl 
and 2; isoforms belonging to UGTl conjugate primarily bilirubin and exogenous 
phenolic compounds, those belonging to UGT2 conjugate mainly endogenous 
substrates, such as steroid hormones and opioids (Bock, 2002). Four types of UGTl 
were detected in the rat small intestine by Kobayashi et al (1998) -  UGTl Al, 1A2,
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1A6, and 1A7. UGT1A7 was the predominant UGTl, both constitutively and BNF- 
induced, compared with UGT1A6 in the liver. UGT1A6 and 1A7 were both shown 
to be inducible by BNF, and both isoforms exhibited a horizontal distribution in the 
intestine. Constitutive expression of UGT1A7 was relatively high, suggesting an 
indispensable role for this enzyme in the maintenance of intestinal homeostasis 
(Kobayashi et a l, 1998).
1-Naphthol is a typical substrate of the phenol-type isoforms of the UGTl family. 
Its glucuronidating activity was distributed mainly in the duodenum and proximal 
region of the small intestine, and induction by BNF via the GI tract was stronger in 
the duodenum and proximal small intestine than in the liver. These findings suggest 
that the small intestine is highly responsive to ingested PAH, and that 
glucuronidation of such compounds occurs primarily in the duodenum and proximal 
small intestine (Bock, 2002; Kobayashi et a l, 1998).
Also previously described in Chapter 1, SULT enzymes are broadly divided into 
two classes, based on substrate preference, phenol SULT and hydroxysteroid SULT. 
In addition, efforts to classify these enzymes more precisely based on DNA 
sequences have revealed sex-specific distribution of certain SULT in the rat. The 
male-predominant phenol-type family is designated SULTl, whereas a second 
family, SULT2, comprising the hydroxysteroid-type enzymes, is predominant in 
females (Dunn & Klaassen, 1998). An investigation into the tissue-specific 
expression of SULT in the rat revealed that of the seven known SULT isoforms, 
SULTlB1 was detected at substantial levels in the intestine, both in males and 
females (Dunn & Klaassen, 1998). This enzyme did not display the male-dominant 
expression associated with this type of SULT, implying that the physiological role 
of this isoform is common among both male and female rats. The presence of 
SULTlB1 in the intestine may have important implications in drug metabolism, 
given the importance of the intestine in the deactivation of certain drugs. However, 
SULTlB1 also exhibits activity towards certain endogenous hormones, including 
the thyroid hormones (Sakakibara et al, 1995), hence modulation of hormone or 
neurotransmitter levels may be significant in the role of extrahepatic sulphation. In 
addition, tissue-specific localisation of SULT enzymes may be involved in the
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susceptibility of certain organs to toxic and carcinogenic effects of xenobiotics 
(Dunn & Klaassen, 1998).
Similarly, the GST exist as two enzyme superfamilies; microsomal GST and the 
soluble, cytosolic enzymes, the latter being involved in the detoxication of 
xenobiotics (see Chapter 1). In the rat, the alpha-class GST is the predominant 
family present in the small intestine (Sherratt & Hayes, 2002). Epoxide hydrolase, a 
microsomal enzyme catalysing the hydration of epoxide groups, yielding the 
dihydrodiol (Gibson & Skett, 1994), is also regarded as a phase II enzyme. Each of 
these phase II activities, both hepatic and intestinal, have been shown to be 
inducible by dietary components such as organosulphur compounds, derived from 
allium vegetables (Guyonnet et a l, 1999) and glucosinolate derivatives, derived 
from cruciferous vegetables (Bradfield & Bjeldanes, 1984; Staack et a l, 1998). In 
addition to dietary modulation, Patel et al (1998) observed that GST expression 
varied as a function of maturation, with GSTAl/2 increasing and GSTA4 
decreasing from 27 days post-natal. However, such changes may also be attributable 
to dietary influences following weaning of the animals to a solid diet. UGT 
expression remained constant throughout pre- and post-natal stages of intestinal 
development (Patel et a l , 1998).
3,1,2 Dietary modulation o f  intestinal cytochromes P450
The content and functional activity of intestinal P450s have been shown to be under 
dietary influences in animals and man (Rosenberg, 1991b), and what are considered 
to be ‘basal’ levels of these enzymes may, in fact, result from the ingestion of such 
dietary inducers. Rosenberg (1991b) demonstrated a pronounced elevation in 
intestinal P450 activity in rats fed a standard cereal-based diet compared with rats 
fed a purified diet which simulated the nutrient levels found in the standard diet, 
suggesting the presence of inducing agents in the natural ingredient diet. Substances 
such as indoles and fiavones have been reported to be present in these crude diets, 
and to induce xenobiotic-metabolising enzymes (Wattenberg, 1993). Enzyme 
induction was most prominent in the proximal region of the small intestine, 
extending longitudinally within the GI epithelium to the colon (Rosenberg, 1991b).
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In the same study, CYPlAl was detected (by Western blotting) in the small 
intestine of rats fed standard diet, an enzyme absent from intestinal microsomes 
from animals maintained on the purified diet, suggesting that the shift in isozymic 
profile in this tissue was a consequence of diet. Thus, this study demonstrates the 
exquisite sensitivity of the P450 content of the GI epithelium to dietary 
manipulation — effects which extend to the liver, albeit to a lesser extent 
(Rosenberg, 1991b).
The P450 profile of the rat small intestine has been studied at the gene expression 
level, as well as the protein level. However, in many of these studies, nutritional 
status and diet have not been considered, and thus conflicting data on intestinal 
P450s have emerged (Rosenberg, 1991a). For example, the marked degree of 
enzyme induction by BNF observed in intestinal epithelial cells may reflect 
extremely low true basal levels in rats maintained on a purified diet.
3,1.4 Objectives
The effects of tea consumption on the induction of hepatic phase I (Bu-Abbas et a l, 
1994b, 1999a, and 1999b) and phase II (Bu-Abbas et a l, 1995 and 1998) 
xenobiotic-metabolising enzymes have already been documented. However, since 
the GI tract is likely to be exposed to the highest levels of the inducing components 
ingested in tea, it is pertinent to investigate such effects on the intestinal epithelial 
cells. The present study comprised two investigations. The first examined the 
effects on intestinal xenobiotic-metabolising enzymes in rats following consumption 
of various tea preparations, or of a caffeine solution, as previously employed in the 
studies on hepatic activities {vide supra). The second examined such effects 
following oral administration of two isolated polyphenolic fractions from black tea, 
namely the theaflavins (TF) and the theafulvins (Tfti). In the latter investigation, 
animals were maintained on a special low-polyphenol diet, as one of the co­
objectives of this investigation was to study the urinary metabolites, primarily 
hippuric acid, of these compounds. In the former investigation, animals were 
maintained on a standard cereal-based diet, as used in the previous hepatic studies.
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3.2 Materials and methods
3.2.1 Materials
Male Wistar albino rats (120-150 g) were obtained from the Experimental Biology 
Unit (EBU), University of Surrey (Guildford, Surrey, UK), and housed in the EBU. 
Low-polyphenol ‘CIO’ diet was obtained from B&K Universal Ltd (Hull, East 
Yorks., UK). Caffeine and trypsin inhibitor were purchased from Sigma Chemical 
Co. (Poole, Dorset, UK). Sagatal (6 %, w/v, sodium pentobarbitone solution) was 
purchased from Rhone Mérieux (Harlow, Essex, UK). Theaflavin and theafiilvin 
fractions, prepared from aqueous black tea extracts, were kindly provided by Dr 
Alan Davies (Unilever Research, Colworth House, Shambrook, Beds., UK) and Dr 
Lindsay Mitchell (University of Surrey) respectively. All other materials were 
obtained as described in Chapter 2.
Green tea (Gunpowder), black tea (Keemun), and decaffeinated black tea (Ceylon) 
were purchased locally and stored at 4°C in a sealed plastic bag. Tea infusions 
(2.5%, w/v) were prepared by adding boiling water (400 ml) to the tea leaves (10 g) 
in a Thermos™ flask, allowing to brew for 10 minutes whilst inverting every 30 
seconds, and then filtering through cotton wool to remove the leaves. Infusions were 
stored in the dark at 4°C overnight to allow the tea to cream fully. ‘Creaming’ is the 
term used to describe the precipitation phenomenon that occurs between the 
polyphenols present in tea and the caffeine content as the tea cools, and generally 
occurs below 70°C. This was carried out in order to minimise variations in the 
composition of the infusions consumed by the animals.
3.2.2 Experimental studies
3.2.2.1 Effects o f tea consumption on intestinal phase land  II activities
Six groups, each of four rats, were used. The first group served as control, 
maintained on water, whilst groups two and three were maintained on aqueous 
extracts (2.5%, w/v) of decaffeinated black tea and whole black tea, respectively, 
for 4 weeks. Group four was maintained on an aqueous extract (2.5%, w/v) of 
decaffeinated black tea supplemented with caffeine (700 mg r \  termed
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‘recaffeinated black tea’) and group five on a solution of caffeine (700 mg 1“ )^ as the 
sole source of liquid for 4 weeks. Finally, group six was maintained on aqueous 
green tea extract (2.5%, w/v).
The concentration of caffeine used to supplement the decaffeinated black tea 
(Ceylon), and of the caffeine solution, was based on the levels of caffeine found in 
the whole black tea extract (Keemun), as determined by HPLC analysis in this 
laboratory (Bu-Abbas et a l, 1999b).
Animals were fasted overnight prior to termination by i.p. injection of Sagatal (0.5 
ml), followed by cardiac puncture (Messenger, 2000). Preparation of intestinal 
mucosal homogenate was based on the method described by Vargas & Franklin 
(1997). The upper segment of the small intestine (approx. 25 cm, proximal to the 
pylorus) was excised and flushed several times with chilled buffer (0.15 M KCl in 
0.05 M Tris-HCl, pH 7.6) to remove partially-digested food and excess mucus. The 
intestinal segment was then opened longitudinally on a glass TLC plate, the mucosa 
scraped gently with the edge of a glass microscope slide, and the scrapings placed in 
buffer on ice. The scrapings from each animal within the group were pooled, i.e. the 
final homogenate represented the intestinal mucosae of the four animals in each 
group, and following weighing, were homogenised in buffer to give a 25% (w/v) 
final homogenate. The buffer contained trypsin inhibitor (5 mg g“* tissue, wet 
weight) to inhibit proteolysis by intestinal enzymes.
3.2.2.2 Effects o f black tea polyphenols on intestinal phase land  II activities
Three groups, each of five rats, were used. The first group served as control, 
whereas groups two and three were treated with black tea theaflavins (TF) and black 
tea theafulvins (Tfii) respectively. The dose administered was estimated to represent 
an intake of TF and Tfii equivalent to that received from approximately six cups of 
strong tea per day in a human diet, and scaled down accordingly (Harbowy & 
Balentine, 1997). Animals were treated daily by gavage with solutions of either TF 
(20 mg kg“*) or Tfii (2 mg kg“*) in RO water for 5 days, followed by 2 days without 
treatment, for 28 days. Control animals were gavaged with RO water only. All 
animals were allowed water and low-polyphenol CIO diet ad libitum. The
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ingredients of this purified diet are listed in the Appendix. At the end of this period, 
animals were terminated by cervical dislocation, and pooled intestinal mucosal 
homogenates prepared as described above.
Intestinal mucosal S9 fraction was prepared as described in Chapter 2 for hepatic 
homogenate, and the S9 stored at -80°C until use in the enzyme assays. Microsomal 
and cytosolic fractions were prepared as required from the S9 fraction, also 
described in Chapter 2 for hepatic S9 fraction.
3.2.3 Enzyme assays and Western blotting
Phase I and II xenobiotic-metabolising enzyme assays were performed as described 
in Chapter 2, using pooled microsomal and cytosolic preparations fi*om the 
intestinal mucosae of the animals. Western blotting and immunodetection of 
microsomal cytochrome P450 proteins were also performed as described in Chapter 
2 , using the aforementioned intestinal microsomes.
3.3 Results
3.3.1 Effects o f  tea consumption on intestinal phase 1 activities
3.3.1.1 Activity o f CYP I AI
Figure 3.1 shows the relative activity of CYPlAl in microsomal preparations firom 
the intestinal mucosa, determined by ËROD activity. CYPIA activity in hepatic 
microsomes from untreated animals, included as a positive control, was 12.55 pmol 
min.“  ^ mg“  ^ protein (average of two determinations, differing from the average by 
not more than 1 0 %).
3.3.1.2 Activity o f CYP2EI
CYP2E1 activity, as determined by measurement of microsomal aniline 
hydroxylase activity, was not detectable in the intestinal microsomes from any of 
the groups in the present study. Aniline hydroxylase activity in hepatic microsomes 
from untreated animals, included as a positive control, was 0.7 pmol min.”  ^ mg”^
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protein (average of duplicate determinations, differing from the average by not more 
than 10%).
3.3.1.3 Activity o f GYP 3A
Figure 3.2 shows intestinal CYP3A activity, assessed by measurement of 
erythromycin A-demethylase activity. Erythromycin A-demethylase activity was not 
detected in microsomes from the group treated with Tfu. Activities of the control 
group and the TF-treated group in this investigation were 31 and 53 pmol min."  ^
mg“  ^ protein respectively. CYP3A activity in hepatic microsomes from untreated 
animals was 0.56 nmol min.“  ^ mg“  ^ protein. The above values are presented as the 
average of duplicate determinations, differing from the average by not more than 
5%^
3.3.1.4 Activity o f GYP 4A
CYP4A activity, as determined by measurement of "^^ C-lauric acid hydroxylation, 
was not detectable in the intestinal microsomes from any of the groups in the 
present study. Laurie acid hydroxylase activity in hepatic microsomes from 
untreated animals, included as a positive control, was 1.24 nmol min.“* mg”  ^protein 
(average of duplicate determinations, differing from the average by not more than 
15%).
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Figure 3.1 Effect of administration of isolated tea polyphenols and of tea on intestinal CYPl A1 
activity in the rat. Studies were conducted using pooled microsomal preparations from the intestinal 
mucosae o f 4 rats. A. Animals were gavaged daily for 4 weeks with either theaflavin solution (TF) or 
with theafulvin solution (Tfu). Control animals received vehicle only. B. Gp 1, rats were maintained 
on water; Gp 2 and Gp 3, rats were maintained on aqueous extracts (2.5%, w/v) o f decaffeinated 
black tea and whole black tea, respectively, as the sole source of liquid for 4 weeks; Gp 4, rats were 
maintained on decaffeinated black tea supplemented with caffeine (700 mg 1"'); Gp 5, rats were 
maintained on a solution of caffeine (700 mg F*) as the sole source of liquid; and Gp 6, rats were 
maintained on aqueous green tea extract (2.5%, w/v) for 4 weeks. CYPl A 1 activity was determined 
fluorimetrically by monitoring resorufin production from ethoxyresorufin. Results are presented as 
the average of two determinations, differing from the average by not more than 15%.
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Figure 3.2 Effect of administration of isolated tea polyphenols and of tea on intestinal CYP3A 
activity in the rat. Studies were conducted using pooled microsomal preparations from the intestinal 
mucosae of 4 rats. Gp 1, rats were maintained on water; Gp 2 and Gp 3, rats were maintained on 
aqueous extracts (2.5%, w/v) of decaffeinated black tea and whole black tea, respectively, as the sole 
source of liquid for 4 weeks; Gp 4, rats were maintained on decaffeinated black tea supplemented 
with caffeine (700 mg 1“*); Gp 5, rats were maintained on a solution of caffeine (700 mg 1“') as the 
sole source of liquid; and Gp 6, rats were maintained on aqueous green tea extract (2.5%, w/v) for 4 
weeks. CYP3A activity was determined spectrophotometrically by monitoring formaldehyde 
production from the A-demethylation o f erythromycin. Results are presented as the average of 
duplicate determinations, differing from the average by not more than 10%.
3.3.2 Effects o f tea consumption on intestinal phase II activities
3.3.2.1 Activity ofUDP glucuronyltransferases
Intestinal microsomal UGT activity, as determined by the colourimetric method 
with 2-aminophenol as substrate, was not detectable. However, Figure 3.3 shows 
the activity of intestinal UGT, as determined using the more sensitive fluorimetric 
measurement of 1 -naphthol glucuronidation. UGT activity in hepatic microsomes 
from untreated animals, included as a positive control, was 702 pmol min.“* mg“  ^
protein (average of two determinations, differing from the average by not more than 
10%).
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Figure 3.3 Effect of administration of isolated tea polyphenols and of tea on intestinal UGT 
activity in the rat. Studies were conducted using pooled microsomal preparations from the intestinal 
mucosae of 4 rats. A. Animals were gavaged daily for 4 weeks with either theaflavin solution (TF) or 
with theafulvin solution (Tfu). Control animals received vehicle only. B. Gp 1, rats were maintained 
on water; Gp 2 and Gp 3, rats were maintained on aqueous extracts (2.5%, w/v) of decaffeinated 
black tea and whole black tea, respectively, as the sole source of liquid for 4 weeks; Gp 4, rats were 
maintained on decaffeinated black tea supplemented with caffeine (700 mg F*); Gp 5, rats were 
maintained on a solution of caffeine (700 mg l ') as the sole source of liquid; and Gp 6, rats were 
maintained on aqueous green tea extract (2.5%, w/v) for 4 weeks. UGT activity was determined 
fluorimetrically by monitoring the glucuronidation of 1-naphthol. Results are presented as the 
average of two determinations, differing from the average by not more than 5%.
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Figure 3.4 Effect of adm inistration of isolated tea polyphenols and of tea on intestinal epoxide 
hydrolase activity in the rat. Studies were conducted using pooled microsomal preparations from 
the intestinal mucosae of 4 rats. A. Animals were gavaged daily for 4 weeks with either theaflavin 
solution (TF) or with theafulvin solution (Tfu). Control animals received vehicle only. B. Gp 1, rats 
were maintained on water; Gp 2 and Gp 3, rats were maintained on aqueous extracts (2.5%, w/v) o f 
decaffeinated black tea and whole black tea, respectively, as the sole source of liquid for 4 weeks; 
Gp 4, rats were maintained on decaffeinated black tea supplemented with caffeine (700 mg 1“'); Gp 
5, rats were maintained on a solution of caffeine (700 mg F ') as the sole source o f liquid; and Gp 6, 
rats were maintained on aqueous green tea extract (2.5%, w/v) for 4 weeks. Epoxide hydrolase was 
determined fluorimetrically by monitoring the hydration of benzo[a]pyrene-4,5-epoxide. Results are 
presented as the average of two determinations, differing from the average by not more than 15%.
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Figure 3.5 Effect of adm inistration of isolated tea polyphenols and of tea on intestinal GST 
activity in the rat. Studies were conducted using pooled cytosolic preparations from the intestinal 
mucosae o f 4 rats. In the first investigation, animals were gavaged daily for 4 weeks with either 
theaflavin solution (TF) or with theafulvin solution (Tfu). Control animals received vehicle only. In 
the second, Gp 1, rats were maintained on water; Gp 2 and Gp 3, rats were maintained on aqueous 
extracts (2.5%, w/v) of decaffeinated black tea and whole black tea, respectively; Gp 4, rats were 
maintained on decaffeinated black tea supplemented with caffeine (700 mg 1"'); Gp 5, rats were 
maintained on a solution of caffeine (700 mg P'); and Gp 6, rats were maintained on aqueous green 
tea extract (2.5%, w/v) for 4 weeks. GST activity was determined by the spectrophotometric 
conjugation with GSH of A. 3,4-dichloronitrobenzene (DCNB) and B. 1-chloro-2,4-dinitrobenzene 
(CDNB). Results are presented as the average of two determinations, differing from the average by 
not more than 20%.
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Figure 3.6 Effect of administration of isolated tea polyphenols and of tea on intestinal 
sulphotransferase activity in the rat. Studies were conducted using pooled cytosolic preparations 
from the intestinal mucosae o f 4 rats. A. Animals were gavaged daily for 4 weeks with either 
theaflavin solution (TF) or with theafulvin solution (Tfu). Control animals received vehicle only. B. 
Gp 1, rats were maintained on water; Gp 2 and Gp 3, rats were maintained on aqueous extracts 
(2.5%, w/v) of decaffeinated black tea and whole black tea, respectively; Gp 4, rats were maintained 
on decaffeinated black tea that was supplemented with caffeine (700 mg P '); Gp 5, rats were 
maintained on a solution of caffeine (700 mg P'); and Gp 6, rats were maintained on aqueous green 
tea extract (2.5%, w/v) for 4 weeks. Sulphotransferase activity was determined 
spectrophotometrically, employing 2-naphthol as substrate. Results are presented as the average of 
triplicate determinations, differing from the average by not more than 15%.
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3.3.2.3 Activity o f glutathione ^-transferases
Figure 3.5 shows the composite results of the activity of each GST isozyme present 
in the intestinal cytosolic preparations, as determined by CDNB and DCNB 
conjugation. GST activity in hepatic cytosolic fraction from untreated animals was 
0.656 pmol min.“* mg"  ^ protein (CDNB) and 49.74 nmol min."  ^ mg~^  protein 
(DCNB), each value the average of two determinations, differing from the average 
by not more than 15%.
3.3.2.4 Activity o f sulphotransferases
Figure 3.6 shows the sulphotransferase activity of the intestinal cytosolic fractions. 
Activity in hepatic cytosolic fraction from untreated animals was 238 pmol min.”  ^
mg“* protein (average of triplicate determinations, differing from the average by not 
more than 15%).
3,3,3 Detection o f intestinal cytochromes P450 by Western blotting
3.3.3.1 Immunodetection o f CYPl A proteins
It can be seen from Figure 3.7 that CYPl A proteins were clearly detectable. 
Although the antibody used did not cross-react with other P450 proteins, it did not 
distinguish between CYPlAl and CYP1A2, and in immunoblots of hepatic 
microsomes from Aroclor-induced rats, two bands were visible, corresponding to 
CYPlAl and CYP1A2 (not shown). CYP1A2 protein has not been detected in the 
intestine of the rat (Fasco et a l, 1993; Zhang et a l, 1996), hence the single bands 
observed in Figure 3.7 correspond to CYPlAl. However, in Figure 3.1 A, two 
brighter bands and a third fainter band are visible in the control sample (C). 
Whether the second brighter band reflects the presence of CYP1A2, or, more likely, 
whether the additional two bands are simply degradation products of CYPlAl, is 
not clear.
What is apparent in Figure 3.7A is the greater intensity of the major band(s) in the 
control (C) sample relative to the TF and Tfu samples. Quantitation of these bands 
revealed that the TF and Tfu samples were only 77% and 79%, respectively, of the
6^
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control. Although this effect was observed in more than one experiment, it was not 
consistently reproducible, and it is therefore difficult to conclude as to the validity 
of this observation.
A.
B.
Figure 3.7 Im m unodetection of C Y Pl A protein by W estern blot analysis o f intestinal 
microsomes from rats treated  with black tea polyphenols and with tea. Intestinal microsomal 
proteins (100 pg) were resolved by SDS-PAGE (12% gel, w/v) and transferred electrophoretically to 
nitrocellulose. Immunodetection was carried out using sheep anti-rat GYP IA antibody (diluted I in 
10000), followed by peroxidase-linked donkey anti-sheep IgG (diluted 1 in 2000). A. Microsomes 
from rats treated with isolated black tea polyphenols. C, control group; TF, TF-treated group; Tfu, 
Tfu-treated group. B. Microsomes from rats treated with various tea preparations. Gp I, rats were 
maintained on water; Gp 2 and Gp 3, rats were maintained on aqueous extracts (2.5%, w/v) of 
decaffeinated black tea and whole black tea, respectively, as the sole source o f liquid for 4 weeks; 
Gp 4, rats were maintained on decaffeinated black tea supplemented with caffeine (700 mg 1"'); Gp 
5, rats were maintained on a solution of caffeine (700 mg 1"') as the sole source o f liquid; and Gp 6, 
rats were maintained on aqueous green tea extract (2.5%, w/v) for 4 weeks. In each experiment, 
hepatic microsomes (0.2 pg protein) derived from rats treated with Aroclor 1254 were used as 
positive control (A).
In Figure 3.7B, there is apparent induction of CYPlAl in group 4 (4), the band 
intensity being 151% of the control group sample (1). However, although this 
observation was reproducible, there is no obvious explanation as to why this may 
have occurred. In each case, hepatic microsomes from rats treated with Aroclor 
1254 (A) were used as positive control, although the band is not visible in Figure 
3.7B.
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3.3.3.2 Immunodetection o f CYP2E1 proteins
Two main bands were detectable in all samples (Figure 3.8), including the positive 
control (hepatic microsomes from isoniazid-induced rats. I), although there were 
more bands visible in the samples from the tea-drinking study (Figure 3.8B). In the 
samples from the isolated polyphenol study (Figure 3.8A), the upper band, in 
accordance with the positive control, was the more intense, with the TF and Tfu 
samples each being 63% of the intensity of the control group (C). In the case of the 
second (lower) band, the TF and Tfu samples were 74% and 84%, respectively, of 
the control.
B.
Figure 3.8 Immunodetection of CYP2E1 protein by Western blot analysis o f intestinal 
microsomes from rats treated with black tea polyphenols and with tea. Intestinal microsomal 
proteins (100 pg) were resolved by SDS-PAGE (12% gel, w/v) and transferred electrophoretically to 
nitrocellulose. Immunodetection was carried out using goat anti-rat CYP2EI antibody (diluted I in 
500), followed by peroxidase-linked monoclonal anti-goat/sheep IgG (diluted 1 in 2000). A. 
Microsomes from rats treated with isolated black tea polyphenols. C, control group; TF, TF-treated 
group; Tfu, Tfii-treated group. B. Microsomes from rats treated with various tea preparations. Gp 1, 
rats were maintained on water; Gp 2 and Gp 3, rats were maintained on aqueous extracts (2.5%, w/v) 
of decaffeinated black tea and whole black tea, respectively, as the sole source o f liquid for 4 weeks; 
Gp 4, rats were maintained on decaffeinated black tea supplemented with caffeine (700 mg F '); Gp 
5, rats were maintained on a solution of caffeine (700 mg T ') as the sole source o f liquid; and Gp 6, 
rats were maintained on aqueous green tea extract (2.5%, w/v) for 4 weeks. In each experiment, 
hepatic microsomes (0.5 pg protein) derived from rats treated with isoniazid were used as positive 
control (I).
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The situation in Figure 3.8B is clearly more complex, but the intensity of the major 
band in group 3 (3) is 121% of the same band in the control group (1). However, the 
major band in the positive control (I) does not appear to correspond precisely with 
any of the bands in the intestinal samples.
3.3.3.3 Immunodetection o f CYP3A proteins
In Figure 3.9A, there are clearly two major bands visible in the control sample (C), 
whereas there is only one in both the TF and Tfu samples. The intensity of this 
common band in the TF and Tfu groups is 93% and 119%, respectively, of that of 
the control group.
A.
B.
TF Tfu
Figure 3.9 Immunodetection of CYP3A protein by Western blot analysis of intestinal 
microsomes from rats treated with black tea polyphenols and with tea. Intestinal microsomal 
proteins (100 pg) were resolved by SDS-PAGE (12% gel, w/v) and transferred electrophoretically to 
nitrocellulose. Immunodetection was carried out using goat anti-rat CYP3A2 antibody (diluted I in 
500), followed by peroxidase-linked monoclonal anti-goat/sheep IgG (diluted I in 2000). A. 
Microsomes from rats treated with isolated black tea polyphenols. C, control group; TF, TF-treated 
group; Tfu, Tfu-treated group. B. Microsomes from rats treated with various tea preparations. Gp I, 
rats were maintained on water; Gp 2 and Gp 3, rats were maintained on aqueous extracts (2.5%, w/v) 
of decaffeinated black tea and whole black tea, respectively, as the sole source o f liquid for 4 weeks; 
Gp 4, rats were maintained on decaffeinated black tea supplemented with caffeine (700 mg P '); Gp 
5, rats were maintained on a solution of caffeine (700 mg F ‘) as the sole source of liquid; and Gp 6, 
rats were maintained on aqueous green tea extract (2.5%, w/v) for 4 weeks. In each experiment, 
hepatic microsomes (O.I pg protein) derived from rats treated with dexamethasone were used as 
positive control (D).
71
Chapter 3 : Intestinal phase land  phase II enzyme systems_________________________
In Figure 3.9B, the double band described above is not visible in the control group 
(1), with only a single band apparent in all groups, corresponding to the major band 
in the positive control (D). The intensities of the bands in groups 2 to 6 are 61%, 
62%, 57%, 61%, and 57%, respectively, relative to the control group. Although the 
band in group 3 (3) appears more intense than the other bands, relative to the 
control, the image analysis software takes into account the band width and spread, 
as well as intensity, therefore, in spite of appearance, the value is not dissimilar to 
the other experimental groups. However, there appears to be no correlation here 
with the A-demethylase activity measured as a probe for CYP3A. The positive 
control (D) was an hepatic microsomal sample derived from rats treated with 
dexamethasone.
3.3.3.4 Immunodetection o f CYP4A proteins
As in the case of CYP2E1, despite the lack of detectable enzyme activity, as 
determined by the hydroxylation of lauric acid, CYP4A protein is clearly detectable 
in the rat intestine (Figure 3.10). In all experimental groups, a single major band 
corresponds to the major band in the positive control sample (hepatic microsomes 
from rats treated with clofibrate. Cl). In Figure 3.10A, there is little difference in 
intensity between groups, with TF and Tfu groups being 86% and 92%, 
respectively, relative to the band intensity in the control group (C). In Figure 3.1GB, 
most groups have a lower intensity relative to the control group (1), values being 
68%, 73%, 70%, 65%, and 83% of the control for groups 2 to 6, respectively.
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A.
B.
Figure 3.10 Immunodetection of CYP4A protein by Western blot analysis of intestinal 
microsomes from rats treated with black tea polyphenols and with tea. Intestinal microsomal 
proteins (100 pg) were resolved by SDS-PAGE (12% gel, w/v) and transferred electrophoretically to 
nitrocellulose. Immunodetection was carried out using goat anti-rat CYP4A antibody (diluted I in 
500), followed by peroxidase-linked monoclonal anti-goat/sheep IgG (diluted I in 2000). A. 
Microsomes from rats treated with isolated black tea polyphenols. C, control group; TF, TF-treated 
group; Tfu, Tfu-treated group. B. Microsomes from rats treated with various tea preparations. Gp I, 
rats were maintained on water; Gp 2 and Gp 3, rats were maintained on aqueous extracts (2.5%, w/v) 
o f decaffeinated black tea and whole black tea, respectively, as the sole source o f liquid for 4 weeks; 
Gp 4, rats were maintained on decaffeinated black tea supplemented with caffeine (700 mg F '); Gp 
5, rats were maintained on a solution of caffeine (700 mg F ‘) as the sole source o f liquid; and Gp 6, 
rats were maintained on aqueous green tea extract (2.5%, w/v) for 4 weeks. In each experiment, 
hepatic microsomes (0.25 pg protein) derived from rats treated with clofibrate were used as positive 
control (Cl).
3.4 Discussion
The aim of this study was to compare the effects in the rat of tea consumption on 
the intestinal xenobiotic-metabolising enzymes with those effects previously 
reported in the liver (Bu-Abbas et al, 1994b, 1995, 1998, 1999a, and 1999b). The 
tea consumption investigation was a joint study in which the effect on salivary
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glands and salivary hormones was also examined, as well as certain intestinal 
hormones (Messenger, 2000), and for this reason, it was not possible to terminate 
the animals by cervical dislocation, as this may have damaged these glands. The 
isolated tea polyphenol fractions investigation was also a joint study, the further 
goals of this part of the study being to examine the effect of these polyphenols on 
hepatic xenobiotic-metabolising enzymes (Catterall, 2001), and to determine the 
nature of the urinary metabolites excreted following ingestion of these compounds, 
hence the use of the low-polyphenol diet (Gôkçe, 1999).
3,4.1 Modulation o f intestinal CYPIA activity and protein levels 
It has been suggested that CYPlAl probably does not occur constitutively in the 
intestine, but is inducible by dietary components of common feeds (Kaminsky & 
Fasco, 1992; Rosenberg, 1991b). Therefore, it may be that the levels of CYPlAl 
detected in the present isolated polyphenol study are due to components of the low- 
polyphenol diet, and that the polyphenolics have in some way suppressed the 
expression of CYPlAl. The purified CIO diet has been used to evaluate dietary 
burden of fiavonoids, and was shown to result in fewer phenolic compounds being 
excreted in the urine (Copeland, 1996). The primary difference between the 
standard, crude diet and the purified, low-polyphenol diet is the absence of the 
cereal component from the CIO diet (see Appendix). Since cereals are a well-known 
source of dietary polyphenols (Clifford, 2000a, 2000b), it is likely that the absence 
of such material accounts for the relative lack of phenolics in the purified diet.
Fasting of animals prior to termination and isolation of enterocytes has been shown 
not to influence levels of P450s (Zhang et al, 1996). It should be noted at this point 
that the two investigations in the present study are not directly comparable with 
each other, owing to the different diets used in each, and the possibly differing 
effects of these diets. Studies on dietary influence on cytochrome P450 profile 
underscore the importance of dietary considerations when designing studies such as 
the present one, suggesting the maintenance of animals on standard cereal-based 
diets may not provide appropriate models for all toxicological studies of this nature 
(Rosenberg, 1991b).
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Only the isolated polyphenol study showed a promising line of further investigation 
regarding the apparent suppression of CYPlAl activity, an observation partially 
supported by the Western blotting results. Figure 3.7A shows two brighter bands 
and a third fainter band in the control sample (C), and it may be that the second 
bright band reflects the presence of CYP1A2, as observed in Aroclor-induced 
hepatic microsomal samples (not shown). However, despite the presence of the 
mRNA detected in previous studies, albeit at very low levels, CYP1A2 protein has 
yet to be detected in rat intestine (Zhang et a l, 1996), and for this reason, CYP1A2 
activity was not investigated in the present study. It is therefore likely that the 
additional two bands are simply degradation products of CYPlAl, since the 
primary antibody used in the present study does not cross-react with other P450 
proteins (Rodrigues et a l, 1987). It is difficult to explain why a similar effect was 
not observed with the black tea-drinking groups as well, other than the possible 
influence of the different diet, as these animals would also have been exposed to TF 
and Tfu. In Figure 3.7B, there is apparent induction of CYPlAl in group 4 (the 
animals maintained on recaffeinated black tea, 4) relative to the control group 
sample (1). However, although this observation was reproducible, there is no simple 
explanation as to why this may have occurred in this particular group, and not in 
any other group maintained in the presence of either caffeine or black tea. Since 
such induction was not reflected in the enzyme activity results, it is therefore likely 
that this observation is due to some anomaly either in the Western blotting 
procedure itself or in the preparation of the samples. It should be borne in mind that 
when preparing the intestinal mucosa by scraping, considerable contaminating 
material is present, and although gels for Western blotting were loaded on the basis 
of protein concentration, the P450 content is likely to differ substantially.
3,4,2 Modulation o f  other intestinal cytochromes P450
Evidently, the results from the present study are by no means conclusive. Clearly, 
had there been any findings of potential significance, the study would require 
repeating on a larger scale, not only to provide a greater quantity of material for use 
in the appropriate assays, that being used in the present study being only minimal, 
but also to enable evaluation of the statistical significance of the results. Hence, the 
present study may be viewed in terms of an extended pilot study, from which the
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findings may have led to a similar study on a larger scale. Also, the scraping method 
of preparation of mucosal homogenate may have been inadequate, resulting in too 
low a specific concentration of the enzymes under investigation, relative to the 
whole protein concentration — presumably due largely to the contaminating 
presence of excessive mucus. This may account for the very low — sometimes 
undetectable — levels of phase I activity observed. However, since this problem 
was not encountered to such an extent with the phase II activities (notably the 
microsomal UGT and epoxide hydrolase activities), it may simply reflect very low 
levels of expression of phase I enzymes. The use of RT-PCR was considered in the 
detection of P450 mRNA in the present study, but this course of action was not 
pursued, since a lack of detection at the protein level (i.e. by Western blotting) 
implies a lack of functional significance of any changes detectable only at the 
mRNA level.
3.4.2.1 Modulation o f CYP2EI
In a study on the induction of CYP2E1 by ethanol in the rat, Roberts et al. (1994) 
suggested that there was a common post-translational mechanism of induction 
between hepatic and extrahepatic tissues. They also found the appearance of a 
second immunoreactive band in the gut following withdrawal of ethanol, suggesting 
a degradative pathway in the gut different from that in other tissues. The current 
findings would appear to support those of Roberts et al. (1994), the putative 
CYP2E1 band in certain gut samples not quite corresponding to the CYP2E1 band 
in the isoniazid-induced hepatic sample, included as a positive control (see Figure 
3.8). However, it cannot be excluded that this band may represent some cross­
reactive P450 breakdown product, or another P450 isozyme, as the antibody used in 
the present study is known to show cross-reactivity with CYP2C11 and CYP2C13 
in particular (Gentest Chemicals product catalogue). Zhang et al. (1996) failed to 
detect CYP2E1 at the mRNA level, even after treatment with pyrazole; they 
suggested that previous reports where 2E1 was detected only by immunoblot 
analysis may be due to cross-reaction of the antibodies used. The same authors 
stated that fasting did not influence levels of any of the P450s they detected, but as 
they failed to detect CYP2E1, this observation may not extend to CYP2E1. It is 
possible, therefore, that the different patterns of immunoreactive bands (Figure 3.8)
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observed between the two investigations in the present study are a consequence of 
the fasting of the animals in the tea-drinking study; this was necessary to satisfy the 
co-objectives of this investigation. The above suggestion is substantiated by the 
sensitivity of CYP2E1 to, and inducibility by, fasting (Roberts et a l, 1994), 
although precisely which mechanism(s) is in operation here is unclear. In addition, 
detection of CYP2E1 may be influenced by distribution within the small intestine, 
Hakkak et al (1993) having detected CYP2E1 in the jejunum of rats treated with 
ethanol, but not in the duodenum.
3.4.2.2 Modulation o f CYP3A and CYP4A
In each of the investigations in the present study, there was no induction of either 
CYP3 A or CYP4A. The pattern of erythromycin Y-demethylase activity observed is 
inconsistent with any attributable inductive effect, although the very low levels of 
activity observed may preclude from any valid conclusions being drawn. Fasco et 
al (1993) have demonstrated erythromycin A-demethylase activity in epithelial 
microsomes, but the very low levels of this activity observed indicated that 
CYP3A1/2 was present at only very low levels, which is consistent with the 
findings of the present study. The isolated black tea polyphenols had no effect on 
the CYP4A sub-family, as determined by Western blotting, but may have partially 
suppressed the expression of GYP3A, as demonstrated by the apparent 
disappearance of the second immunoreactive band, seen in the control group, from 
the TF and Tfii groups (see Figure 3.9A). This observation may indeed be due to the 
suppression of a CYP3A isozyme, or it may be due to the presence of a cross­
reactive protein or degradation product in the control group sample.
Consumption of the various tea preparations appeared to suppress the protein 
expression of these sub-families, as determined by Western blotting. In the case of 
CYP3A, the present results are consistent with those effects observed on hepatic 
CYP3A (Bu-Abbas et a l, 1994b, 1999a, 1999b), where consumption of both green 
tea and black each suppressed the CYP3A-mediated A-demethylation of 
erythromycin. However, in the case of CYP4A, the present results are in contrast to 
the findings of the same studies (Bu-Abbas et a l, 1994b, 1999a), where lauric acid 
hydroxylase activity, attributed to CYP4A (Bu-Abbas et a l, 1994), and
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immunologically-determined levels of CYP4A were induced in the livers of animals 
consuming tea.
It may be of interest to note at this point that in the co-investigation of the present 
study, treatment of rats with solutions of TF and Tfu also failed to modulate the 
corresponding hepatic xenobiotic-metabolising enzymes (Catterall, 2001). This 
suggests that induction of such enzymes observed following consumption of black 
tea (Bu-Abbas et al, 1999a, 1999b) is due to some component of black tea other 
than TF or Tfii, probably caffeine (Bu-Abbas et a l, 1999a).
3,4,3 Modulation o f  intestinal phase II  enzyme activities
Most drug-metabolising reactions are subject to induction by a wide range of 
chemically unrelated xenobiotics (Vargas et a l, 1998), including sulphate 
conjugation (Liu & Klaassen, 1996). In a study by Vargas et al (1998), three 
different inducers failed to modify intestinal levels of UGT or GST, even though 
hepatic levels were induced, suggesting that the requirements for induction of phase 
II enzymes in the small intestine may be markedly different from those in the liver. 
In the present study, none of the phase II activities investigated were induced or 
suppressed to any significant degree, nor was there any discernible pattern of 
modulation of such activities. This is in contrast to the findings of the previous 
studies investigating the effects of tea consumption on hepatic phase II activities, 
where induction of both UGT and GST activities was observed (Bu-Abbas et al, 
1995, 1998). However, in studies comparable with the present study, the same 
authors failed to show induction of either hepatic epoxide hydrolase or of hepatic 
SULT. From the relative abundance of UGT activity observed in the present study, 
and given the importance of glucuronidation in the intestine (Kaminsky & Fasco, 
1992), it may be of interest to have supported these results with Western blot 
analysis. However, to date, anti-rat UGT antibodies are not commercially available, 
and despite the availability of anti-human UGT antibodies, these could not be 
guaranteed to produce valid data (personal communication, Cambridge Bioscience).
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3,4,4 Isolation o f  enterocytes and preparation o f  microsomes
In vitro models of intestinal metabolism are based on either gut microsomes, gut 
mucosal preparations, freshly-isolated enterocytes, or immortalised cell lines. All of 
these models have limitations, e.g. lack of cytosolic enzymes in microsomal 
preparations, whereas mucosal preparations do not accurately predict phase II 
transformations, thus limiting their use in metabolism studies (Lampen et a l, 1998). 
Intestinal slices (human jejunal and colonic) have also been used in metabolic 
studies, analogously to liver slices (Vickers et a l, 1992, 1995). Many of the 
available data on intestinal P450s are marred by inconsistencies, and a probable 
basis for such inconsistencies lies in variations in the procedures for preparation of 
intestinal epithelial microsomes (Fasco et al, 1993).
The two principal methods for enterocyte isolation are scraping and elution of the 
intestinal mucosa, and there is extensive variation in the application of these 
methods in the literature (Kaminsky & Fasco, 1992). Although intestinal 
microsomes have been frequently used in metabolic studies, their preparation is 
complicated by exposure to intestinal proteases during their isolation (Emoto et al, 
2000b), but this may be reduced by the inclusion of various protease inhibitors in 
the preparation, such as in the present study. Varying degrees of mucus 
contamination is also a potential disadvantage of the scraping technique (Kaminsky 
& Fasco, 1992).
The many elution methods described in the literature can be loosely categorised as 
either enzymatic, vibrational, or chelator-based. Among the enzymes employed in 
the enzymatic elution of enterocytes are trypsin, hyaluronidase, and collagenase, 
whereas the chelator-based approaches have included the use of various buffered 
solutions of citrate, EDTA, and dithiothreitol (Kaminsky & Fasco, 1992). 
Vibrational techniques involve the eversion of intestinal segments over steel rods in 
buffered solution before subjecting the segments to mechanical vibration, thus 
detaching the enterocytes from the lamina propria (Shirkey et a l, 1979a, 1979b).
Everted sacs of the small intestine were originally used for studies of the transfer of 
substances from the mucosal to the serosal surfaces. However, Emoto et al (2000a)
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have recently used everted gut sacs in the study of xenobiotic-metabolising enzymes 
in the mouse small intestine. Using a variety of substrates, these authors found that 
P450 activity decreased along the length of the small intestine, and in the case of 
CYP3A, this was coincident with a decrease in the density of immunoreactive 
bands, detected using anti-rat CYP3A2 antibody. In most cases, enzyme activity in 
the everted sacs was higher than in isolated microsomes. The limitations of this 
model, as highlighted by the authors, include absorption of substrate by mucosal 
cells — although this was not taken into account, the fact that the sacs are whole 
tissues means that they more closely resemble the in vivo situation — and difficulty 
in extrapolating intestinal drug metabolism from in vitro to in vivo due to 
localisation of the P450 systems (Emoto et al., 2000a).
Certain cell lines of intestinal origin also express a variety of P450s, and in 
particular, CaCo-2 cells were found to produce a metabolic profile similar to that 
found in vivo for a range of test chemicals, which may make this cell line of 
particular use for studies of intestinal biotransformation (Lampen et al., 1998). As 
in the human small intestine, CYP1A2 is not present in CaCo-2 cells (Gonzalez, 
1992). In addition, CaCo-2 cells have been shown to express GST isoforms, and 
that the expression of CYPlAl is inducible by BNF and 3-MC (Boulenc et al., 
1992; Peters & Roelofs, 1992).
Many of the xenobiotic-metabolising activities were very low in the present study, 
and this may be due to the method of preparation of the microsomes and the 
contaminating presence of excess mucus. However, this is a widely-used method of 
enterocyte isolation (Kaminsky & Fasco, 1992), hence the low activities may 
simply reflect correspondingly low levels of these enzymes. Improved results, in the 
form of higher activities or clearer patterns of modulation, may be obtainable in 
future studies by modifying the procedures employed, e.g. by using a more selective 
method of enterocyte isolation, such as vibrational elution, or by using a purified 
diet in the feeding stage to eliminate the confounding effects of dietary inducers.
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3,4,5 Role o f  intestinal enzyme induction in anticarcinogenic effects 
Modulation of intestinal xenobiotic-metabolising enzymes may also have 
consequences in chemical carcinogenesis. Elevation of CYPlAl by dietary 
components could diminish the uptake of ingested PAH and HAA procarcinogens, 
thereby diminishing the carcinogenic consequences of their systemic uptake (Zhang 
et a l, 1997). Certain xenobiotics elicit induction of phase II enzyme activities only, 
and such compounds may play a unique role as chemoprotectants because they 
enhance detoxication without increasing P450-dependent bioactivation. The best 
known of these are antioxidants, such as /er/-butyl-4-hydroxyanisole (BHA), 
exerting their effect via the antioxidant response element (ARE). In rats, GST and 
UGT activities are induced both in the liver and small intestine by BHA. However, 
this effect has not always been observed in a variety of different studies, employing 
a variety of dosing regimens, suggesting a dose-related effect is also in operation 
(Vargas et a l ,  1998).
Studies on the time-course of CYPlAl induction demonstrated that this enzyme 
was more rapidly responsive to induction in the small intestine than in the liver, 
even when the inducer was administered intraperitoneally, thereby excluding earlier 
exposure as a causative factor. However, induced levels of intestinal CYPlAl were 
maintained for a shorter time than in the liver, presumably a consequence of the 
shorter life span of enterocytes. This short-lived level of induction would therefore 
require frequent use of dietary inducers. Despite observations that CYP1A2 mRNA 
has been detected by RT-PCR, CYP1A2 protein was again not detected, presumably 
as a consequence of the low levels of mRNA expressed in this tissue (approx. 0.1% 
of CYPlAl mRNA levels, both in BNF-induced animals). These authors also 
suggest that CYPlAl translational efficiency is higher, or that CYPlAl protein is 
more stable in the liver than in the small intestine (Zhang et a l ,  1997).
It would appear that induction occurs initially in the crypt cells, with subsequent 
induction occurring in the mature villous cells. Also, inducibility decreases with 
distance from the pylorus along the length of the rat small intestine. This has been 
explained, at least in part, by a comparable fall-off in Ah receptor levels along the 
small intestines, this receptor being involved in the induction of CYPlAl. In
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contrast to the liver, the glucocorticoid receptor plays no apparent role in the 
induction of intestinal CYPlAl (Zhang et a l, 1997). UGT1A6 and 1A7 content 
was also higher proximally than distally, and may correlate with the decreased 
expression of the Ah receptor along the small intestine in a similar fashion to 
CYPlAl (Kobayashi e ta l, 1998).
Hirose et al (1993) demonstrated that dietary administration of green tea catechins 
significantly reduced the numbers of chemically-induced tumours in the small 
intestine of the rat, (using MNU, DMH, and A-diethylnitrosamine) even though 
hepatocarcinogenesis was slightly enhanced. In the multi-organ model they 
employed, green tea catechins inhibited carcinogenesis during the initiation stage, 
after carcinogen exposure, and both during and after exposure, although the effect 
was most pronounced when given at the initiation stage. The suggested mechanism 
of action was through the lowering of proliferation of intestinal epithelial cells, or of 
intestinal tumour cells.
Green tea consumption has been shown to reduce the incidence of azoxymethane- 
induced aberrant crypt foci in rat colon (Challa et a l, 1997), particularly when 
administered in combination with another dietary component, phytic acid, present in 
grains. Since green tea alone had little effect, but had a significant synergistic effect 
in combination with phytic acid, these authors suggested that it is important that 
dietary components should not be studied individually for anticarcinogenic activity. 
In the same study however, green tea consumption did not influence GST activity, 
either in the colon or in the liver.
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FRACTIONATION OF GREEN TEA BY HPLC: 
LOCALISATION OF AN ANTIMUTAGENIC 
FRACTION AND ITS MECHANISM OF ACTION
Chapter 4 : Fractionation o f green tea
4.1 Introduction
The antimutagenic and anticarcinogenic potential of green tea has been widely 
studied, both in vivo and in vitro. However, the mechanism(s) of action involved in 
these effects is not clearly defined. Indeed, there are many conflicting reports as to 
the beneficial effects of tea, or lack of such effects, the results of epidemiological 
studies being mixed and inconclusive (Schut & Yao, 2000) and particularly 
regarding the respective roles of individual components of tea. Studies in rodents 
have, however, demonstrated significant chemopreventive effects of tea and tea 
components in a number of experimental models.
4,L1 Components o f  tea
It is widely believed that the biological effects of tea are due largely to the 
polyphenolic content. The polyphenols found in tea are described in more detail in 
Chapter One, but it is worth briefly recalling the salient points relevant to the 
present study. Tea contains relatively large quantities of polyphenols and 
methylxanthines, as well as several organic acids. Of the numerous polyphenols 
present in green tea leaves, the flavan-3-ols (catechins) and the fiavonols are the 
most important; the fiavanols comprise approximately 30% of the total dry weight, 
compared with only about 5% in black tea (Balentine, 1992; Lunder et a l, 1992). 
Caffeine, in both green tea and black tea, accounts for approximately 5% of the dry 
weight. Table 4.1 shows the fiavanol and caffeine content of the aqueous green tea 
extract used in the present study.
4.L2 Antimutagenicity o f  tea
Green tea, and to a lesser extent black tea, is widely accepted to be antimutagenic 
and to inhibit carcinogen-induced tumorigenesis in animal models, but the precise 
mechanisms remain unclear (Hemaez et a l, 1997). Among the mechanisms 
proposed to account for the inhibition by tea of chemical carcinogenesis are the 
induction of phase I and II detoxication pathways and the scavenging of reactive 
intermediates of such carcinogens (Hemaez et a l, 1998). Bu-Abbas et al (1994a) 
demonstrated the involvement of two mechanisms in the marked and concentration-
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dependent inhibition by green tea of the mutagenic activity of a variety of direct- 
and indirect-acting mutagens in the Ames test. The principal mechanism was the 
inhibition by the green tea extract of the cytochrome P450-dependent bioactivation 
of the promutagens, the second involving direct interaction between the reactive 
species of the mutagens and the nucleophilic component(s) of the tea (Bu-Abbas et 
al, 1994a). Such studies appear to suggest that green tea may exert its 
anticarcinogenic effect, at least in part, at the initiation stage.
Table 4.1 Fiavanol and caffeine content of aqueous green tea extract.
Compound Concentration*
(p g  ml~^)
(+)-catechin 21
(-)-epicatechin 203
(-)-epigallocatechin 205
(-)-epicatechin-3 -gallate 112
(-)-epigallocatechin-3 -gallate 980
Total fiavanols 1521
gallic acid 36
caffeine 489
’Aqueous extract o f green tea (2.5%, w/v) was prepared in a Thermos™ flask, allowed to brew for 10 
minutes whilst inverting every 30 seconds, and then filtered through cotton wool to remove the 
leaves. Components were quantified by HPLC (monitored at 280 nm) with reference to standard 
calibration curves. (From Bu-Abbas et a l, 1999b).
4.1.2.1 Scavenging o f reactive intermediates
Inhibition of the direct-acting mutagenicity of A-hydroxy IQ in the Ames test also 
showed a concentration-dependent relationship, with green tea being a more 
effective inhibitor than black tea (Hemaez et a l, 1998). This study also showed that 
most of the antimutagenic components were released within a 3-minute brew time, 
and increased with the concentration of the brew.
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Because of their high content in green tea, flavanols have widely been considered as 
the most likely component responsible for the antimutagenic and anticarcinogenic 
properties of green tea (Bu-Abbas et al, 1997). In addition, earlier work has shown 
that one of the flavanols present in green tea, EGCG, inhibited the mutagenic 
activity of A-hydroxylated metabolites of HAA structurally related to IQ (Hayatsu 
et a l, 1992). A previous study whereby green tea extract was fractionated by HPLC 
(Hemaez et a l, 1998) revealed that most of the antimutagenic activity against N- 
hydroxy IQ co-eluted with EGG and EGCG, both of which are known for their anti­
oxidant properties (Lunder, 1992).
Bu-Abbas et al (1997) attempted to correlate the antimutagenic effect of green tea 
fractions with flavanol content. Following fractionation by solvent extraction, four 
fractions of green tea were characterised by HPLC with respect to their flavanol 
content. Subsequent evaluation of their antimutagenicity against a range of 
mutagens in the Ames test failed to establish a relationship between antimutagenic 
activity and flavanol content. However, it was established that the effectiveness of 
each fraction varied with the nature of the model mutagen, indicating that more than 
one component or that more than one mechanism of action was responsible.
4.1.2.2 Inhibition o f phase I  metabolism
The same authors (Bu-Abbas et a l, 1996) further evaluated the contribution of 
flavanols to the antimutagenic effect of green tea by comparison with black tea and 
decaffeinated black tea, both much lower in flavanol content. They concluded that, 
owing to the similar effects of all three types of tea in vitro, the flavanols were 
unlikely to be the major antimutagenic components of green tea, unless their 
fermentation products, as found in black tea, were similarly active. Evidence for the 
latter suggestion is provided by Catterall et al (1998), following a similar 
investigation into the antimutagenic properties of theafulvins, a polyphenolic 
fraction of black tea. They concluded that the theafulvins were indeed important in 
the antimutagenic activity of black tea, this activity being manifested by inhibition 
of the P450-mediated bioactivation of carcinogens.
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4.1.2.3 Role o f phase IIpathways
Further mechanisms by which green tea may exert its anticarcinogenic effect 
include stimulation of phase I and II detoxicating enzymes. Consumption of green 
tea has been shown to induce hepatic CYP1A2 and CYP4A1 (Bu-Abbas et al, 
1994b), though the former would seem to contradict the reported anticarcinogenic 
potential of green tea, given the role of CYP1A2 in the activation of chemical 
carcinogens. However, with some carcinogens, such as IQ, CYP1A2 also catalyses 
the detoxifying 5-hydroxylation reaction. Perhaps of greater significance is the 
induction of phase II detoxicating pathways following green tea consumption (Bu- 
Abbas et a l, 1995, 1998). No induction was observed of the enzymes which 
detoxicate reactive oxygen species (ROS), i.e. catalase, superoxide dismutase 
(SOD), and GSH peroxidase, thus the antioxidant properties of tea most likely result 
from direct effects on ROS, i.e. free radical scavenging (Yen & Chen, 1995).
However, induction of UGT activity was observed, which may facilitate the 
deactivation of chemical carcinogens, as was induction of GST activity, enhancing 
detoxication of reactive intermediates and prohibiting their subsequent interaction 
with DNA. Two substrates were used to monitor induction of UGT, only one of 
which showed induction following tea treatment, hence it may be concluded that the 
result reflects differential induction of UGT isoforms (Bu-Abbas et a l, 1995). The 
induction of UGT may account for the elevated levels of glucuronides excreted in 
the urine of rats treated with IQ following consumption of green or black tea (Xu et 
al, 1996). Sulphotransferase and epoxide hydrolase activities were not influenced, 
while GST activity was only increased by consumption of tea brews of higher 
concentrations. An evaluation of the contribution of flavanols to the modulation of 
phase II activities concluded that flavanols were not largely responsible; a similar 
conclusion was reached for the role of caffeine (Bu-Abbas et a l, 1998).
4.1.2.4 Contribution o f non-polyphenolics
It is conceivable that the antimutagenic effects of tea are not due, at least solely, to 
the polyphenolic content. Grapefruit juice is a well-known inhibitor of the 
cytochrome P450-mediated metabolism of a number of drugs, particularly by 
enzymes of the CYP3A subfamily (Edwards et a l, 1996). Since these enzymes play
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a role in the activation of some procarcinogens, their inhibition by dietary 
components may be useful in the prevention of cancer. Attempts to identify the 
active inhibitor(s) present in grapefruit juice have focused on the flavonoid content, 
such as naringin and quercetin. However, both compounds failed to demonstrate the 
metabolic inhibition seen with grapefruit juice. From an organic extract of 
grapefruit juice, Edwards et al (1996) isolated a furanocoumarin compound, 6',7'- 
dihydroxybergamottin, a potent inhibitor of CYP3A, which accounted almost 
completely for the in vitro inhibition of CYP3 A activity by grapefruit juice. Similar 
compounds have also been shown to be potent inhibitors of CYPIA and CYP2B in 
vitro, and it is not implausible that such a compound(s) may be present in tea.
Chlorophyllin, a copper/sodium salt of chlorophyll, which itself may be a 
component of green tea, is also an antimutagen (Hemaez et a l, 1997), and an 
inhibitor of cytochrome P450 (Yun et a l, 1995). Hemaez et al (1997) suggested 
that, to some extent, chlorophyllin inhibited the direct-acting mutagenicity of N- 
hydroxy IQ by complexing with, and facilitating the degradation of, the active 
metabolites. Following investigation of the in vitro non-specific inhibition of 
cytochrome P450 activity, Yun et al (1995) proposed this as the dominant 
mechanism of inhibition of mutagenicity by chlorophyllin. The presence of 
chlorophyll(in) in tea has already been discussed (Chapter 1), thus it may be of 
interest to assess the presence of chlorophyll in aqueous green tea extract (GTE), 
and hence its contribution to the antimutagenic effect of tea.
4,1,3 Objectives
Following the separation of an aqueous infusion of green tea by HPLC, the effluent 
was fractionated with the aim of isolating a fraction, or fractions, with 
antimutagenic activity against a variety of mutagens in the Ames test. Subsequently, 
it was hoped to define the fraction(s) and identify the active components present 
which were responsible for the observed effects. After identifying an antimutagenic 
fraction, the mechanism of action was investigated with regard to the metabolic 
activation of indirect-acting mutagens, and then to the scavenging of reactive 
genotoxic species.
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In the present study, most of the model mutagens employed are food carcinogens, 
these being pertinent to the study of the antimutagenic effects of tea, since they are 
likely to be consumed with tea in the diet. Therefore, the effect of tea on their 
mutagenicity is of particular interest.
4.2 Materials and methods
4,2,1 Materials
IQ was purchased from Toronto Research Chemicals (Toronto, Canada). 
Benzo[a]pyrene, iV-nitrosopyrrolidine (NPyr), #  -methyl-# -nitro-jV-
nitrosoguanidine (MNNG), menadione, caffeine, gallic acid, (-)-epicatechin (EC), 
(-)-epicatechin gallate (ECG), glucose-6-phosphate dehydrogenase, and 
chlorophyllin (copper/sodium salt) were all purchased from Sigma Chemical Co. 
(Poole, Dorset, UK). (-)-Epigallocatechin gallate (EGCG) was kindly provided by 
Dr Alan Davies, Unilever Research, Colworth, Bedfordshire, UK. The Salmonella 
typhimurium strains TA98 and TAIOO were gifts from Prof. Bruce Ames, 
University of California at Berkeley, USA. The degallase (tannase) enzyme 
preparation (26.3 U mg"\ 2 mg ml“  ^ in MES buffer, 0.1 M, pH 6) was kindly 
provided by Prof. Gary Williamson and Mr Geoff Plumb, Institute of Food 
Research, Norwich, UK. Acetonitrile (HPLC grade) and acetic acid (analytical 
grade) were purchased from Fisher Chemicals, (Loughborough, Leics., UK). Male 
Wistar albino rats (200 g), for the preparation of hepatic activation systems used in 
the Ames test, were obtained from B&K Universal Ltd (Hull, UK) and housed in 
the EBU.
Green tea (Gunpowder) and black tea (Keemun) were purchased locally and stored 
at 4°C in a sealed plastic bag. Tea infusions (2.5%, w/v) were prepared by adding 
boiling water (200 ml) to the tea leaves (5 g) in a Thermos™ flask, allowing to brew 
for 10 minutes whilst inverting every 30 seconds, and then filtering through cotton 
wool to remove the leaves.
<99
Chapter 4 : Fractionation o f green tea
4.2.2 Analysis o f  green tea by HPLC
The method was adapted from the analytical procedures developed in this laboratory 
(Copeland, 1996). A 2.5% (w/v) aqueous green tea extract was prepared as 
described above, and aliquots (1 ml) placed on ice in Eppendorf tubes for 30 
minutes to allow the tea to cream. The aliquots were then centrifuged at 8,000g for 
2 minutes in a benchtop centrifuge (Centrifuge 5402, Eppendorf) to clarify the 
samples for HPLC analysis. Separation (100 pi aliquots) was achieved on a Hi- 
Chrom Hypersil ODS 3 pm column (12.5 cm x 4.6 mm i.d.) with 2% acetonitrile in 
0.5% acetic acid (solvent A) and 30% acetonitrile in 0.5% acetic acid (solvent B). 
Solvents were prepared in RO water. A linear gradient from 0-100% solvent B over 
30 minutes was employed, followed by 6 minutes isocratic elution with solvent B, 
at a flow rate of 1 ml min."\ using a P4000 quaternary pump and AS 1000 
autosampler (ThermoSeparation Products). Effluent was monitored at 280 nm using 
a Spectra Physics FOCUS forward optical scanning detector. Data were collected 
and processed using PC1000 HPLC software via an SN4000 system controller (also 
ThermoSeparation Products).
4.2.3 Fractionation o f  green tea by HPLC
Based on the analytical procedure described above, fractionation was carried out by 
injecting larger aliquots (1 ml) of the same tea preparation onto the column. 
Separation was achieved in the same way, and fractions collected every 3 minutes 
from 0 to 36 minutes (Foxy Jr fraction collector, Jones Chromatography). Following 
an initial elution to allow full equilibration of the system, six aliquots were eluted 
consecutively to give 12 fractions, each of 18 ml. Fractions were reduced to near­
dryness by rotary evaporation at 40°C under reduced pressure, then redissolved in 6 
ml of a variety of solvents, as appropriate. The fractions were redissolved in this 
volume since this was the original volume of tea preparation from which the 
fractions were derived. The concentrated fractions were wrapped in aluminium foil 
and stored in darkness at 4°C until use in the Ames test the following day.
Following method development, separation and fractionation was subsequently 
achieved using a semi-preparative column (Hi-Chrom Hypersil ODS 5 pm column.
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150 mm X 10 mm i.d.) and employing a linear gradient from 0 to 100% solvent B 
(solvent A, 2% acetonitrile; solvent B, 30% acetonitrile) and an eluent flow rate of 4 
ml min."\ The fractions, each of 72 ml, were treated as described above, and finally 
redissolved in 6 ml of water.
4.2.4 Antimutagenicity testing
Antimutagenic activity of the tea fractions was investigated using the Ames test, as 
described in Chapter Two, employing S. typhimurium strains TA98 and TAIOO and 
using a 10% (v/v) activation system where appropriate. The S9 activation system 
was derived from the livers of rats treated with Aroclor 1254 (IQ and B[ûr]P) or with 
isoniazid (NPyr), also described in Chapter Two. The standard plate incorporation 
test was used, with the addition of the test green tea fraction (500 pi).
4.2.5 Mechanism o f  antimutagenicity
4.2.5.1 Inhibition ofMROD activity
In order to assess the contribution of inhibition of CYP1A2 activity to their 
antimutagenic properties, the tea fractions were incorporated into the MROD assay, 
as described in Chapter Two. Hepatic microsomes were used, derived from the 
livers of rats treated with Aroclor 1254, the preparation of which is described in 
Chapter Two. In addition to the tea fractions, authentic standards of tea components 
were incorporated into the assay to assess inhibitory activity. Preparations of such 
standards were used at concentrations equal to those found in whole green tea, as 
determined in this laboratory (Bu-Abbas et a l, 1999b). For assessment of the effect 
of degallation on the inhibitory activity of the tea fractions and authentic standards, 
aliquots (2 ml) were incubated with degallase (2.5 U) for 60 minutes in a shaking 
water bath at 37°C. Degallation was confirmed by HPLC analysis of authentic 
EGCG, before and after treatment with degallase, with reference to chromatograms 
of EGC and gallic acid standards.
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4.2.5.2 Scavenging o f reactive metabolites
In order to assess whether the antimutagenic activity of the tea fractions was due to 
the scavenging of the reactive intermediates of the test mutagens, the Ames test was 
modified as follows. Initially, the bacteria, mutagen, and activation system were 
pre-incubated for 20 minutes in a shaking water bath at 37°C. Microsomal 
metabolism was terminated by the addition of menadione (100 pi, 900 pM), and a 
second 20-minute pre-incubation was carried out in the presence of the appropriate 
tea fraction. Top agar (2 ml) was added, the mixture poured onto minimal agar 
plates, and the plates incubated for 48 hours at 37°C. Isolated hepatic microsomes 
(derived from rats treated with Aroclor 1254) were used in the activation system, 
rather than S9 fraction, hence the system was supplemented with glucose-6- 
phosphate dehydrogenase (1 U per plate).
All mutagenicity studies were performed in triplicate, and results were reproducible.
4,2.6 Determination o f  total solids
Total solids were determined by freeze-drying aliquots (6 ml) of whole green tea 
and of green tea fractions in pre-weighed 25 ml polystyrene tubes (FreezeMobile 6, 
The Virtis Company), and then calculating the amount of solids by weight 
difference.
4.3 Results
4,3,1 Fractionation o f  green tea
Figure 4.1 shows a typical chromatogram of aqueous green tea extract obtained by 
analytical HPLC. The major peaks, identified by reference to previous work carried 
out in this laboratory (Bu-Abbas et a l, 1997), were confirmed by analysis of 
authentic standards. Quantitative HPLC analysis has identified caffeine and EGCG 
as the major components of green tea extract, present at 489 and 980 pg ml”* 
respectively (Bu-Abbas et a l , 1999b).
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Initially, fractionation of green tea extract (aliquots of 1 ml) was performed using 
the same analytical system from which the above chromatogram was obtained. 
However, although apparently successful, it was decided that the column was being 
overloaded, and that fractionation may be compromised by inadequate resolution of 
the tea components (chromatograms not shown). Subsequently, fractionation was 
achieved by semi-preparative HPLC. This required development of the method in 
order to ensure sufficient separation of the components to produce well-defined 
fractions.
Caffeine EGCG
?
EC
EGC
ECGGA
0.0
0 3 6 9 12 15 18 21 24 27 30 33 36
Retention time (minutes)
Figure 4.1 Analytical H PLC  chrom atogram  of aqueous green tea. Aqueous green tea extract 
(2.5%, w/v) was analysed by HPLC, monitored at 280 nm. Peaks were identified by reference to 
previous work carried out in this laboratory (Bu-Abbas et a l, 1997). GA, gallic acid; EGC, (-)- 
epigallocatechin; EC, (-)-epicatechin; EGCG, (-)-epigallocatechin-3-gallate; ECG, (-)-epicatechin- 
3-gallate. Absorbance is presented in Absorbance Units (AU).
After extensive evaluation of various conditions (chromatograms not shown), 
increasing the flow rate to 4 ml min.”  ^ achieved acceptable separation, whilst not 
increasing the volume of each fraction to impractical levels for reconstitution. 
Figure 4.2 shows an example of a fractionation chromatogram, obtained by semi­
preparative HPLC. The three-minute fractionation windows are denoted by the 
vertical red gridlines, and indicate the major peak(s), and hence components.
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present in each fraction. The relative positions of the peaks remain unchanged from 
Figure 4.1, although the resolution is inferior, and the retention times in Figure 4.2 
are greater than those in Figure 4.1.
3 .0  1
2.0 -
<
0 .5  -
0 .0  4
0 3 6 9 12 15 18 21 24 27 30 33 36
Retention time (minutes)
Figure 4.2 Sem i-preparative H PLC  chrom atogram  of aqueous green tea extract. The vertical 
gridlines indicate the fraction collection windows o f 3 minutes per fraction, revealing the expected 
content o f each fraction. Aliquots (1 ml) o f green tea extract (2.5%, w/v) were injected onto the 
column and separated employing a linear gradient, from 100% solvent A (2% acetonitrile) to 100% 
solvent B (30% acetonitrile), at a flow rate o f 4 ml min.“’ over 36 minutes. The HPLC effluent was 
monitored at 280 nm, with absorbance presented in Absorbance Units (AU).
Following development of a suitable system for semi-preparative HPLC 
fractionation, further development was necessary, since the analytical solvent 
system proved to be toxic to the bacteria used in the Ames test (data not shown). 
The more volatile acetonitrile component of the solvent system would be removed 
by the rotary evaporation procedure used in the reconstitution of the tea fractions, 
hence it was concluded that the acetic acid component of the solvent system was 
causing the toxicity. This was confirmed by experimenting with various mixtures of 
the solvent system with the bacteria, both in the absence and presence of an S9 
activation system prepared in phosphate buffer.
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Figure 4.3 Antimutagenic effect of green tea fractions against IQ-induced mutagenicity. This 
study employed Salmonella typhimurium strain TA98, and the mutagenic response was elicited with 
(A) 1 ng IQ, and (B) 5 ng IQ, in the presence of an hepatic activation system (10%, v/v) derived 
from rats treated with Aroclor 1254. Results are presented as mean ± SD for triplicates, and the 
spontaneous reversion rates o f 31 ± 4  (A) and 40 ± 4 (B) and have already been subtracted. IQ, IQ 
only present; GTE, 2.5% (w/v) aqueous green tea extract (250 pi) incorporated into the mutagenicity 
assay; FI -  F 12, Fractions 1 -  12 (500 pi), isolated by semi-preparative HPLC o f aqueous green tea 
extract, incorporated into the mutagenicity assay.
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However, such efforts failed to solve the problem; further attempts to prevent 
toxicity by reconstituting the fractions in buffered solutions also met without 
success. Consequently, the acetic acid was excluded from the solvent system, and 
the reconstituted fractions were found to be no longer toxic to the bacteria. In 
addition, removal of the acetic acid from the solvent system appeared to have no 
discernible effect on the semi-preparative HPLC profile of the tea extract.
4.3,2 Antimutagenic effects o f  green tea fractions
Figure 4.3 shows the effect of the tea fractions, and of whole green tea, on the 
mutagenic response elicited by the indirect-acting food carcinogen IQ in the Ames 
test. The whole green tea extract virtually eliminated the response, but in addition. 
Fractions 1 and 6 (FI and F6 respectively) demonstrated marked antimutagenic 
activity. However, whereas the antimutagenicity of F6 was consistently 
reproducible, the antimutagenicity of FI was only sporadically so, and thus may not 
be a reliable result.
Figure 4.4 shows the results of similar evaluation against NPyr. Again, whole tea 
has a considerable antimutagenic effect, whereas this time, F6 has apparently little 
effect on the mutagenic response. However, when compared with the rest of the 
fractions, which appear largely to potentiate the mutagenic response, the effect of 
F6 may still prove to be of significance. The effect of the fractions on the 
mutagenicity of one more indirect-acting mutagen, B[a]P, was investigated (Figure 
4.5). Once again, along with whole tea, F6 proved to be strongly antimutagenic. 
However, in addition to F6, several other fractions inhibited the mutagenic response 
to B[a]P, particularly Fractions 2 and 5.
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Figure 4.4 Antimutagenic effect of green tea fractions against NPyr-induced mutagenicity. This 
study employed Salmonella typhimurium strain TA1530, and the mutagenic response (NPyr, 6 mg) 
was elicited in the presence o f an hepatic activation system (10%, v/v) derived from rats treated with 
isoniazid. Results are presented as mean ± SD for triplicates, and the spontaneous reversion rate of 
7 4 + 1 3  (in the presence of 89) has already been subtracted. NPyr, NPyr only present; GTE, 2.5% 
(w/v) aqueous green tea extract (250 pi) incorporated into the mutagenicity assay; FI -  F 12, 
Fractions 1 -  12 (500 pi), isolated by semi-preparative HPLC o f aqueous green tea extract, 
incorporated into the mutagenicity assay.
Finally, the antimutagenicity of the tea fractions against a direct-acting mutagen, 
MNNG, was investigated (Figure 4.6). At lower concentrations of MNNG, neither 
whole tea nor any of the fractions appeared to have any effect on the mutagenic 
response induced by MNNG (data not shown). However, when MNNG was used at 
higher concentrations, the mutagenicity was suppressed, both by whole tea, and by 
all of the fractions to a greater or lesser extent. Indeed, most of the fractions 
suppressed the mutagenicity to a greater extent than the whole tea, particularly at 
the higher concentration of 1.5 pg per plate (Figure 4.6 B), compared with 1.25 pg 
per plate (Figure 4.6 A), though this may simply be due to the smaller volume of tea 
used (300 pi) compared with the tea fractions (500 pi).
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Figure 4.5 Antimutagenic effect of green tea fractions against B[a]P-induced mutagenicity. This 
study employed Salmonella typhimurium strain TA98, and the mutagenic response (B[a]P, 25 pg) 
was elicited in the presence o f an hepatic activation system (10%, v/v) derived from rats treated with 
Aroclor 1254. Results are presented as mean ± SD for triplicates, and the spontaneous reversion rate 
of 26 ± 4 has already been subtracted. B[a]P, B[a]P only present; GTE, 2.5% (w/v) aqueous green 
tea extract (250 pi) incorporated into the mutagenicity assay; FI -  F12, Fractions 1 -  12 (500 pi), 
isolated by semi-preparative HPLC of aqueous green tea extract, incorporated into the mutagenicity 
assay.
To investigate further the apparent potentiation of the mutagenicity of NPyr by the 
tea fractions, the effect of whole tea and three selected fractions was studied at a 
series of volumes (Figure 4.7). Whole green tea, at 100 pi per plate, had no effect, 
but at larger volumes strongly inhibited the mutagenic response. At 100 pi per plate, 
F6 strongly increased the mutagenic response, but inhibited the response at greater 
volumes in a dose-dependent fashion. In contrast, F2 had no effect at 100 pi per 
plate, but increased the mutagenicity at subsequently greater volumes. The 
mutagenic response was suppressed by F9 to a similar extent at all volumes studied.
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Figure 4.6 Antimutagenic effect of green tea fractions against MNNG-induced mutagenicity.
This study employed Salmonella typhimurium strain TAIOO, and the mutagenic response was 
elicited with MNNG (A, 1.25 pg; B, 1.5 pg). Results are presented as mean ± SD for triplicates, and 
the spontaneous reversion rates of 246 ± 4 (A) and 266 ± 8 (B) have already been subtracted. 
MNNG, MNNG only present; GTE, 2.5% (w/v) aqueous green tea extract (300 pi) incorporated into 
the mutagenicity assay; FI -  F12, Fractions 1 - 1 2  (500 pi), isolated by semi-preparative HPLC of 
aqueous green tea extract, incorporated into the mutagenicity assay.
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Figure 4.7 Potentiation of NPyr-induced mutagenicity by green tea fractions. This study 
employed Salmonella typhimurium strain TA 1530, and the mutagenic response (NPyr, 5 mg) was 
elicited in the presence of an hepatic activation system (10%, v/v) derived from rats treated with 
isoniazid. Results are presented as mean ± SD for triplicates, and the spontaneous reversion rate of 
20 + 3 has already been subtracted. NPyr, NPyr only present; GTE, 2.5% (w/v) aqueous green tea 
extract incorporated into the mutagenicity assay; F2, F6, and F9, Fractions 2, 6, and 9, isolated by 
semi-preparative HPLC of aqueous green tea extract, incorporated into the mutagenicity assay.
Following the marked inhibition by F6 of the mutagenic response to several 
diagnostic mutagens in the Ames test, the contribution of this fraction to the 
antimutagenic properties of whole green tea was investigated. Tea fractions were 
prepared as before by semi-preparative HPLC, but following fractionation. 
Fractions 5, 6, and 7 were recombined, as were the remaining fractions. In addition, 
whole tea was fractionated, then recombined in its entirety for inclusion in the 
investigation. This recombination was carried out to assess the effect of the 
fractionation procedure, if any, on the antimutagenic properties of the whole tea. 
The recombined fractions were then reduced by rotary evaporation and reconstituted 
as previously described. The recombined fractions were then incorporated into the 
Ames test in the same way as the individual fractions to determine their combined 
antimutagenic effect (Figure 4.8). When assessed against IQ (Figure 4.8A), whole 
tea, recombined whole tea, and recombined Fractions 5-7 strongly inhibited the IQ-
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induced mutagenic response. However, the remaining recombined fractions had 
only a modest, but still inhibitory, effect on the mutagenic response.
Figure 4.8B shows the result of a similar experiment using NPyr instead of IQ. 
Again, whole tea markedly inhibited the mutagenic response, but in contrast, the 
recombined whole tea and the recombined fractions potentiated the mutagenicity. 
Nevertheless, the recombined whole tea and recombined F5-7 did not increase the 
response to the same degree as the remaining recombined fractions.
4 3 3  Mechanism o f  action o f  antimutagenicity o f  green tea fractions
To elucidate the mechanism of action of the observed antimutagenic effects of the 
tea fractions, further studies were carried out investigating the ability of the 
fractions to inhibit hepatic cytochrome P450 activity, and to scavenge reactive 
genotoxic species in a modified Ames test. These investigations centred on F6, this 
fraction having the most potent and consistent antimutagenic effect. The scavenging 
study employed IQ as the model mutagen, as the mutagenicity of this compound 
was suppressed most strongly by F6.
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Figure 4.8 A ntim utagenic effect of recombined green tea fractions against indirect-acting 
mutagens. This study employed Salmonella typhimurium strains TA98 (IQ) and TA 1530 (NPyr), 
and the mutagenic response was elicited in the presence of an hepatic activation system (10%, v/v) 
derived from rats treated with either Aroclor 1254 or isoniazid respectively. Recombined fractions, 
isolated by semi-preparative HPLC of aqueous green tea extract, were assessed for antimutagenic 
activity against IQ (A) and NPyr (B). GTE, whole green tea extract; F5-7, Fractions 5-7 recombined; 
REC all fractions recombined, excluding Fractions 5-7; REC 'w', whole green tea extract 
fractionated and recombined. All fractions, and whole GTE were incorporated into the Ames test at 
500 pi per plate. Results are presented as mean ± SD for triplicates, and the spontaneous reversion 
rates of 31 ± 4  (A) and 18 ± 4 (B) have already been subtracted.
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Figure 4.9 Inhibition of M ROD activity by green tea fractions. Studies were conducted using 
pooled hepatic microsomal preparations from animals treated with Aroclor 1254. Aqueous green tea 
extract (2.5%, w/v) was used either whole (GTE), or following fractionation by semi-preparative 
HPLC (F3, F6, and F 10, Fractions 3, 6, and 10 respectively). Caffeine solution (Caff) was prepared 
to give a concentration equivalent to that found in the green tea extract (approx. 490 pg ml”'). 
MROD activity was initially determined in the absence of any tea fraction (Control), and then in the 
presence of the indicated volume (pi) o f tea fraction. Results are presented as the average o f two 
determinations.
From Figure 4.9, the concentration-dependent inhibition of hepatic microsomal 
MROD activity by F6 is clear. However, the effect is not as marked as that of whole 
green tea, particularly when taking into account the smaller volumes of whole tea 
used. Caffeine solution, of the same concentration as that found in the aqueous 
green tea extract (490 pg ml"'), and Fractions 3 and 10 had no inhibitory effect at 
these levels. These observations prompted further investigation into the inhibitory 
effect of F6. Inhibition by F6 of three hepatic mixed function oxidase activities was 
measured, as represented by MROD, EROD, and PROD activities, along with 
whole green tea, and two of the flavanols found in green tea, EC and EGCG (Figure
4.10). Ethanol was also included as a control, as this was the solvent in which the 
flavanols were prepared for this experiment.
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EGCG, along with F6 and whole tea, markedly inhibited MROD activity, and these 
observations prompted fiirther investigation into the inhibition of MROD activity. 
Although F6 and whole tea inhibited EROD activity, the effect of the flavanols was 
no different from the ethanol control. In contrast, F6 enhanced the activity of 
PROD, whereas all other samples appeared to inhibit this activity. The inhibitory 
effect of ethanol on PROD activity may falsely suggest the absence of any effect 
due to the flavanols; without the inhibitory effect of the ethanol, the flavanols may 
have enhanced the PROD activity in a similar fashion to F6.
To assess further the possible contribution of EGCG to the inhibitory effect of F6, 
the study was repeated first using samples treated with degallase enzyme (Figure 
4.11) and then including whole tea treated with degallase (Figure 4.12). Again, 
whole tea, F6, and to a lesser extent, EGCG, inhibited MROD activity. In all cases, 
degallation reduced this inhibitory effect, completely in the case of EGCG. EGC 
and gallic acid, the products of degallation of EGCG, were also studied using 
solutions of appropriate concentrations, but had no effect at these levels.
In the second mechanistic study, the scavenging of reactive species was investigated 
by employing a modified Ames test, where reactive IQ metabolites were generated 
in a pre-incubation prior to the addition of the putative scavenging fraction. The 
results of this study are presented in Figure 4.13. Both whole tea and F6 suppressed 
the mutagenic response to similar extents, suggesting scavenging of the genotoxic 
IQ species, but there was no apparent concentration-dependent relationship. In 
contrast. Fractions 3 and 10 failed to show any effect on the mutagenic response.
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Figure 4.10 Inhibition of hepatic mixed-function oxidase activity by green tea com ponents. All
studies were conducted using pooled hepatic microsomal preparations from animals treated with 
Aroclor 1254. Aqueous green tea extract (2.5%, w/v) was used either whole (GTE, 25 pi), or 
following fractionation by semi-preparative HPLC (F6, Fraction 6; 50 pi). EGCG and EC solutions 
(50 pi) were prepared to give concentrations equivalent to those found in green tea extract (approx. 
980 and 200 pg ml”' respectively). Ethanol (EtOH, 50 pi) was included as a control, as this was the 
solvent used to prepare the catechin solutions. Results are presented as the average of two 
determinations.
105
Chapter 4 : Fractionation o f green tea
1.0
0.9
0.8
a  0.7
g  0.6
I 0.5
I
S  0.4
j  0.3 <
0.2
0.1
0.0
Control MES 100 F 6 100 EGCG 50 EGCG 75 EGCG MESde F6de 100 EGCGde EGCGde EGCGde
100 100 50 75 100
Figure 4.11 Effect of degallation on the inhibition of MROD activity by green tea fractions.
Studies were conducted using pooled hepatic microsomal preparations from animals treated with 
Aroclor 1254. Aqueous green tea extract (2.5%, w/v) was fractionated by semi-preparative HPLC, 
and Fraction 6 (F6) reconstituted for use in this experiment. EGCG solution was prepared to give a 
concentration equivalent to that found in the green tea extract (approx. 980 pg ml”’). For degallation 
studies, denoted by the suffix ‘-de’, samples were incubated with degallase enzyme (1.25 U ml”’) in 
MES buffer (O.IM, pH 6). MES buffer alone was also used as a control, MROD activity was initially 
determined in the absence of any tea fraction (Control), and then in the presence o f the indicated
volume (pi) o f test component. Results are presented as the average o f two determinations.
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Figure 4.12 Further investigation into the effect of degallation on the inhibition of MROD 
activity by green tea fractions. Studies were conducted using pooled hepatic microsomal 
preparations from animals treated with Aroclor 1254. Aqueous green tea extract (2.5%, w/v) was 
fractionated by semi-preparative HPLC and Fraction 6 (F6) reconstituted for use in this experiment. 
EGCG solution was prepared to give a concentration equivalent to that found in the green tea extract 
(approx. 980 pg ml”'). For degallation studies, denoted by the suffix ‘-de’, samples were incubated 
with degallase enzyme (1.25 U ml”' in MES buffer, O.IM, pH 6). EGC and gallic acid (GA) 
solutions were prepared to give a concentration equivalent to those resulting from degallation of the 
EGCG. MROD activity was initially determined in the absence o f any tea fraction (Control), and 
then in the presence of the indicated volume (pi) o f test component. Results are presented as the 
average o f two determinations.
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Figure 4.13 Antim utagenic effect of green tea fractions against IQ  —  scavenging of reactive 
interm ediates. This study was carried out using IQ (7.5 ng per incubation) and Salmonella 
typhimurium strain TA98 in the presence of an hepatic microsomal activation system (10%, v/v) 
derived from the livers o f rats treated with Aroclor 1254, supplemented with glucose-6-phosphate 
dehydrogenase (lU  per plate). The tea fractions, prepared by semi-preparative HPLC o f aqueous 
green tea extract (2.5%, w/v), or whole green tea, were added prior to a second pre-incubation after 
termination of microsomal metabolism by the addition of menadione. Results are presented as the 
mean ± SD o f triplicates, and the spontaneous reversion rate o f 35 ± 1 has already been subtracted.
4.3.4 HPLC analysis o f green tea fractions
Following fractionation of the whole tea extract, the individual fractions were 
analysed by HPLC using the analytical system previously described for green tea. 
Figure 4.14 shows the chromatogram of F6, the major peaks corresponding to EC 
and EGCG. However, in all fractions, the levels of flavanols appeared considerably 
lower than in the whole tea extract, an observation also noted when recombined 
whole tea was analysed under the same conditions (see Figure 4.19). In order to 
establish whether the observed antimutagenic and inhibitory effects of F6 were not 
simply due to a greater amount of material present, the total solid content of each 
fraction was determined, along with that of whole green tea extract. Table 4.2 
clearly shows that this is not the case. Also, the sum of the total solids in each
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fraction (8.1 mg ml approximately corresponds to the total solid content of the 
whole tea extract (6.7 mg ml'* ± 0.3).
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Figure 4.14 HPLC chromatogram of Fraction 6 collected from aqueous green tea extract.
Aqueous green tea extract (2.5%, w/v) was fractionated by semi-preparative HPLC, following which. 
Fraction 6 was analysed by HPLC. The HPLC effluent was monitored at 280 nm, and absorbance is 
presented in Absorbance Units (AU).
The activity of degallase was confirmed by HPLC analysis of authentic EGCG 
before and after treatment with the enzyme, yielding EGC and gallic acid (Figure 
4.15). The presence of EGCG in F6 was also confirmed by HPLC analysis, before 
and after incubation with degallase enzyme. Figure 4.16 clearly demonstrates the 
elimination of the EGCG peak from the F6 chromatogram following degallation, 
and although the increase in the EGC content is not as clear, the gallic acid peak is 
considerably larger, thus confirming the original presence of EGCG.
Figure 4.17 further demonstrates the action of degallase, this time on whole green 
tea extract. Again, the EGCG peak is no longer prominent, but in addition, the ECG 
peak is also absent following degallation. As would be expected, the gallic acid, 
EGC, and EC peaks are all larger following treatment of whole green tea with 
degallase.
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Table 4.2 Total solid content of green tea fractions.
Fractions were isolated by semi-preparative HPLC of aqueous green tea extract (2.5%, w/v), freeze- 
dried in pre-weighed containers, and the total mass o f solid in each fraction calculated by difference. 
Results are presented as the average of two determinates ± the range. The total solid content o f whole 
green tea extract, determined in the same way, was 6.7 mg ml“‘ ± 0.3.
Tea
fraction
Total solids 
(mg ml“ )^
Tea
fraction
Total solids 
(mg mP^)
1 2.3 ± 0.4 7 0.6 ±0.1
2 1.1 ±0.5 8 0.3 ±0.1
3 0.4 ±0.1 9 0.2 ± 0.0
4 0.5 ± 0.0 10 0.3 ±0.0
5 1.4 ±0.7 11 0.2 ± 0.0
6 0.5 ± 0.0 12 0.3 ±0.1
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Figure 4.15 H PLC chrom atogram s of EGCG before and after trea tm ent with degallase 
enzyme. EGCG, at a concentration equal to that found in 2.5% (w/v) aqueous green tea extract (980 
pg m P'), was analysed before and after treatment with degallase enzyme (1.25 U ml”' in MBS 
buffer, O.IM, pH 6), displayed in blue and in red respectively. The HPLC effluent was monitored at 
280 nm, and absorbance is presented in Absorbance Units (AU). EGCG, (-)-epigallocatechin-3- 
gallate; EGC, (-)-epigallocatechin; GA, gallic acid.
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Figure 4.16 HPLC chromatograms of Fraction 6 collected from aqueous green tea extract 
before and after treatment with degallase enzyme. Aqueous green tea extract (2,5%, w/v) was 
fractionated by semi-preparative HPLC, with Fraction 6 retained for analysis by HPLC (displayed in 
blue). Fraction 6 was also treated with degallase enzyme (1.25 U m P' in MES buffer, O.IM, pH 6)) 
and then analysed by HPLC (displayed in red). HPLC effluent was monitored at 280 nm, and 
absorbance is presented in Absorbance Units (AU).
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Figure 4.17 HPLC chromatograms of aqueous green tea extract before and after treatment 
with degallase enzyme. Aqueous green tea extract (2.5%, w/v) was analysed by HPLC, monitored at 
280 nm, before and after treatment with degallase enzyme, displayed in blue and in red respectively. 
Absorbance is presented in Absorbance Units (AU). Labels have already been defined.
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Figure 4.18 HPLC chromatograms of recombined fractions of aqueous green tea extract.
Aqueous green tea extract (2.5%, w/v) was fractionated by semi-preparative HPLC into 12 fractions. 
Fractions 5, 6, and 7 were recombined (A), as were the remaining 9 fractions (B). The resulting 2 
fractions were analysed by HPLC, monitored at 280 nm, and absorbance is presented in Absorbance 
Units (AU).
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Figure 4.19 H PLC chrom atogram s of whole aqueous green tea ex tract before and after 
fractionation. Aqueous green tea extract (2.5%, w/v) was fractionated by semi-preparative HPLC 
into 12 fractions and then all 12 fractions recombined for analysis by HPLC (A). Whole green tea 
extract which had not been fractionated was also analysed, and is shown for comparison (B). 
Absorbance is presented in Absorbance Units (AU). Labels have already been defined.
Figures 4.18 and 4.19 show HPLC chromatograms of recombined tea fractions and 
recombined whole tea following fractionation. As already noted, the fractionation 
procedure appears to cause a reduction in the flavanol content, demonstrated
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unequivocally by the recombined whole tea analysis. This is presumably due to 
oxidation of the flavanols during the fractionation and reconstitution procedure. 
Although there was some loss of caffeine, present in F5, following fractionation, the 
loss is not of the same order as the loss of flavanols. The caffeine peak appeared to 
be relatively constant both before and after fractionation.
4.4 Discussion
4.4.1 Fractionation o f  aqueous green tea extract
Although the initial attempts at fractionating the green tea using an analytical HPLC 
column appeared to be successful, the profile was unsatisfactory, and separation and 
resolution of the peaks were poor. However, preliminary results with the fractions 
were promising, with Fraction 6 showing the greatest antimutagenic effect (data not 
shown). Nevertheless, it was felt that the poor separation would compromise the 
fractionation; since the aim of the study was ultimately to isolate a discrete 
fraction(s) demonstrating antimutagenic activity, and to define that fraction(s), the 
poor separation resulting from overloading the analytical column may have led to 
considerable overlap of the composition of each fraction, with subsequent overlap 
of the biological effects of the fractions in question. The fractionation HPLC profile 
of the tea extract from the semi-preparative column, although clearly not as well- 
resolved as the analytical profile, was a considerable improvement, and provided 
adequate separation of most of the major peaks (Figure 4.2).
From Figure 4.2, it can be seen that the major components of F6 (15-18 minutes) 
were EC and EGCG, although the peaks did not separate well, EC appearing as a 
‘shoulder’ on the EGCG peak. Other major peaks were found in F3 (gallic acid and 
theogallin), F5 (EGC and caffeine), and F8 (ECG).
4.4.2 Antimutagenic effects o f  green tea fractions
The mutagenic response to the food mutagen IQ was consistently and dramatically 
reduced by F6, that containing EGCG, and this observation is in keeping with 
previous studies which demonstrated the antimutagenicity of whole tea and green
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tea fractions towards IQ and A-hydroxy IQ (Bu-Abbas et a l, 1996; Hemaez et al, 
1998). The mechanism of action was elucidated, and the effect was found to be due 
largely to the inhibition of the bioactivation of IQ to form the reactive intermediates, 
but also, to a lesser degree, to the scavenging of such reactive intermediates (Bu- 
Abbas et a l, 1994a). Similar findings with a different mutagen, B[a]P, were also 
shown with whole tea, and with the direct-acting mutagen, MNNG. The effect on 
MNNG-induced mutagenicity was presumably due to the scavenging of the 
genotoxic species (Lunder, 1992), since no bioactivation is involved.
The unusual effect of the tea firactions on the mutagenicity of NPyr is not unique. 
Catterall et al (2000a, 2000b) reported a similar potentiation of the mutagenicity of 
NPyr by polyphenolics, including monomeric flavanols [(+)-catechin and (-)- 
epicatechin], and a variety of oligo- and polymeric procyanidins isolated fi*om 
various fruits. These authors suggested that such an effect, at least in the case of (+)- 
catechin, may be due to the interaction of the polyphenol with the bacterial DNA, 
thus facilitating the covalent binding of the ultimate mutagen of the nitrosamine to 
the DNA. In addition, a synergistic genotoxic effect was observed between black tea 
theafulvins and afiatoxin Bi, where it was suggested that such an effect may be due 
to the theafulvins in some way facilitating an increase in the bioactivation of the 
afiatoxin (Catterall et a l, 1998). This mechanism may be germane to the present 
study; a possible explanation for this observation may be related to the apparent 
increase in PROD activity due to F6, which also proved to be reproducible (Figure
4.10). However, only the effect of F6 on PROD activity was investigated. Although 
whole GTE inhibited the mutagenicity of NPyr, F6 had only a modest effect, 
whereas most of the remaining fractions potentiated the mutagenic response. 
Attempts to establish the basis of this response were unsuccessful, a concentration- 
dependent relationship between the volume of tea fraction and the enhancement of 
the response remaining unclear.
To evaluate further the contribution of F6 and its components to the antimutagenic 
properties of whole GTE, such properties of recombined tea fractions were 
investigated. Fractions 5, 6, and 7 were recombined (termed F5-7) since these 
would contain any components of F6 which may be overlapping into its
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neighbouring fractions. The remaining nine fractions were recombined (termed 
REC -') to represent the remainder of the tea extract, i.e. whole tea minus F5-7. 
Finally, fractionated whole tea was entirely recombined in order to establish the 
effect, if any, of fractionation and reconstitution on the properties of whole GTE.
Again, whole GTE proved to be strongly antimutagenic against IQ in the Ames test, 
as did F5-7 and recombined whole GTE. However, REC had only a modest 
effect, suggesting that the components of F6 did indeed contribute substantially to 
the antimutagenic effect of green tea. When the same recombined fractions were 
evaluated against NPyr, only whole GTE suppressed the mutagenic response. All 
recombined fractions, including recombined whole GTE, enhanced the mutagenic 
response, though F5-7 and recombined whole GTE did not enhance the response to 
as great an extent as REC This finding would appear to be in agreement with 
those for the individual fractions when evaluated against NPyr, but the mechanism 
was not investigated any further in this experiment.
4,4,3 Mechanism o f  antimutagenicity
4.4.3.1 Inhibition o f hepatic mixedfunction oxidases
The inhibition of MROD, EROD, and PROD activities by F6 and other selected 
green tea fractions was investigated in order to establish the role of inhibition of 
bioactivation of indirect-acting mutagens in their antimutagenic effects. Initially, 
inhibition of MROD activity was examined, and Figure 4.9 shows the 
concentration-dependent inhibition of this activity by whole GTE and by F6. The 
same volumes of Fractions 3 and 10, selected for their apparent lack of 
antimutagenicity in the Ames test, failed to inhibit MROD activity. This activity is a 
selective measure of CYP1A2, and a substrate and potent inducer of this enzyme is 
caffeine (Ayalogu et a l, 1995).
Caffeine is found in considerable quantity in whole GTE, and although not 
apparently present in F6, was the major component of F5, raising the possibility of 
some overlap into F6. In addition, caffeine has been shown in vitro to be 
antimutagenic (Weisburger et a l, 1998) and in vivo was responsible for the
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considerable suppression of the urinary excretion of IQ-derived mutagens in the rat 
following consumption of tea (McArdle et al, 1999). In this context, it was 
pertinent to investigate the inhibitory effect of caffeine, at levels approximating to 
those found in whole GTE, to assess its contribution to the effect of F6. However, 
caffeine failed to show any inhibition of MROD activity, even at twice that of the 
effective volume of F6. Hence, it may be concluded that caffeine does not appear to 
play a major role in the in vitro antimutagenic activity of green tea, a finding 
supported by Bu-Abbas et al (1996).
Previous studies have discounted the role of the fiavanols in the antimutagenic 
effects of green tea, or at least, have found them to be of minor importance (Bu- 
Abbas et a l, 1997). But, the presence of EGCG and EC in F6, and the apparent 
failure of caffeine to account for any of this activity, suggested EGCG and EC 
required further investigation. Once again, whole GTE and F6 inhibited MROD 
activity to a similar extent, but in addition, EGCG also inhibited MROD to the same 
degree. EC demonstrated only a small degree of inhibition, as did the ethanol 
control, suggesting the effect of EGCG was not complicated by the presence of 
ethanol. In this experiment, the fiavanols were dissolved in ethanol to give a more 
accurate determination of their concentrations, since available spectrophotometric 
data related to ethanolic solutions.
In the EROD assay, a selective marker of CYPlAl activity (Namkung et a l, 1988), 
whole GTE and F6 proved to be inhibitory. But, although EGCG and EC displayed 
inhibitory activity, this was only to the same degree as the ethanol control, and may 
therefore have been due to the ethanol rather than the fiavanols. This line of 
investigation was not pursued any further. Whole GTE had no apparent effect on 
PROD activity, whereas EC had a slight inhibitory effect. This may have been due 
to the presence of ethanol, which also inhibited the PROD activity. However, F6 
considerably enhanced the PROD activity, an observation which was reproducible. 
EGCG demonstrated only a slight enhancement of the activity, but this may have 
been tempered with the inhibitory effect of the ethanol, and hence EGCG may have 
the potential for similar enhancement of PROD activity to F6. Neither whole GTE 
nor F6 led to an increase in fluorescence in the PROD assay in the absence of 
substrate, hence this was not an additive effect, but an enhancement of some
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description. This may be of relevance however, since CYP2B is one of the major 
catalysts of the bioactivation of nitrosamines (Ayrton et a l, 1987; McCoy et a l, 
1979; Yang et a l, 1985), and this augmentation of PROD activity may go some 
way to accounting for the observed potentiation of NPyr mutagenicity in the present 
study. However, this line of investigation was not pursued either. It may be worth 
noting at this point that caffeine is also an inducer of CYP2B, as well as CYP1A2 
(Ayalogu et a l, 1995).
Focusing on the inhibition of MROD activity, since CYP1A2 is responsible for the 
bioactivation of IQ to genotoxic species, the role of EGCG was investigated further. 
If EGCG was responsible for a significant proportion of the inhibitory activity of 
F6, then treatment of the tea fraction, and of EGCG itself, with the enzyme 
degallase (also known as tannase) would result in a reduction in the inhibitory 
activity of both. This hypothesis was confirmed, the concentration-dependent 
inhibition of MROD activity by EGCG being abolished following degallation. The 
inhibitory activity of F6 was also greatly diminished by treatment with degallase, 
though not completely, as was the case with EGCG, suggesting the presence of 
another, albeit minor, inhibitory factor in F6. A similar observation was noted when 
whole GTE was treated with degallase, the inhibitory activity being greatly 
diminished but not abolished. For clarity, EGC and gallic acid, the products of 
degallation of EGCG, were also studied; neither demonstrated any inhibition of 
MROD activity. The inhibition of cytochrome P450 by green tea and/or its 
components may be partially ascribed to their ability to impair the flow of electrons, 
as demonstrated by the flavanols’ inhibition of NADPH-cytochrome P450 
reductase, thereby non-specifically interfering with the bioactivation of mutagens in 
vitro (Steele et a l, 1985), but since green tea has differential effects on the 
metabolism of the various substrates, it may be inferred that this is not the only site 
of action (Bu-Abbas et al, 1994a); the results of the present study suggest that such 
inhibition may be in addition to selective direct inhibition of certain P450 enzymes.
4.4.3.2 Scavenging o f reactive genotoxic species
In this investigation, a modified Ames test was used to evaluate the scavenging of 
reactive genotoxic species by green tea fractions. The bacteria were pre-incubated
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with IQ in the presence of an hepatic microsomal activation system, thus generating 
the reactive intermediates of IQ. Microsomal metabolism was then terminated by 
the addition of menadione, a potent inhibitor of the NADPH-dependent mixed 
function oxidase (Bu-Abbas et a l, 1994a), and a second pre-incubation carried out 
in the presence of the tea fractions. This second pre-incubation allows the tea 
fractions to scavenge the reactive metabolites generated by the microsomal mixed 
function oxidase system, prior to the final 48-hour incubation. Thus, effective 
scavenging of such intermediates would result in a reduced mutagenic response.
Both whole GTE and F6 suppressed the mutagenic response to a similar extent, but 
surprisingly, the effect was evidently not concentration-dependent. This may be due 
to some unknown limiting factor of the system, such as the nature of the metabolites 
generated and the specific ability of the putative scavengers to interact with such 
metabolites, or simply that maximum inhibition through this mechanism had 
already been achieved — in Figure 4.13, even whole GTE does not show a 
concentration-dependent effect. The scavenging effect of neither whole GTE nor F6 
was as marked as their antimutagenic effect in the conventional Ames test, and 
Fractions 3 and 10 had little or no effect, even at the highest volumes used. This 
could also be regarded as a somewhat surprising observation, given that both 
fractions suppressed the mutagenicity of MNNG in the conventional Ames test, 
suggesting that each has some ability to interact with genotoxic species. It may be 
concluded here that scavenging of reactive intermediates is the minor mechanism of 
the antimutagenicity of F6.
In a previous study whereby green tea was fractionated by HPLC (Hemaez et al, 
1998), the antimutagenicity against the direct-acting mutagen A-hydroxy IQ was 
associated with three fractions. These fractions co-eluted with EGC and (+)- 
catechin, caffeine, and EC and EGCG; no single fraction was as effective as the 
equivalent volume of whole tea, but these three fractions combined accounted for 
most of the inhibitory activity associated with the whole tea. When testing purified 
standards against A-hydroxy IQ, caffeine failed to show any inhibition of the 
mutagenic response, suggesting that component(s) other than caffeine present in 
that particular fraction were responsible for the observed effect. Indeed, only EGC
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and EGCG produced dose-related antimutagenic activity. The authors also 
suggested that the most likely inhibitory mechanism was the scavenging of reactive 
species derived from A-hydroxy IQ, since complex formation with this mutagen 
appeared to be insignificant.
The conversion of A-hydroxy IQ to the reactive nitrenium ion, via O-acetylation or 
sulphation, may occur spontaneously, but can be facilitated by the presence of 
acetyltransferases and sulphotransferases, such as the 0-acetyltransferase present in 
S. typhimurium. The antimutagenic tea constituents EGC and EGCG may suppress 
the mutagenicity of A-hydroxy IQ by inhibiting the enzyme(s) that generate the 
genotoxic species and scavenging the reactive electrophiles (Hemaez et a l, 1997,
1998). A study by Hemaez et al (1997) indicated that the antimutagenic effect of 
EGCG was dependent, at least in part, on a functional 0-acetyltransferase activity in 
the bacteria. However, the present study demonstrates the inhibition of CYP1A2 by 
EGCG, and by implication, the generation of the A-hydroxy IQ species in the first 
place. The same authors also showed that gallic acid and EC exhibited dose-related 
antimutagenic activity against A-hydroxy IQ, but were less effective than EGC and 
EGCG. However, these were not investigated in the present study.
4,4,4 Analyses o f  green tea and green tea Fraction 6
Figure 4.14 shows a chromatogram of green tea Fraction 6. The major peaks present 
are EC and EGCG, as confirmed by reference to the chromatogram of whole GTE, 
and to the chromatogram of F6 following treatment with degallase (Figure 4.15). 
Note that the retention time is different from that of the EGCG peak in the semi­
preparative HPLC chromatogram (Figure 4.2); this is due to the different conditions 
used for fractionation and analysis. Also apparent is the reduction in peak size 
relative to the chromatogram of whole GTE (Figure 4.1), indicating a reduction in 
the flavanol content in F6. This content should, theoretically, have remained 
approximately constant, given that the fractions were reconstituted to the original 
volume of whole GTE from which they were derived. The reduction in flavanol 
content may be a complicated matter, since the EGCG and EC may be undergoing 
oxidation, possibly forming products similar to those found in black tea. The effect 
of fractionation on the flavanol content of the green tea fractions is further
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demonstrated by the chromatograms of the recombined fractions (Figure 4.18) and 
recombined whole GTE (Figure 4.19A). In all cases, the flavanol content as a 
whole, not just EGCG, has decreased, this observation further highlighted by the 
relatively constant caffeine peak, caffeine not being subject to oxidation in the same 
way as the flavanols. This possible destruction of the flavanols may, in part, account 
for the reduced antimutagenic potency of F6 relative to the whole tea.
Work has been carried out in this laboratory on the fractionation of aqueous black 
tea extract (BTE) and the antimutagenic properties of these fractions (Thomas,
1999). Fractionation of aqueous black tea extract (2.5%, w/v) was achieved by 
semi-preparative HPLC under similar conditions to those described in the present 
study, and the antimutagenic properties of these fractions, and of whole BTE, 
evaluated against the same diagnostic mutagens. The results were less emphatic 
than those from the present study, although the whole BTE showed the expected 
marked inhibition of the mutagenic response in all cases, except MNNG. Against IQ 
and B[a]P, Fractions 1 and 2 demonstrated the strongest antimutagenic effect, but 
against NPyr and MNNG, results were not reproducible, hence it is difficult to 
conclude as to the significance of these findings. Interestingly, when evaluated 
against NPyr, many of the fractions augmented the mutagenic response in a similar 
manner to that observed with the green tea fractions in the present study, while 
whole BTE inhibited the NPyr-induced response. It was suggested from these 
findings that the black tea polyphenols likely to contribute to the antimutagenic 
effects observed were the theacitrins, a sub-class of condensed tannins isolated from 
thearubigins (Powell, 1995). Gallic acid was also suggested as a contributing factor, 
but proved ineffective in the present study.
Theafulvins, another class of black tea polyphenols, have also demonstrated 
antimutagenic activity against a variety of mutagens (Catterall et a l, 1998). In 
addition to the theacitrins, theafulvins are also a sub-class of the thearubigins, and 
appear to be the major polyphenolic fraction of black tea (Bailey et a l, 1992; 
Powell, 1995). Since theafulvins, like theacitrins, are a sub-class of thearubigins, it 
is likely that they would elute in similar fractions to the theacitrins. It is therefore 
conceivable that theafulvins are responsible for, or contribute to, the antimutagenic 
properties of whole black tea.
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4.4.5 Assessment o f  the chlorophyll content o f  aqueous green tea extract
Preliminary experiments were carried out in order to assess the chlorophyll content 
of aqueous green tea extract (2.5%, w/v) with a view to determining the likely 
contribution of chlorophyll to the antimutagenic properties of green tea (data not 
shown). However, scanning spectrophotometry (300-500 nm) of GTE and of a 
solution of chlorophyllin standard failed to show the presence of a peak attributable 
to chlorophyllin in the tea extract, hence this line of investigation was not pursued 
any further. The Xmax. for the chlorophyllin solution was around 400 nm.
4.4.6 Summary
Tea, and its components, appear to act via multiple inhibitory mechanisms (Hemaez 
et a l, 1997), a position substantiated by the findings from the present study. 
Fractionation of aqueous green tea extract by semi-preparative HPLC led to the 
isolation of a potent antimutagenic fraction, F6, the major components of which 
were identified as EC and EGCG. Hayatsu et al (1992) also demonstrated the 
antimutagenicity of EGCG in the Ames test, although this study employed direct- 
acting derivatives of food mutagens, notably A-hydroxy IQ. However, in the present 
study, the flavanol content of F6 was substantially lower than expected, and this 
may be due to oxidation of the flavanols during the process of fractionation and 
reconstitution. Such oxidation products may also have contributed to the 
antimutagenic effect of F6 in a similar fashion to the oxidised components present 
in black tea.
Inhibition of the bioactivation of promutagens by the hepatic mixed function 
oxidase system was established as the predominant mechanism of action involved in 
the antimutagenic activity of F6. EGCG demonstrated similar inhibitory activity, as 
exemplified by inhibition of MROD activity. The role of EGCG in the inhibition of 
CYP1A2 was confirmed by treatment of EGCG, F6, and whole GTE with degallase 
enzyme, which, in all cases, diminished the inhibitory activity. Scavenging of 
reactive genotoxic species appeared to be the less important mechanism of action 
involved in the antimutagenic activity of F6.
122
Chapter 4 : Fractionation o f green tea
4,4,7 Acknowledgement
Fractionation of black tea extract and studies on the antimutagenicity of the 
fractions were carried out by Mr Tristan Thomas under my direct supervision in this 
laboratory, and the work submitted to the University of Surrey in partial fulfilment 
of the requirements for the degree of M.Sc. (Toxicology).
723
CHAPTER 5
MODULATION BY TEA OF THE URINARY 
EXCRETION OF MUTAGENS IN RATS
TREATED WITH IQ
Chapter 5 : Urinary excretion o f mutagens
5.1 Introduction
It is now widely appreciated that tea possesses anticarcinogenic activity in animal 
models — an increasing number of studies has indicated that both green tea and 
black tea can afford protection against spontaneous as well as chemically- and 
radiation-induced cancers (Ahmad et al, 1998; Landau et al, 1998; Yang et a l, 
1997). A unique characteristic of tea is that it appears to act beneficially at all stages 
of carcinogenesis; it prevents the A-nitrosation of secondary amines to form 
carcinogenic nitrosamines, prevents the formation of HAA (Tanaka et a l, 1998; 
Weisburger et al, 1994), suppresses the genotoxic effects of mutagenic carcinogens 
(Bu-Abbas et a l, 1994, 1996; Weisburger et a l, 1996), and inhibits the promotion 
and progression stages of carcinogenesis (Hyang et a l, 1992; Lea et a l, 1993; 
Wang et a l, 1994; Yang et a l, 1998).
5.1.1 Antimutagenic effects o f  tea
In studies aimed at identifying the mechanisms responsible for the antimutagenic 
effects of tea, it has been demonstrated that two distinct mechanisms are involved in 
the in vitro suppression of the mutagenicity of a variety of food carcinogens in the 
Ames test; inhibition of the cytochrome P450-dependent bioactivation of the 
carcinogens and, to a lesser extent, scavenging of the reactive intermediates (Bu- 
Abbas et a l, 1994, 1996). A third possible mechanism through which tea may 
impair the initiation stage of chemical carcinogenesis is by stimulating the activity 
of enzymes that detoxicate the carcinogenic reactive intermediates, or by directing 
the metabolism of the carcinogens towards pathways that generate innocuous, 
readily-excretable metabolites (Bu-Abbas et a l, 1995; Sohn et a l, 1994). The 
nature of the tea component(s) responsible for its antimutagenic activity in such 
studies has not yet been defined. Flavonoids, polyphenolics predominant in green 
tea (Harbowy & Balentine, 1997), appear not to be responsible (Bu-Abbas et a l, 
1997), whereas theafulvins, polyphenolics present only in black tea, appear to 
contribute substantially to the antimutagenic effects of black tea by inhibiting the 
bioactivation of the chemical carcinogens (Catterall et a l, 1998).
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Although in in vitro studies tea, both green and black, inhibited cytochrome P450 
activity (Bu-Abbas et al, 1994, 1996), when rats were kept on an aqueous infusion 
of tea (2.5%, w/v), green or black, induction of hepatic CYPIA and CYP4A 
proteins was observed (Bu-Abbas et a l, 1994, 1999a; Sohn et a l, 1994), the effect 
on the former cytochrome P450 subfamily being attributed to caffeine (Bu-Abbas et 
al, 1999; Chen et a l, 1996). Thus, it is evident that the effects of tea on cytochrome 
P450 activity in vitro cannot be extrapolated to the in vivo situation. A similar effect 
was observed with another naturally-occurring plant chemical, anthraflavic acid, 
which reduced the mutagenicity of HAA in vitro by inhibiting CYP1A2 (Ayrton et 
al, 1988a), but induced the same enzyme when administered in vivo (Ayrton et al, 
1988b).
5.L2 Pharmacokinetics o f  IQ
The HAA IQ has been identified as one of the compounds responsible for a high 
proportion of the mutagenic activity found in protein-rich foods cooked at high 
temperatures, and is strongly mutagenic in S. typhimurium strain TA98 in the 
presence of an activation system derived from rat liver. In a balance study of "^Re­
labelled IQ in rats, Sjodin & Jagerstad (1984) showed that approximately 90% of a 
single dose of IQ had left the body within 24 hours of ingestion, up to 48% of which 
was excreted in the urine, and very little of which was unchanged IQ. In the 
subsequent 48 hours, only a further 4% of the radioactivity was excreted in the 
urine, and after 72 hours, less than 2% remained in the carcasses. However, no 
mutagenicity was detected in any of the urine samples.
Studies on IQ in vivo have revealed a number of metabolites excreted in the urine, 
bile, and faeces. In one such study, Turesky et al (1986) identified the major biliary 
metabolite of IQ as the sulphamate derivative, A-[3-methylimidazo[4,5-/]quinolin- 
2-yl] sulphamic acid. Urinary excretion of this metabolite accounted for 5% of an 
administered dose of "^RC-labelled IQ, and again, very little unchanged IQ was 
recovered from urine, nor from the bile and faeces. In addition, the sulphamate was 
shown to be non-mutagenic in bacterial mutation assays, with or without an 
activation system. Formation of this metabolite is likely to be prominent in the 
detoxication and rapid excretion of IQ (Turesky et a l, 1986).
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A further major pathway of IQ metabolism in the rat is ring-hydroxylation at the 5- 
position (Luks et a l, 1989). 5-Hydroxy IQ was found to be present in the urine and 
bile as both the 0-glucuronide and sulphate ester, demonstrated by their sensitivity 
to p-glucuronidase and arylsulphatase respectively. The urinary excretion of the 5- 
0-glucuronide and the 5-sulphate ester accounted for approximately 9% and 11% 
respectively of the dose of IQ administered (or approximately 28% and 35% of 
urinary metabolites, respectively). In addition, another minor metabolite was 
characterised, identified as the A-glucuronide of IQ (GlcA as a substituent on the 
exocyclic amino group), as demonstrated by its resistance to p-glucuronidase and 
arylsulphatase, and its acid-lability. The A-glucuronide accounted for less than 5% 
of urinary metabolites (Luks et a l, 1989).
5.1.3 The bacterial tester strains
In the present study, several strains of S. typhimurium were used in the Ames test, 
each engineered to under- or over-express enzymes believed to be involved in the 
activation of IQ to genotoxic species. Such strains have been successfully employed 
in assessing the mutagenicity of human urine collected from smokers (Kuenemann- 
Migeot et a l, 1997) and from volunteers consuming raw fish or cooked beef (Sasaki 
et al, 1996). Primarily, strain YG1024 was used, due to its greater sensitivity to the 
low levels of mutagens excreted in the urine than the standard Ames tester strain, 
TA98. YG1024 is a derivative of TA98 over-expressing O-acetyltransferase activity 
(OAT), this activity being important in the generation of the ultimate genotoxic 
species (Watanabe et al, 1990). To investigate further the role of OAT in the 
bioactivation of IQ, a strain under-expressing OAT activity, TA98/1,8-DNP6, was 
used (McCoy et a l, 1982, 1983). In addition, the role of bacterial nitroreductase in 
mediating the mutagenic response was investigated using TA98NR and YG1021, 
strains under- and over-expressing nitroreductase activity respectively (Rosenkranz 
et a l, 1982; Watanabe et a l, 1989). In these further studies, the standard TA98 
strain was also used as a reference.
727
Chapter 5 : Urinary excretion o f mutagens
5,1,4 Objectives
In order to evaluate the effect of tea consumption on the metabolism of chemical 
carcinogens in vivo, a different approach has been employed here. Rats maintained 
on various aqueous infusions of tea for 4 weeks were subsequently treated orally 
with the food carcinogen IQ. The urinary excretion of mutagens and promutagens 
was then assayed using the Ames mutagenicity test.
Three experimental studies were undertaken to investigate the effects of tea 
consumption on the urinary excretion of mutagens. These were preceded by a series 
of preliminary studies having several objectives, the first of which was to establish 
the effect of an increasing volume of urine, collected from untreated rats, on the 
spontaneous reversion rates of the bacterial strains used in the Ames test. The 
second objective was to establish the pattern of urinary excretion of mutagens 
following administration of IQ to rats. The third was to establish that the IQ-induced 
excretion of mutagens in the urine of rats was dose-dependent, and from this to 
select an appropriate dose of IQ that induces an adequate mutagenic response from 
the rat urine. From these preliminary experiments, conditions were determined for 
the experimental studies.
5.2 Materials and methods
5,2.1 Materials
Male Wistar albino rats (120-150 g) were obtained from B&K Universal Ltd (Hull, 
UK) and housed in the EBU. IQ was purchased from Toronto Research Chemicals 
(Toronto, Canada). p-Glucuronidase (type B-1, from bovine liver), arylsulphatase 
(type H-1, from Helix pomatia), D-saccharic acid-1,4-lactone, and caffeine were all 
purchased from Sigma Chemical Co. (Poole, Dorset, UK). The Salmonella 
typhimurium strains were all gifts from B. Ames, University of California at 
Berkeley, USA (TA98), M. Plewa, University of Illinois, USA (YG1021 and 
YG1024), and H. Hayatsu, Okayama University, Japan (TA98NR and TA98/1,8- 
DNPe).
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Green tea (Gunpowder), black tea (Keemun), and decaffeinated black tea (Ceylon) 
were purchased locally and stored at 4°C in a sealed plastic bag. Tea infusions 
(2.5%, w/v) were prepared by adding boiling water (400 ml) to the tea leaves (10 g) 
in a Thermos^^ flask, allowing to brew for 10 minutes whilst inverting every 30 
seconds, and then filtering through cotton wool to remove the leaves. Infusions were 
stored in the dark at 4°C overnight to allow the tea to cream fully. This was carried 
out in order to minimise variations in the composition of the infusions consumed by 
the animals.
5.2.2 Preliminary studies
5.2.2.1 Experiment 1
Four male Wistar albino rats (200-300 g) were kept individually in metabolism 
cages and urine from each animal collected every 24 hours for 48 hours. Urine 
samples were decanted into 25 ml polystyrene Sterilin tubes, centrifuged at l,000g 
for 15 minutes at 4°C (Beckman J6 centrifuge, JS 4.2 rotor) to remove solid 
material, the supernatant decanted off and then filter-sterilised (0.2 pm Minisart 
filters, performed in a class 2 safety cabinet) into fresh tubes. The two urine samples 
from each animal were pooled, then stored at -20°C until required. Urine samples 
were tested at a range of volumes (0-500 pi, the total volume added made up to 500 
pi with sterile water) with S. typhimurium strains TA98 and TAIOO, in the absence 
of an activation system.
5.2.2.2 Experiment 2
Animals were treated with a single dose of 2.5, 5.0, or 10.0 mg kg”* of IQ in com 
oil by gavage, and urine collected every 24 hours, for 24 hours prior to and for 72 
hours following IQ administration. After dosing, the rats were placed in metabolism 
cages for the duration of urine collection. Following collection, urine was 
centrifuged at l,000g for 10 minutes, then filter-sterilised into fresh tubes and stored 
at -20°C until use in the Ames test.
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5.2.3 Experimental studies
In the first study, the effect of green tea consumption on the urinary excretion of IQ- 
derived mutagens was investigated. Three groups, each of four rats, were used. The 
first group served as control, maintained on water, whilst groups two and three were 
maintained on aqueous extracts of green tea (2.5%, w/v) as their sole source of 
liquid for 4 weeks. At the end of this period, the tea was withdrawn from group 
three and replaced with water. All three groups subsequently received a single dose 
of IQ in com oil (5 mg kg”*) by gavage, 24 hours after the withdrawal of the green 
tea from group three. Urine was collected every 24 hours, for 24 hours prior to and 
for 48 hours following the administration of IQ.
Similarly, in the second study, three groups of four animals were also used. Group 
one served as control, whereas groups two and three were maintained on aqueous 
extracts of black tea and decaffeinated black tea (2.5%, w/v) respectively for 4 
weeks. At the end of this period, all three groups received a single dose of IQ in 
com oil (5 mg kg”*) by gavage, and urine was collected for 24 hours prior to and for 
48 hours following the administration of IQ. In the final study, group one served as 
control, whereas groups two and three were maintained on aqueous extracts (2.5%, 
w/v) of decaffeinated black tea and decaffeinated black tea supplemented with 
caffeine (700 mg 1”*, termed ‘recaffeinated black tea’) respectively for 4 weeks. At 
the end of this period, all three groups reeeived a single dose of IQ in com oil (5 mg 
kg”*) by gavage, and urine was collected for 24 hours prior to and for 48 hours 
following the administration of IQ. The concentration of caffeine used to 
supplement the decaffeinated black tea (Ceylon) was based on the levels of caffeine 
found in the whole black tea (Keemun), as determined by HPLC analysis in this 
laboratory (Bu-Abbas et a l, 1999b).
Mutagenic activity in the urine was monitored using the Ames test, as described in 
Chapter 2, using a 10% (v/v) activation system where appropriate. The S9 activation 
system was derived from the livers of rats treated with Aroclor 1254, also described 
in Chapter 2. For the studies investigating the effects of tea consumption, 
mutagenicity was monitored both in the absence and presence of an activation 
system, and employed S. typhimurium strain YG1024. The urine was also treated
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with deconjugating enzymes, and the effect of this treatment on mutagenic activity 
assessed. Aliquots of urine (300 pi) from each animal were mixed with an equal 
volume of sodium acetate buffer (0.2 M, pH 5) containing either p-glucuronidase 
(5000 U ml”*) or arylsulphatase (250 U ml”*, supplemented with D-saccharic acid- 
1,4-lactone, at 17 mM, to inhibit inherent glucuronidase activity). Urine samples 
were then incubated in a shaking water bath at 37°C for 16 hours overnight 
(Steensma et a l, 1994). Mutagenic activity was then determined in the absence and 
presence of an activation system.
The urine was not concentrated for use in these studies; when mutagenic activity 
was determined in the absence of an activation system, urine was used neat, and 
when determined in the presence of an activation system, urine was diluted as 
required with sterile water. In each case, mutagenic response was calculated by first 
subtracting the spontaneous reversion rate, then correcting for any dilution made, 
and then finally expressed in terms of the whole volume collected per 24 hours. 
Statistical evaluation was carried out using Student’s /-test. All analyses were 
performed using Microsoft Excel software.
5.3 Results
5.3.1 Preliminary studies
The first objective of the preliminary studies was to determine the effect of urine 
from untreated rats on the spontaneous reversion rates of the Salmonella tester 
strains. Figure 5.1 shows that, although there is clearly a dose-dependent 
relationship between volume of urine incorporated and an increase in spontaneous 
reversion rate, the effect on TA98, the strain initially intended for use in the 
experimental studies, is minimal. It was therefore decided that removal of histidine 
from the urine was unnecessary. Similarly, the effect of urine from untreated rats on 
the mutagenic response of TA98 when exposed to a diagnostic mutagen (Figure 5.2) 
was also deemed to be insufficient to warrant any processing of the urine prior to 
use.
131
Chapter 5 : Urinary excretion o f mutagens
TA98
100
90
80
70
6 0
t  4 0
E 30  
E
Z  2 0
10
5 0 100 200
V olum e o f urine (pi)
3 0 0 4 0 0 5 0 0
TA100
3 0 0
2 5 0
200
150TJ
50
50 100 200
V olum e of urine (f l^)
3 0 0 4 0 0 5 0 0
Figure 5.1 Effect of urine from untreated  rats on the spontaneous reversion rates of Salmonella 
typhimurium  strains TA98 and TAIOO. Urine from 4 animals was collected every 24 hours for 48 
hours, and the urine from each animal incorporated into spontaneous reversion tests for TA98 and 
TAIOO. Urine was tested over a range of volumes, all made up to a final volume o f 500 pi with 
water. All tests were performed in triplicate. Results are presented as mean ± S.D. for 4 animals.
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Figure 5.2 Effect of urine from untreated rats on the IQ-induced mutagenic response in 
Salmonella typhimurium  strain TA98. Urine from 2 animals was collected every 24 hours for 48 
hours, and the urine from each animal incorporated into the Ames test. Mutagenic response was 
induced with IQ (5 ng per plate) in the presence o f an hepatic activation system (10%, v/v) derived 
from rats treated with Aroclor 1254. Urine was tested over a range of volumes, all made up to a final 
volume o f 500 pi with water. All tests were performed in triplicate. Results are presented as mean of 
triplicates for 2 animals ± the range.
In the second part of the preliminary study, the pattern of excretion of IQ-induced 
urinary mutagens was investigated. This included establishing whether the excretion 
of IQ-induced urinary mutagens was dose-dependent, as became apparent. Initially, 
these investigations employed Salmonella strain TA98 in the Ames test. However, 
the mutagenic response was relatively poor, especially at the lower doses of IQ, and 
it proved difficult to show adequately the dose-response relationship. Therefore, the 
more sensitive tester strain, YG1024, was subsequently used. From Figure 5.3, it 
can be seen that there is indeed a dose-dependent relationship between dose of IQ 
administered and mutagenic response. Also clear is the effect of increasing the 
volume of urine incorporated into the Ames test on the mutagenic response, and 
from these results, the volume of urine to be used (500 pi) in subsequent studies was 
determined. In addition, it is evident that most of the mutagenicity excreted in the 
urine occurs within 24 hours of IQ administration.
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Figure 5.3 Dose-response effect of urine from rats treated  with IQ on the m utagenic response 
of Salmonella typhimurium  in the Ames test. Urine was collected from animals every 24 hours, for 
24 hours prior to and for 72 hours following the administration o f IQ. Each animal received a single 
dose o f IQ, by gavage, o f either 2.5, 5.0, or 10.0 mg kg"'. Urine was tested over a range o f volumes, 
all made up to a final volume o f 500 pi with water. All tests were performed in duplicate, employing 
S. typhimurium strain YG1024 in the absence of an activation system. Results are presented as the 
average of two determinates, the error bars denoting the range.
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Figure 5.4 Preliminary study to determine the pattern of excretion of mutagens and 
promutagens in the urine of rats treated with IQ. Mutagenic activity is expressed in terms o f 
histidine revertants per day, and was determined using the Ames test employing Salmonella 
typhimurium strain YG1024. Mutagenicity was determined in the absence (A) and in the presence 
(B) of an hepatic activation system (10%, v/v) derived from rats treated with Aroclor 1254. Rats 
received a single dose of IQ, by gavage, o f either 2.5, 5.0, or 10.0 mg k g ' .  Urine was collected every 
24 hours, for 24 hours prior to and for 72 hours following administration o f IQ. Each analysis was 
performed in duplicate. The spontaneous reversion rates of 46 ± 3 (A) and 83 + 14 (B) have already 
been subtracted.
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Figure 5.5 Preliminary study to determine the pattern of excretion of mutagens and 
promutagens in the urine of rats treated with IQ following deglucuronidation. Mutagenic 
activity is expressed in terms o f histidine revertants per day, and was determined using the Ames test 
employing Salmonella typhimurium strain YG1024. Mutagenicity was determined in (A) urine 
treated with (3-glucuronidase, and (B) urine treated with (3-glucuronidase and in the presence o f an 
hepatic activation system (10%, v/v) derived from rats treated with Aroclor 1254. Rats received a 
single dose of IQ, by gavage, o f either 2.5, 5.0, or 10.0 mg kg ''. Urine was collected every 24 hours, 
for 24 hours prior to and for 72 hours following administration o f IQ. Each analysis was performed 
in duplicate. The spontaneous reversion rates of 81 ± 2  (A) and 91 ± 4 (B) have already been 
subtracted.
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Figure 5.6 Preliminary study to determine the pattern of excretion of mutagens and 
promutagens in the urine of rats treated with IQ following desulphation. Mutagenic activity is 
expressed in terms o f histidine revertants per day, and was determined using the Ames test 
employing Salmonella typhimurium strain YG1024. Mutagenicity was determined in (A) urine 
treated with aryl sulphatase, and (B) urine treated with arylsulphatase and in the presence of an 
hepatic activation system (10%, v/v) derived from rats treated with Aroclor 1254. Rats received a 
single dose o f IQ, by gavage, o f either 2.5, 5.0, or 10.0 mg kg ''. Urine was collected every 24 hours, 
for 24 hours prior to and for 72 hours following administration o f IQ. Each analysis was performed 
in duplicate. The spontaneous reversion rates o f 81 ± 2  (A) and 9 1 + 4  (B) have already been 
subtracted.
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This preliminary study was repeated to confirm the pattern of excretion of urinary 
mutagens, and to investigate the effect of the presence of an activation system and 
treatment with deconjugating enzymes on the mutagenic response. Figures 5.4 to
5.6 show the results of this experiment, directly comparing the results from the three 
different doses of IQ. These results confirm the previous observation that excretion 
of mutagenic material is virtually complete within 24 hours of IQ administration, as 
well as more clearly illustrating that the excretion of mutagenic material is dose- 
dependent, at least up to 10 mg kg“  ^ of IQ. Figures 5.5 and 5.6 show the effect of 
treatment of the urine with deconjugating enzymes on the mutagenic response, both 
in the absence and presence of an activation system. From these data, it would 
appear that both deglucuronidation and desulphation resulted in considerable 
elevation of the mutagenicity of the urine. However, this may be due to inter- 
experimental variation, since these assays were not performed simultaneously, 
particularly in the light of subsequent results, which suggest that deconjugation has 
little effect on urinary mutagenicity.
5.3.2 Effect o f tea administration on the urinary excretion o f mutagens
The direct-acting mutagenic activity in the urine from IQ-treated animals was 
suppressed following consumption of green tea, but statistical significance was not 
achieved owing to wide variation and the small size of the groups. This decrease in 
mutagenic activity was not influenced by the 24-hour abstinence of the animals 
from green tea (Figure 5.7A). In the presence of an activation system, a marked 
mutagenic response was seen in the urine following treatment with IQ, again most 
of the mutagenic activity present in the 24-hour samples, with only very low levels 
present in the 48-hour samples. Consumption of green tea, with or without the 24- 
hour abstinence, significantly decreased the mutagenic response (Figure 5.7B). 
Urinary mutagenic response was not modulated by incubating the urine samples 
with either p-glucuronidase (Figure 5.8A) or arylsulphatase (Figure 5.9A). In the 
presence of an activation system, again incubation with either p-glucuronidase 
(Figure 5.8B) or arylsulphatase (Figure 5.9B) failed to increase the mutagenic 
response. In each case, the green tea-mediated decrease in mutagenicity was 
maintained. In the presence of an activation system, the decrease in mutagenic
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response observed in the urine of the animals consuming green tea was statistically 
significant.
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Figure 5.7 Effect of green tea administration on the excretion of mutagens and promutagens in 
the urine of rats treated with IQ. Mutagenic activity is expressed in terms of histidine revertants 
per day, and was determined using the Ames test employing Salmonella typhimurium strain 
YG1024. Mutagenicity was determined in the absence (A) and in the presence (B) o f an hepatic 
activation system (10%, v/v) derived from rats treated with Aroclor 1254. Group 1, rats were 
maintained on water and then received a single dose o f IQ (5 mg kg ') by gavage; Group 2, rats were 
maintained on aqueous green tea extract (2.5%, w/v) and after 4 weeks received a single dose of IQ 
(5 mg k g '')  by gavage; and Group 3, rats were maintained on aqueous green tea extract (2.5%, w/v) 
for 4 weeks, tea was withdrawn, then 24 hours later the rats received a single dose of IQ (5 mg k g '')  
by gavage. Results are presented as mean ± S.E.M. for 4 animals. Each analysis was performed in 
triplicate. The spontaneous reversion rates of 58 ± 10 (A) and 92 ± 4 (B) have already been 
subtracted. *P < 0.05.
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Figure 5.8 Effect of green tea administration on the excretion of mutagens and promutagens in 
the urine of rats treated with IQ following deglucuronidation. Mutagenic activity is expressed in 
terms o f histidine revertants per day, and was determined using the Ames test employing Salmonella 
typhimurium strain YG1024. Mutagenicity was determined in urine treated with (3-glucuronidase 
(A), and urine treated with |3-glucuronidase and in the presence of an hepatic activation system (10%, 
v/v) derived from rats treated with Aroclor 1254 (B). Group 1, rats were maintained on water and 
then received a single dose o f IQ (5 mg k g '')  by gavage; Group 2, rats were maintained on aqueous 
green tea extract (2.5%, w/v) and after 4 weeks received a single dose o f IQ (5 mg k g '')  by gavage; 
and Group 3, rats were maintained on aqueous green tea extract (2.5%, w/v) for 4 weeks, tea was 
withdrawn, then 24 hours later the rats received a single dose o f IQ (5 mg k g '')  by gavage. Results 
are presented as mean ± S.E.M. for 4 animals. Each analysis was performed in triplicate. The 
spontaneous reversion rates of 58 ± 10 (A) and 92 ± 4 (B) have already been subtracted. **P <0.01.
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Figure 5.9 Effect of green tea administration on the excretion of mutagens and promutagens in 
the urine of rats treated with IQ following desulphation. Mutagenic activity is expressed in terms 
o f histidine revertants per day, and was determined using the Ames test employing Salmonella 
typhimurium strain YG1024. Mutagenicity was determined in (A) urine treated with arylsulphatase, 
and (B) urine treated with arylsulphatase and in the presence o f an hepatic activation system (10%, 
v/v) derived from rats treated with Aroclor 1254. Group 1, rats were maintained on water and then 
received a single dose of IQ (5 mg kg'") by gavage; Group 2, rats were maintained on aqueous green 
tea extract (2.5%, w/v) and after 4 weeks received a single dose of IQ (5 mg kg ') by gavage; and 
Group 3, rats were maintained on aqueous green tea extract (2.5%, w/v) for 4 weeks, tea was 
withdrawn, then 24 hours later the rats received a single dose of IQ (5 mg kg“') by gavage. Results 
are presented as mean ± S.E.M. for 4 animals. Each analysis was performed in triplicate. The 
spontaneous reversion rates o f 58 ± 10 (A) and 9 2 + 4  (B) have already been subtracted. **P < 0.01.
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The IQ-induced direct-acting mutagenicity in the urine of rats was decreased in the 
animals pre-treated with whole black tea, the effect being statistically significant. In 
contrast, no such effect was seen when the animals were maintained on the same 
concentration of decaffeinated black tea (Figure 5.10A). When indirect 
mutagenicity was determined, in the presence of an activation system, consumption 
of decaffeinated black tea caused a modest decrease in the mutagenic response that 
was not statistically significant. Treatment with whole black tea, however, resulted 
in a dramatic and statistically-significant reduction in mutagenicity (Figure 5.1 OB). 
No increases in mutagenic response were noted when the urine was incubated with 
either P-glucuronidase (Figure 5.11 A) or arylsulphatase (Figure 5.12A), nor did 
such treatment increase indirect-acting mutagenicity in the presence of an activation 
system (Figures 5.1 IB and 5.12B respectively). In each case, direct and indirect 
mutagenic activity was still lower in urine from rats treated with whole black tea, 
and the lesser effect of decaffeinated black tea on indirect mutagenic activity was 
still seen.
Supplementation of decaffeinated black tea with caffeine resulted in a statistically- 
significant decrease in the urinary excretion of direct-acting mutagens following 
treatment of the rats with IQ (Figure 5.13 A). Recaffeinated black tea markedly, and 
significantly, reduced the indirect mutagenicity of the urine, in the presence of an 
activation system (Figure 5.13B). Figures 5.14 and 5.15 show the effects on the 
urinary mutagenicity of treatment with P-glucuronidase and arylsulphatase 
respectively, in the absence (A) and presence (B) of an activation system. Again, the 
recaffeinated black tea drastically reduced the mutagenic response in the presence of 
an activation system, whereas decaffeinated black tea had little or no effect. The 
reduction of the urinaiy mutagenicity due to recaffeinated black tea in the absence 
of activation was less pronounced, but still greater than the effect of decaffeinated 
black tea.
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Figure 5.10 Effect of black tea and decaffeinated black tea administration on the excretion of 
mutagens and promutagens in the urine of rats treated with IQ. Mutagenic activity is expressed 
in terms of histidine revertants per day, and was determined using the Ames test employing 
Salmonella typhimurium strain YG1024. Mutagenicity was determined in the absence (A) and in the 
presence (B) of an hepatic activation system (10%, v/v) derived from rats treated with Aroclor 1254. 
Group 1, rats were maintained on water and then received a single dose of IQ (5 mg kg ') by gavage; 
Group 2, rats were maintained on aqueous black tea extract (2.5%, w/v) and after 4 weeks received a 
single dose of IQ (5 mg kg"') by gavage; and Group 3, rats were maintained on aqueous 
decaffeinated black tea extract (2.5%, w/v) and after 4 weeks received by gavage a single dose o f IQ 
(5 mg kg"'). Results are presented as mean ± S.E.M. for 4 animals. Each analysis was performed in 
triplicate. The spontaneous reversion rates of 24 ± 4 (A) and 64 + 8 (B) have already been subtracted. 
*P < 0.05 .
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Figure 5.11 Effect of black tea and decaffeinated black tea administration on the excretion of 
mutagens and promutagens in the urine of rats treated with IQ following deglucuronidation.
Mutagenic activity is expressed in terms of histidine revertants per day, and was determined using 
the Ames test employing Salmonella typhimurium strain YG1024. Mutagenicity was determined in 
(A) urine treated with (3-glucuronidase, and (B) urine treated with (3-glucuronidase and in the 
presence o f an hepatic activation system (10%, v/v) derived from rats treated with Aroclor 1254. 
Group 1, rats were maintained on water and then received a single dose of IQ (5 mg kg"') by gavage; 
Group 2, rats were maintained on aqueous black tea extract (2.5%, w/v) and after 4 weeks received a 
single dose o f IQ (5 mg kg ') by gavage; and Group 3, rats were maintained on aqueous 
decaffeinated black tea extract (2.5%, w/v) and after 4 weeks received by gavage a single dose o f IQ 
(5 mg kg"'). Results are presented as mean ± S.E.M. for 4 animals. Each analysis was performed in 
triplicate. The spontaneous reversion rates o f 24 ± 4 (A) and 64 ± 8 (B) have already been subtracted. 
*P < 0 .05 .
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Figure 5.12 Effect of black tea and decaffeinated black tea administration on the excretion of 
mutagens and promutagens in the urine of rats treated with IQ following desulphation.
Mutagenic activity is expressed in terms of histidine revertants per day, and was determined using 
the Ames test employing Salmonella typhimurium strain YG1024. Mutagenicity was determined in 
(A) urine treated with arylsulphatase, and (B) urine treated with arylsulphatase and in the presence of 
an hepatic activation system (10%, v/v) derived from rats treated with Aroclor 1254. Group 1, rats 
were maintained on water and then received a single dose of IQ (5 mg kg"') by gavage; Group 2, rats 
were maintained on aqueous black tea extract (2.5%, w/v) and after 4 weeks received a single dose 
of IQ (5 mg kg ') by gavage; and Group 3, rats were maintained on aqueous decaffeinated black tea 
extract (2.5%, w/v) and after 4 weeks received a single dose of IQ (5 mg kg"') by gavage. Results are 
presented as mean ± S.E.M. for 4 animals. Each analysis was performed in triplicate. The 
spontaneous reversion rates of 24 ± 4 (A) and 64 ± 8 (B) have already been subtracted. *P < 0.05.
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Figure 5.13 Effect of addition of caffeine to decaffeinated black tea on the excretion of 
mutagens and promutagens in the urine of rats treated with IQ. Mutagenic activity is expressed 
in terms of histidine revertants per day, and was determined using the Ames test employing 
Salmonella typhimurium strain YG1024. Mutagenicity was determined in the absence (A) and in the 
presence (B) of an hepatic activation system (10%, v/v) derived from rats treated with Aroclor 1254. 
Group 1, rats were maintained on water and then received a single dose of IQ (5 mg kg ') by gavage; 
Group 2, rats were maintained on aqueous decaffeinated black tea extract (2.5%, w/v) and after 4 
weeks received a single dose of IQ (5 mg kg ') by gavage; and Group 3, rats were maintained on 
aqueous decaffeinated black tea extract (2.5%, w/v) supplemented with caffeine (700 mg 1"') and 
after 4 weeks received a single dose of IQ (5 mg kg"') by gavage. Results are presented as mean ± 
S.E.M. for 4 animals. Each analysis was performed in triplicate. The spontaneous reversion rates of 
32 + 3 (A) and 150 + 27 (B) have already been subtracted. *P < 0.05.
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Figure 5.14 Effect of addition of caffeine to decaffeinated black tea on the excretion of 
mutagens and promutagens in the urine of rats treated with IQ following deglucuronidation.
Mutagenic activity is expressed in terms o f histidine revertants per day, and was determined using 
the Ames test employing Salmonella typhimurium strain YG1024. Mutagenicity was determined in 
(A) urine treated with (3-glucuronidase, and (B) urine treated with P-glucuronidase and in the 
presence of an hepatic activation system (10%, v/v) derived from rats treated with Aroclor 1254. 
Group 1, rats were maintained on water and then received a single dose o f IQ (5 mg kg"') by gavage; 
Group 2, rats were maintained on aqueous decaffeinated black tea extract (2.5%, w/v) and after 4 
weeks received a single dose of IQ (5 mg kg"') by gavage; and Group 3, rats were maintained on 
aqueous decaffeinated black tea extract (2.5%, w/v) supplemented with caffeine (700 mg 1"') and 
after 4 weeks received a single dose of IQ (5 mg kg ') by gavage. Results are presented as mean ± 
S.E.M. for 4 animals. Each analysis was performed in triplicate. The spontaneous reversion rates of 
32 ± 3 (A) and 150 + 27 (B) have already been subtracted. *P < 0.05.
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Figure 5.15 Effect of addition of caffeine to decaffeinated black tea on the excretion of 
mutagens and promutagens in the urine of rats treated with IQ following desulphation.
Mutagenic activity is expressed in terms of histidine revertants per day, and was determined using 
the Ames test employing Salmonella typhimurium strain YG1024. Mutagenicity was determined in 
(A) urine treated with arylsulphatase, and (B) urine treated with arylsulphatase and in the presence of 
an hepatic activation system (10%, v/v) derived from rats treated with Aroclor 1254. Group 1, rats 
were maintained on water and then received a single dose of IQ (5 mg kg"') by gavage; Group 2, rats 
were maintained on aqueous decaffeinated black tea extract (2.5%, w/v) and after 4 weeks received a 
single dose of IQ (5 mg kg ') by gavage; and Group 3, rats were maintained on aqueous 
decaffeinated black tea extract (2.5%, w/v) supplemented with caffeine (700 mg 1"') and after 4 
weeks received a single dose of IQ (5 mg kg"') by gavage. Results are presented as mean ± S.E.M. 
for 4 animals. Each analysis was performed in triplicate. The spontaneous reversion rates o f 32 ± 3 
(A) and 150 + 27 (B) have already been subtracted. *P < 0.05, **P < 0.01.
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5,3.3 Nature o f  urinary mutagens
Urinary mutagenicity was also investigated in S. typhimurium bacterial strains 
under- and over-expressing enzyme systems involved in the bioactivation of amines 
(Figure 5.16). The highest increase in urinary mutagenic activity following 
treatment of the rats with IQ was seen with strain YG1024, over-expressing OAT 
activity. The marked inhibitory effect of black tea on the excretion of direct-acting 
mutagens in the urine of IQ-treated rats is also clearly evident.
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Figure 5.16 Effect of black tea and decaffeinated black tea administration on the excretion of 
mutagens in the urine of rats treated with IQ, as determined using bacterial strains under- and 
over-expressing nitroreductase and O-acetyltransferase activity in the Ames test. Mutagenic 
activity is expressed in terms of histidine revertants per day, determined in the 24-hour urine 
samples, using the Ames test employing Salmonella typhimurium strains TA98, TA98NR 
(nitroreductase deficient), TA98/1,8-DNP6 (O-acetyltransferase deficient), YG1021 (nitroreductase 
over-expressing), and YG1024 (0-acetyltransferase over-expressing). No IQ, urine from control 
animals prior to administration of IQ; IQ, rats were maintained on water and then received a single 
dose of IQ (5 mg kg"') by gavage; Black tea + IQ, rats were maintained on aqueous black tea extract 
(2.5%, w/v) and after 4 weeks received a single dose of IQ (5 mg kg"') by gavage; and Decaff, black 
tea + IQ, rats were maintained on aqueous decaffeinated black tea extract (2.5%, w/v) and after 4 
weeks received a single dose of IQ (5 mg kg ') by gavage. Results are presented as mean ± S.E.M. 
for 4 animals. Each analysis was performed in triplicate. The spontaneous reversion rates o f 28 ± 2, 
23 ± 1, 14 ± 1, 90 ± 1, 30 ± 3 for TA98, TA98NR, TA98/1,8-DNP6, YG1021, and YG1024, 
respectively, have already been subtracted. *P < 0.05 and **P < 0.01.
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When TA98NR and TA98/1,8-DNP6, under-expressing nitroreductase and OAT 
respectively, were used, there was little difference in mutagenic response with 
TA98NR, and a reduction in mutagenic response with TA98/1,8-DNP6, relative to 
the standard TA98, thus further supporting the role of OAT in mediating the 
mutagenic response. Although there was an elevated response relative to standard 
TA98 when YG1021, over-expressing nitroreductase, was used, the increase was a 
simple rise in numbers of revertants, and the differences between the groups were 
not amplified, as with YG1024.
5.4 Discussion
In this study, IQ was chosen for a number of reasons. Primarily, it is a carcinogen 
present in cooked food (Skog & Jagerstad, 1998), and as such, may be ingested 
concurrently with tea, providing a reasonable model of the true situation. In 
addition, IQ is a very potent mutagen in the Ames test (Sugimura et a l ,  1993), 
enabling smaller quantities to be used, again more accurately reflecting the true 
situation. Also, tea has been shown to modulate the biological effects of IQ; tea 
markedly inhibits the mutagenicity of IQ in the Ames test (Bu-Abbas et a l ,  1994), 
and has been shown to protect against IQ-induced colonic aberrant crypts in the rat 
(Xu et a l ,  1996). Furthermore, the in vivo metabolism of IQ has been extensively 
studied in the rat.
5.4.2 Metabolism and excretion o f  IQ
In a balance study of "^^C-labelled IQ in the rat, Sjodin & Jagerstad (1984) 
concluded that, owing to the small amount of radioactivity found in expired air, IQ 
does not undergo any degradation of the ^"^C-labelled imidazole part of the molecule 
during metabolism of the molecule. This structure is necessary for the mutagenicity 
of IQ, but they failed to detect mutagenic activity in any of the urine samples 
analysed, either in the absence or in the presence of an activation system. However, 
in that study, S. typhimurium TA98 was used, which, during the present study, was 
established as being relatively insensitive to the mutagenicity excreted in the urine. 
They also showed, by TLC and autoradiography, that up to 8 metabolites were 
excreted in the urine and bile, with only very minor spots that might have
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corresponded to unchanged IQ. Consequently, they suggested that almost all of the 
IQ ingested is excreted as metabolites with virtually no mutagenic activity (Sjodin 
& Jagerstad, 1984).
Following the detection in the bile of the 5-O-glucuronide and sulphate ester, the 
absence of these conjugates of 5-OH IQ from faeces suggests they are hydrolysed in 
the gut, presumably by the gut microflora (Luks et a l, 1989). Therefore, 5-OH IQ 
should be present in the faeces at considerable level; this was later conflrmed by 
Vavrek & Weisburger (1990). The 5-OH metabolite of IQ is formed by the direct 
hydroxylation of IQ through the action of specific enzymes, such as CYP1A2 or 
prostaglandin synthases (Luks et al, 1989). The activation of IQ by prostaglandin H 
synthase (PHS) may be of interest with regard to extrahepatic formation of reactive 
intermediates, since this enzyme is present in the microsomal fraction of several 
mammalian tissues (Flammang et a l, 1989). The arachidonic acid-dependent 
activation of IQ by PHS in vitro yields two mutagenic metabolites, namely azo-IQ 
and nitro-IQ (Morrison et a l, 1993; Wolz et a l, 1995), and given the relative 
stability of these metabolites, in vivo formation may lead to their transport to other 
tissues, or to their excretion.
A further pathway of IQ metabolism is ring hydroxylation at the C-7 position by 
intestinal microflora, 7-OH IQ having been detected in the faeces of rats treated 
with IQ (Vavrek & Weisburger, 1990). Unchanged IQ, which may arrive in the 
intestine directly, or via decomposition of an IQ metabolite such as the sulphamate, 
is converted directly by microflora in the intestines of rats, mice, and humans to the
7-OH derivative. Interestingly, this metabolite has been shown to be directly 
mutagenic in S. typhimurium strain TA98 in the Ames test, i.e. an activation system 
was not required for the mutagenicity to be manifested (Rumney et a l, 1993). 
However, unless this metabolite undergoes any reabsorption and subsequent 
excretion in the urine, it is likely to be of little significance in the present study.
5,4.1 Biological effects o f  tea
The potent in vitro antimutagenic activity of tea against HAA, such as IQ, is 
primarily due to inhibition of the bioactivation of HAA by CYP1A2 (Bu-Abbas et
151
Chapter 5 : Urinary excretion o f mutagens
al, 1994, 1996). However, when administered in vivo, tea causes a selective 
induction of CYP1A2 in the livers of rats. Indeed, hepatic preparations from rats 
were more effective than controls in activating IQ to mutagenic intermediates. In 
order to account for these seemingly contrasting effects, an initial study was 
conducted where two groups of animals each consumed green tea. One group was 
maintained on tea for the duration of the study, whereas the other group had the tea 
withdrawn 24 hours prior to the administration of IQ. The rationale for this design is 
that in the first group, the metabolism and activation of IQ may be modulated by 
components(s) of tea present in the body simultaneously with the carcinogen that 
may interact with CYP1A2 and render it catalytically inactive, even if induction has 
occurred. In the second group, withdrawal of tea for 24 hours prior to IQ 
administration allows for such components of tea to be cleared, so that any increase 
in CYP1A2 levels following exposure to tea will be catalytically manifested.
As is evident from the present results, the urine from both groups of rats pre-treated 
with green tea was less mutagenic than that from the control group, illustrating that 
green tea can influence the overall metabolism and activation of IQ in vivo, in 
accordance with the results of previous studies (Bu-Abbas et a l, 1994, 1999). 
However, there appeared to be no significant difference between the two groups that 
consumed green tea, indicating that the induction of CYP1A2 did not result in 
increased urinary excretion of mutagens following IQ administration. Moreover, 
components of tea did not directly modulate the metabolism of IQ resulting in 
changes in the profile of urinary mutagens. It is pertinent to point out at this stage 
that the same treatment with tea also stimulates deactivating enzymes, such as GST 
and UGT, in the rat liver (Bu-Abbas et al., 1998; Sohn et a l, 1994).
Incubation of the urine with the deconjugating enzymes p-glucuronidase and 
arylsulphatase failed to increase the mutagenic response, indicating that no 
mutagens are excreted in the form of sulphate or glucuronide conjugates. This 
observation concurs with those from metabolic studies in rats, which revealed that 
the only 0-glucuronides excreted in the urine are derived from 5-hydroxy IQ (Luks 
e ta l, 1989).
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Pre-treatment of rats with green tea also decreased the excretion of promutagens in 
the urine of rats treated with IQ, confirming the ability of tea to influence the 
metabolic fate of the carcinogen. Once again, no significant difference was observed 
between the two groups receiving green tea, and again, treatment with 
deconjugating enzymes did not stimulate mutagenic activity. The 7V-conjugates of 
IQ are more stable to acid conditions and to hydrolases compared with those of 
primary aromatic amines (Turesky et a l, 1986).
Similar to green tea, black tea suppressed the urinary excretion of mutagens in rats 
treated with IQ, with the effect being even more pronounced. In contrast, 
decaffeinated black tea had no effect. As far as promutagens are concerned, black 
tea consumption caused a marked decrease in their urinary excretion, whereas the 
effect of decaffeinated black tea was modest. Bearing in mind that the levels of 
flavanols in green tea are much higher than those found in black tea (Constable et 
al, 1996; Wang et a l, 1994; Yen & Chen, 1996), it may be inferred that the 
flavanols are not the principal components of tea responsible for the changes in 
urinary excretion of mutagens and promutagens in IQ-treated rats. From the results 
presented here, the component responsible for the observed effects appears, 
primarily, to be caffeine, since the consumption of decaffeinated black tea, in 
contrast to whole black tea, had no effect on the excretion of mutagenic material, 
and gave rise to only a modest effect on the excretion of promutagens, presumably 
mediated by the oxidised flavanols present in black tea.
5.4.3 Role o f  caffeine
In a further study to confirm the role of caffeine, addition of caffeine to 
decaffeinated black tea also resulted in suppression of urinary excretion of IQ- 
derived mutagens and promutagens. Caffeine is an extensively consumed dietary 
anutrient present in many beverages, including aqueous extracts of whole tea, where 
it is found at substantial levels (Constable et a l, 1996; Wang et a l, 1994; Yen & 
Chen, 1996). Caffeine undergoes extensive metabolism, catalysed predominantly by 
the cytochromes P450, and is a known substrate and inducer of CYP1A2, which, 
significantly, is primarily responsible for the metabolism of IQ (Ayalogu et a l, 
1995; Tassaneeyakul, et a l, 1993). The mechanism of caffeine-mediated induction
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of CYP1A2 is not believed to be via the Ah receptor, but may be due to other 
mechanisms such as mRNA or protein stabilisation, or through interaction with 
receptors related to the Ah receptor. In animal models, caffeine has been shown to 
both potentiate and suppress chemical carcinogenesis, and it is conceivable that this 
may be due to its effects on the enzymes involved in the activation and detoxication 
of such carcinogens (Ayalogu et a l, 1995). Following induction of CYP1A2 by 
caffeine, the metabolism of IQ, both activation and deactivation, would be 
enhanced, leading to the decrease in urinary excretion of promutagens observed in 
the present study. However, caffeine has also been shown to inhibit the hepatic 
microsomal activation of HAA in vitro (Alldrick & Rowland, 1988), so that the 
presence of caffeine in the liver would competitively inhibit IQ metabolism, thus 
partly masking its inductive effect. However, such a mechanism appears not to be 
operative, since even 24 hours after withdrawing green tea from the animals, the 
urinary excretion of IQ-derived promutagens was suppressed to a similar extent.
Caffeine also modulates the mutagenicity of chemical carcinogens in vitro. 
Weisburger et al (1998) noted that decaffeinated black tea was a slightly less potent 
antimutagen than whole black tea. This finding was further investigated, and it was 
found that caffeine itself significantly lowered the mutagenicity of PhIP in the Ames 
test (Weisburger et a l, 1998). Like IQ, PhIP is metabolised to the reactive N- 
hydroxy derivative by CYP1A2 to generate the ultimate mutagen via reactive 
conjugates, hence the observed antimutagenicity of caffeine may be due to 
competitive inhibition.
It is difficult to compare the results of the above study directly with those of the 
present study, since the concentration of the caffeine solution used in the above 
study (0.2%) is some three to five times that found in the tea extracts employed in 
the present study (Bu-Abbas et a l, 1999b). In addition, the above authors expressed 
the antimutagenicity of caffeine in the Ames test in terms of micrograms per plate. 
However, in a similar in vitro study, Bu-Abbas et al (1996) demonstrated the 
antimutagenicity of similar tea extracts to those used in the present study against 
another HAA, Glu-P-1. The volumes of tea which suppressed the mutagenicity of 
Glu-P-1 in this study would have contained similar quantities of caffeine to those 
found to suppress the mutagenicity of PhIP (Weisburger et al, 1998).
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In contrast, Tsuda et al. (1999) reported an enhancement by caffeine of HAA- 
induced carcinogenesis in rats. Humans are exposed to complex mixtures of HAA 
in the diet, and such mixtures of HAA have been shown to have an additive 
carcinogenic effect. This additive effect may be further enhanced by other 
compounds present in the diet, such as caffeine. Concurrent feeding of caffeine with 
PhIP to rats resulted not only in induction of CYP1A2, but also an increase in 
colonic ACF relative to feeding PhIP alone. In humans, the rapid CYP1A2 and 
NAT-2 phenotype is linked with high susceptibility to HAA-induced cancers, and 
these findings suggest that caffeine may be an important enhancing risk factor in 
HAA-induced carcinogenesis (Tsuda et a l, 1999). Although the levels of caffeine 
used in the above studies are several-fold higher than in the human diet, the half-life 
of caffeine is considerably longer in man than in the rat, hence plasma levels will be 
elevated for longer in man. Therefore, the role of caffeine in modulating 
carcinogenesis will also be a factor of time of caffeine intake, relative to that of the 
carcinogen. Prior intake of caffeine may induce CYP1A2 activity, potentially 
enhancing carcinogenesis, whereas simultaneous ingestion may result in diminished 
carcinogenic response due to competitive inhibition (Ayalogu et a l, 1995). It is also 
worth noting that caffeine intake is orders of magnitude higher that that of HAA.
However, the mechanism through which caffeine in tea influences the excretion of 
mutagens and promutagens derived from IQ cannot be elucidated in the absence of 
data on the effect of tea on the urinary metabolic profile of IQ.
5.4,4 Nature o f  the urinary mutagens
In order to obtain some basic information as to the nature of the metabolites 
responsible for the mutagenic response in the urine of IQ-treated rats, mutagenicity 
studies were carried out using bacteria engineered to under- and over-express key 
enzymes in the activation of HAA. It is conceivable that A-hydroxy IQ may be 
oxidised to nitro-IQ and excreted in this form. As the Salmonella strains employed 
in the present study are endowed with high nitroreductase activity, they could 
reduce nitro-IQ to the (proximate) mutagenic hydroxylamine, and thus be 
responsible for the mutagenic response observed in the urine. However, mutagenic 
activity was not modulated when assessed in bacterial strains under- or over­
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expressing nitroreductase, indicating that nitro-IQ makes little or no contribution to 
the urinary mutagenicity. To date, it would appear that nitro-IQ has not been 
detected as a urinary metabolite of IQ. Although there was an increase in mutagenic 
response with all samples when YG1021 was used, the differences between the 
groups were not proportionally amplified. This may be due to a slight increase in 
OAT activity which may be associated with the over-expression of nitroreductase, 
or simply as a consequence of the higher spontaneous reversion rate of this strain 
compared with the other strains used. Alternatively, since it also occurred in the 
control urine, the increase may be due to the presence of other urinary nitro­
compounds not related to IQ (or tea). Mutagenic activity was, however, exaggerated 
when the bacterial strain over-expressed OAT activity and was suppressed when the 
same activity was under-expressed. These findings indicate that the mutagen(s) 
responsible for the urinary mutagenicity must have a free A-hydroxy group that can 
be 0-acetylated, with the unstable acetate ester spontaneously breaking down to the 
highly genotoxic nitrenium ion.
The A-hydroxy IQ metabolite is highly reactive, and it is unlikely to survive passage 
to the kidney and excretion into the urine. It is, however, conceivable that, similar to 
aromatic amines (Verna et a l, 1996), A-hydroxy IQ generated in the liver 
undergoes A-glucuronidation, and that this conjugate is transported to the urinary 
bladder where it is broken down, either under the acidic conditions prevailing in this 
tissue or as a result of the action of constitutive p-glucuronidase, to release A- 
hydroxy IQ. The hydroxylamine would be expected to react in situ, but a fraction of 
the free hydroxylamine may escape in the urine and mediate the mutagenic response 
seen in the present study. Such a situation may also exist in the intestine. Turesky et 
al (1986) postulated that two highly polar metabolites detected in the bile of rats 
treated with ^"^C-labelled IQ, which were not subsequently detected in the faeces, 
may have been metastable conjugates of a procarcinogenic form of IQ, such as N- 
hydroxy IQ, which do not survive passage through the intestinal tract. By 
decomposing in the intestinal lumen, thus releasing a reactive species of IQ, these 
metabolites could be responsible for IQ-induced tumours observed in intestinal 
tissues. Similarly, the sulphamate of IQ may break down in the bladder to yield IQ, 
thus accounting for urinary promutagenicity; sulphamate formation has not been
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considered to be an important conjugation reaction, owing to the lability of 
arylsulphamates. This metabolite was not affected by treatment with arylsulphatase 
(Turesky et a l, 1986).
The observation that neither p-glucuronidase nor arylsulphatase treatment increased 
mutagenic activity, either in the absence or presence of an activation system, 
implies that 5-hydroxy IQ, a major urinary metabolite in the rat (Luks et a l, 1989), 
is not mutagenic and, moreover, cannot be converted metabolically to a mutagen, 
despite possessing an intact amino group. These findings are compatible with 
previous reports where ring-hydroxylated metabolites of aromatic amines, such as 
2-naphthylamine and 4-aminobiphenyl, could not be further metabolised to 
mutagenic species (loannides et a l, 1989; Tong et a l, 1986).
Studies in humans have revealed that Tochu tea suppressed the excretion of 
mutagens and promutagens, resulting from the consumption of raw fish and cooked 
beef, in a similar fashion to the present study (Sasaki et a l, 1996). Tochu tea, an 
aqueous extract of the leaves of Eucommia ulmoides, is a popular beverage in Japan, 
and differs considerably in composition from infusions of ‘normal’ tea from 
Camellia sinensis. However, the principal components are glycosides of irridoids, 
lignans, and flavonoids, and various phenols, many of which have been well-studied 
with regard to their antigenotoxic properties.
There is a further possible explanation as to why consumption of tea resulted in the 
decreased excretion of mutagens and promutagens observed in the present study. If 
the induction of CYP1A2 associated with consumption of tea does indeed increase 
the metabolism of IQ, it is not inconceivable that IQ undergoes increased activation, 
as well as detoxication, and that the elevated levels of activated IQ react covalently 
with biological macromolecules and are retained in the body. This would, of course, 
conflict with observations that consumption of tea reduces incidences of 
carcinogenesis in animal models. A similar hypothesis was proposed by Sasaki et 
al (1996) to explain the observation that the Tochu tea drinkers excreted less 
urinary mutagenicity following consumption of raw fish and cooked beef than 
control subjects. However, the same authors discounted this possibility by showing
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that in mice gavaged with Tochu tea 6 hours prior to i.p. injection with mitomycin 
C, induction of micronuclei was reduced; if excretion of mutagens was suppressed, 
micronucleus induction would be enhanced. Assuming this finding in mice could be 
extrapolated to humans, this hypothesis was disregarded by these authors.
In summary, it has been demonstrated in the present study that the consumption of 
aqueous extracts of both green tea and black tea influences the excretion of 
mutagens and promutagens in the urine of animals pretreated with IQ, and that this 
effect can be largely ascribed to caffeine.
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CHAPTER 6
MODULATION BY TEA OF DNA ADDUCT 
FORMATION IN RATS TREATED WITH IQ
Chapter 6 : Formation o f DNA adducts
6.1 Introduction
6.1.1 Genotoxicity and DNA adduct formation
It is widely believed that the formation of covalent adducts between a carcinogen 
and DNA constitutes a critical step in the initiation of cancer and, consequently, 
may be an important biomarker for human exposure to carcinogens. Total adduct 
formation has been correlated with tumour incidence in the small and large 
intestines of rats exposed to IQ in the diet (Schut et a l, 1988). However, such a 
correlation did not exist in the liver, and it is possible that persistence of specific 
adducts, rather than total adduct formation determined at a specific timepoint 
following IQ administration, may be more closely related to the tumour incidence in 
a particular organ (Schut et a l, 1988).
6.1.2 The DNA ^^P-postlabelling assay fo r  DNA adduct formation
One of the most sensitive techniques for studying chemically-induced DNA damage 
is the measurement of adduct formation using the ^^P-postlabelling procedure, 
originally developed to study the binding of non-radioactive aromatic carcinogens 
to DNA (Gupta et a l, 1982). Subsequent studies indicated that this procedure could 
be adapted to study the binding of HAA to DNA following separation of the various 
adducts by HPLC (Wohlin et a l, 1996). The method involves initially enzymatic 
digestion of the DNA adducts to 3 '-deoxynucleotides, using a nuclease and a 
phosphodiesterase. In the next step, ^^ P is enzymatically transferred to the 5'-0H 
group of the deoxyribose moiety, this reaction being catalysed by T4 polynucleotide 
kinase (PNK). The labelled adducts are then separated and quantitated by 
radiochemical HPLC, or may be separated by TLC and then quantitated by 
scintillation counting of the radioactive spots following autoradiography. This is a 
sensitive procedure that can measure up to one adduct in 10*® normal nucleotides, 
and requires only very small quantities of DNA (as little as 5 pg). In order to 
improve the labelling of nucleotide adducts, normal nucleotides may be 
dephosphorylated using nuclease PI; dephosphorylated nucleotides are no longer 
substrates for the polynucleotide kinase.
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CARCINOGEN-ADDUCTED DNA
1 micrococcal nuclease
spleen phosphodiesterase
Ap + Tp + Gp + Cp + Xp + Yp
(normal nucleotides)
1 (nucleotide adducts)1 postlabelling
([y-^ P^] ATP + polynucleotide kinase)
*pAp + *pTp + *pCp + *pGp + *pXp + *pYp
1 HPLC analysis of labelled digest
QUANTITATION OF ADDUCTS
Figure 6.1 Schematic representation of the ^^P-postlabelling assay. The three principal steps are 
illustrated above, namely (i) digestion o f isolated DNA, (ii) ^^P-postlabelling o f  digestion products, 
and (iii) separation and analysis o f labelled nucleotides and adducts by HPLC. The prefix ‘d’ (deoxy) 
has been omitted for clarity. Radiolabelled phosphate is denoted by (Adapted from Gupta et al., 
1982).
6.1,3 Dietary modulation o f  DNA adduct formation and cancer chemoprevention
6.1.3.1 Dietary chemopreventive agents
As previously discussed in Chapter 1, there is strong epidemiological evidence that 
diet is a major factor in modulating the incidence of certain cancers, although the 
underlying mechanisms remain elusive. Polyphenolics are a class of dietary 
components widely believed to be responsible for the reduced incidence of cancer in 
people consuming diets rich in fruit and vegetables (Ahmad et a l ,  1998). Tea, also 
rich in polyphenols, is believed to influence favourably all recognised stages of 
carcinogenesis (Bu-Abbas et a l,  1994a, 1996; Katiyar et a l ,  1993, 1997). A study 
by Hirose et a l (1999) demonstrated the inhibition of HAA-induced carcinogenesis 
by phenolic compounds administered in the diet. The synthetic antioxidant 1-0- 
hexyl-2,3,5-trimethylhydroquinone (HTHQ) was found to inhibit the development 
of preneoplastic GST placental form-positive foci in the livers of rats treated with 
MelQx, as were green tea catechins. HTHQ also decreased PhlP-DNA adduct 
formation in the rat colon, but such an effect with the green tea catechins was not 
investigated (Hirose et a l,  1999).
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However, recent studies have demonstrated a cancer chemopreventive effect of tea, 
or constituents of tea, in animal models (see Xu et a l, 1996). Xu et al. (1996) 
investigated the effect of tea consumption on IQ-induced formation of hepatic DNA 
adducts and colonic ACF in rats. They demonstrated that both green tea and black 
tea, as well as indole-3-carbinol (13 C), a natural constituent of cruciferous 
vegetables, inhibited both the formation of DNA adducts and ACF in a similar 
manner. Schut & Yao (2000) supported these findings with similar results using 
PhIP, another HAA. In this study, consumption of tea inhibited formation of PhlP- 
DNA adducts in the liver, colon, small intestine, and in mammary epithelial cells in 
the female rat, but did not, however, have any effect on adduct levels in, among 
other tissues, the heart, kidneys, or lungs. Tea has also been shown to inhibit the 
formation of colonic PhlP-DNA adducts in the male rat (Huber et a l, 1997). Inter­
organ distribution of PhlP-DNA adducts is known to be similar in both sexes 
(Friesen et a l, 1996; He et al, 2000). It should be noted at this point that results 
from a further study by Hirose et al (2001) suggest that green tea may enhance 
tumour development, wherein rats fed a mixture of green tea catechins in the diet 
demonstrated an elevated incidence of DMH-induced colon carcinogenesis.
Other dietary components that have attracted attention as potential chemoprotectants 
against HAA-induced adduct formation include 4-ipomeanol, a naturally-occurring 
mycotoxin (Cummings & Schut, 1995), and conjugated linoleic acids (CLA), a 
mixture of isomeric heat-generated derivatives of linoleic acid, each with a 
conjugated double bond system (Ha et a l, 1987). CLA are of particular interest, 
since in addition to being present in milk and cheese, they are present in cooked 
meats, along with HAA (Liew et a l, 1995; Zu & Schut, 1992). As well as 
demonstrating antimutagenic activity towards IQ in the Ames test, administration of 
CLA to rats treated with IQ reduced incidence of colonic ACF, and levels of colonic 
and hepatic IQ-DNA adducts (Liew et a l, 1995), and similarly reduced adduct 
formation in a variety of tissues in mice treated with IQ (Zu & Schut, 1992). The 
co-presence of CLA in cooked meats with HAA may be significant in inhibiting the 
initiation of the carcinogenic process by such HAA.
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6.1.3.2 HAA-DNA adducts
Of course, HAA are themselves dietary components, and their very presence has 
important consequences in carcinogenesis. Formation of DNA adducts with a 
number of HAA has been investigated, and several such adducts have been 
identified. For example, the major PhIP adduct isolated from a number of animal 
tissues following treatment with PhIP has been identified as A^(deoxyguanosin-8- 
yl)-PhIP (Schut & Yao, 2000).
The two predominant IQ-DNA adducts have been identified as #-(deoxyguanosin-
8-yl)-IQ (dG-C8-IQ) and 5-(deoxyguanosin-A^-yl)-IQ (dG-A^-IQ) (Schut & 
Snyderwine, 1999), and are illustrated in Figure 6.2.
A. B.
NH
•NH;
l-CH;
deoxyribose
CH.
HN"
deoxyribose
Figure 6.2 Chemical structure of IQ-DNA adducts. The two major adducts are illustrated; dG-C8- 
IQ (A) and dG-Æ -^IQ (B). (From Schut & Snyderwine, 1999).
6.L4 Objectives
Following studies which demonstrated the stimulation of hepatic phase I and II 
xenobiotic-metabolising enzyme activity in rats administered tea (Bu-Abbas et al, 
1994b, 1995, 1998, 1999), it has been shown in this laboratory that consumption of 
green or whole black tea suppresses the urinary excretion of IQ-derived mutagens 
and promutagens (McArdle et a l, 1999). Clearly, the modulation of these activities 
leads to changes in the metabolism of IQ, but what is not clear is whether the 
alteration in IQ metabolism affords protection against the genotoxicity of this 
carcinogen. Consequently, the principal objective of the present study was to 
evaluate whether the consumption of tea inhibits the formation of IQ-DNA adducts.
163
Chapter 6 : Formation o f DNA adducts
There were, however, several objectives of the present study. Following the 
establishment of the ^^P-postlabelling-HPLC procedure to measure the formation of 
DNA adducts, the in vitro formation of IQ-DNA adducts was investigated. After 
evaluation of various enrichment techniques, with the aim of improving detection of 
IQ-DNA adducts, the in vivo formation of DNA adducts in rats administered IQ 
was investigated, first in the liver, then in extrahepatic tissues. Finally, the principal 
investigation of the present study was to determine the effect of tea consumption on 
the formation of DNA adducts in rats administered IQ, primarily in the liver, but 
also in certain extrahepatic tissues.
6.2 Materials and methods
6,2,1 Materials
Male Wistar albino rats (120-150 g) were obtained from the Experimental Biology 
Unit (EBU), University of Surrey (Guildford, Surrey, UK), and housed in the EBU. 
[y-^ ^P] ATP (37 MBq, 111 TBq mmol”') from NEN Life Science Products 
(Zaventem, Belgium), T4 polynucleotide kinase (from recombinant Escherichia 
coli) from Stratagene Ltd (Cambridge, Cambs., UK), Proteinase K (from 
Tritirachium album) from Melford Laboratories Ltd (Ipswich, Suffolk, UK), and 
Optifiow Safe 1 (EG&G Berthold, Milton Keynes, UK) and Ultima-Flo AF 
(Canberra Packard, Pangboume, Berks., UK) scintillation cocktails were all 
purchased. Bicine buffer, calf thymus DNA (sodium salt. Type I), D,L-dithiothreitol, 
equilibrated phenol (molecular biology reagent), isoamyl alcohol, micrococcal 
nuclease (from Staphylococcus aureus, Foggi strain), nuclease Pi (from Pénicillium 
citrinum), spermidine, spleen phosphodiesterase (from bovine calf spleen), RNase A 
(Type I-A, from bovine pancreas), RNase T% (from Aspergillus oryzae), and SDS 
were all obtained from Sigma Chemical Co. (Poole, Dorset, UK). IQ and 2-azido-3- 
methylimidazo[4,5-/]quinoline (azido-IQ) were purchased from Toronto Research 
Chemicals (Toronto, Ontario, Canada).
Green tea (Gunpowder), black tea (Keemun), and decaffeinated black tea (Ceylon) 
were purchased locally and stored at 4°C in a sealed plastic bag. Tea infusions 
(2.5%, w/v) were prepared by adding boiling water (400 ml) to the tea leaves (10 g)
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in a Thermos’^  ^ flask, allowing to brew for 10 minutes whilst inverting every 30 
seconds, and then filtering through cotton wool to remove the leaves. Infusions were 
stored in the dark at 4°C overnight to allow the tea to cream fully. This was carried 
out in order to minimise variations in the composition of the infusions consumed by 
the animals.
6,2,2 ^^P-Postlabelling and HPLC
The method was adapted in this laboratory from that described by Moller et al 
(1993).
6.2.2.1 Preparation o f IQ-DNA adducts
To serve as a positive control and to enable identification of IQ-DNA adducts, 
azido-IQ (50 nmol) was allowed to interact with calf thymus DNA (1 mg ml”* in 
potassium phosphate buffer, 50 mM, pH 7.4) during photoactivation at 360 nm for 
30 minutes, as previously described (Turesky & Markovic, 1994). Decomposition 
products were extracted with a mixture of chloroformdsoamyl alcohol (96:4). DNA 
was precipitated by the addition of 0.1 volume of sodium acetate (5 M) and one 
volume of ice-cold ethanol. The precipitated DNA was washed with 70% ethanol 
and redissolved in bicine buffer (1 mM, pH 8.2).
6.2.2.2 DNA extraction from tissues
Animals were killed by cervical dislocation, and tissues immediately excised and 
placed in chilled KCl (1.15%) on ice. Tissues were then either homogenised 
immediately, or frozen and stored at -20°C until homogenising. Scissor-minced 
tissues were homogenised in SDS/EDTA (1% SDS, 1 mM EDTA) containing Tris- 
HCl (240 pi g”* tissue, 1 M, pH 7.4) to give a 10% homogenate. The intestinal 
mucosa was removed by scraping, as described in Chapter 3. Liver and gut tissues 
were homogenised with a glass Potter-Elvehj em-type homogeniser with Teflon^^ 
pestle, whereas kidney, lung, and heart tissues were first homogenised with a 
Polytron homogeniser prior to homogenising with a Potter-Elvehj em-type 
homogeniser.
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RNase A (240 pi g”' tissue) and RNase Ti (80 pi g~* tissue) were added to an 
aliquot (5 ml) of tissue homogenate which was then incubated at 37°C in a shaking 
water bath for 1 hour. Proteinase K was then added (600 pi g“* tissue), followed by 
incubation at 37°C for a further 30 minutes.
DNA was extracted by gently mixing the homogenate with an equal volume of 
phenol for 3 hours at room temperature. The mixture was then transferred to a 
polypropylene centrifuge tube and centrifuged at 4,000g for 10 minutes at 4°C 
(Beckman J2-21 high-speed centrifuge, JA20.1 angle-head aluminium rotor) to 
separate the phases and remove protein. The (upper) aqueous layer was transferred 
to a fresh tube, and an equal volume of chlorofbrmiisoamyl alcohol mixture (96:4) 
added before gentle mixing by inversion. The mixture was then centrifuged at 
3,000g for a further 10 minutes.
Following centrifugation, the aqueous layer was transferred to a 25 ml Sterilin tube 
and placed on ice for 5 minutes. Sodium acetate (x 0.25 volume, 5 M) was added to 
the tube, followed by 96% ethanol (x 1 volume) at -20°C, and the tube gently 
swirled to mix. The clump of precipitated DNA was hooked from the mixture (using 
a hooked glass Pasteur pipette), rinsed in 70% ethanol, then dried under vacuum. 
The dried DNA was dissolved in bicine buffer (1 mM, pH 8.2, containing 0.5 mM 
CaCl]) before assessing purity and concentration by UV spectrophotometry. An 
aliquot of the DNA solution was diluted in water by 1 in 50 to 1 in 100, and the 
absorbance at 230, 260, 270, and 280 nm determined using a quartz cuvette (Uvikon 
860 dual-beam spectrophotometer, Kontron Instruments). Purity was acceptable if 
A260/A280 was > 1.75, and A230/A260 was < 0.5. In addition, the absorption spectrum 
of the DNA solution was obtained; significant deviation from a kmax of 259 nm was 
indicative of contamination with RNA. DNA concentration was calculated based on 
the assumption that for a 50 pg ml”* solution of DNA, A260 = 1.0 (Wallace, 1987).
6.2.2.3 DNA digestion
An aliquot of the DNA solution (of a volume appropriate to give 5 pg DNA, or 1 pg 
in the case of the in vitro studies) was incubated with micrococcal nuclease (MN,
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0.2 U pg” DNA, 200 U ml * solution in bicine buffer) at 37°C in a water bath for 2 
hours. Incubations were performed in 500 pi microfuge tubes, briefly centrifuging 
to deliver the contents to the bottom of the tube. Spleen phosphodiesterase (SPD, 8 
mU ug * DNA, 8 U ml * solution in 20 mM sodium acetate buffer, pH 5.0) was then 
added and the mixture incubated at 37°C for a further 2 hours. Digestion of DNA 
was confirmed by HPLC analysis of a DNA digest mixture (UV detection only), 
made up to 100 pi with water. The major peaks of the DNA digest corresponded to 
authentic mononucleotides by comparison of retention times. The HPLC system 
employed was similar to that described below (section 6.2.2.5), but with a linear 
gradient from 100% solvent A to 100% solvent B over 20 minutes, and without the 
use of scintillation cocktail.
6.2.2.4 ^^P-Postlabelling
Each DNA digest was made up to a total volume of 30 pi with water. PNK buffer 
(0.4 pi pg”* DNA) was then added to each digest, followed by PNK (2 U pg”* 
DNA) and [y-^ ^P] ATP (1.5 pi pg”* DNA). PNK buffer comprised D,L-dithiothreitol 
(100 mM), spermidine (10 mM), and MgCb (100 mM) in bicine buffer (200 mM, 
pH 9.6). DNA digests were then incubated at 37°C in a water bath for 30 minutes. 
Each labelled digest mixture was made up to a final volume of 80 pi with RO water, 
then mixed and centrifuged, before analysis by HPLC.
6.2.2.5 HPLC analysis o f adducts
HPLC analysis was performed using the following equipment: P4000 quaternary 
pump and UV2000 UVWIS dual wavelength detector with remote control and data 
capture by PC 1000 HPLC software via an SN4000 integrator, all from 
ThermoSeparation Products. Radiochemical detection was achieved with a Berthold 
LB506 C-1 HPLC radioactivity monitor with Z1000-4 detection cell, coupled to a 
Berthold LB5035 HPLC scintillator pump, and with Borwin Winflow HPLC 
software for radiochemical data capture.
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The ^^P-postlabelled DNA digest was manually injected into the HPLC system via a 
Rheodyne injector with a 100 pi loop. Separation was achieved on a Waters 
DeltaPak 5 pm C|g column, 150 mm x 3.9 mm i.d., with 1 M ammonium formate, 
pH 4.5 (solvent A) and 20% acetonitrile in 1 M ammonium formate, pH 4.5 (solvent 
B). A linear gradient from 0 to 100% solvent B over 40 minutes was employed, 
followed by 5 minutes isocratic elution with solvent B, at a solvent flow rate of 0.7 
ml min.”*, before re-equilibration with solvent A. HPLC scintillation cocktail 
(Optifiow Safe 1, EG&G Berthold) flow rate was 3 ml min.”*, and was employed 
for the first 45 minutes of the analysis for radiochemical detection.
Several aspects of the procedure were modified during the course of the study, and 
such modifications are presented in section 6.3.6.2, illustrated by the appropriate 
result(s).
6.2,3 Evaluation o f  enrichment techniques fo r  the detection o f  DNA adducts
The choice of a suitable enrichment procedure is an important step in the ^^ P- 
postlabelling method, with detection limits being significantly improved by the 
application of a suitable enrichment procedure prior to postlabelling (Gupta & 
Earley, 1988). Such an enrichment may be achieved either by the selective 
extraction of modified nucleotides (i.e. the adducts), e.g. butanol extraction (Gupta, 
1985) or solid-phase extraction (Turesky & Markovic, 1994), or alternatively, by 
creating conditions that favour the labelling of such modified nucleotides, e.g. 
enrichment using nuclease PI (Reddy & Randerath, 1986).
6.2.2.1 Butanol extraction
Following enzymatic digestion of the DNA (5 pg), the volume of the digest was 
made up to 50 pi with water, mixed with tetrabutylammonium chloride (10 pi, 10 
mM), and extracted with butan-l-ol (100 pi, saturated with water). A second aliquot 
(10 pi) of tetrabutylammonium chloride was added to the aqueous phase, and the 
mixture again extracted with butan-l-ol. The butanol extracts were then combined 
and back-extracted with an equal volume of water (saturated with butanol), and the 
organic phase evaporated to dryness under vacuum or under a stream of nitrogen.
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6.2.2.2 Solid phase extraction
Solid phase extraction (SPE) of modified nucleotides was attempted using two 
different types of column, Superclean NEVI-18 SPE columns (Turesky & 
Markovic, 1994) and Isolute HCX-3 mixed-mode SPE columns. Each column was 
conditioned with methanol (3 ml) followed by phosphate buffer (3 ml, 1 mM, pH 
3). DNA digest (containing 2 pg DNA) was made up to 1 ml with phosphate buffer, 
then passed through the column. The Superclean column was washed with water (2 
ml), followed by buffer (2 ml), before elution of the adducts with methanol (2 ml). 
Similarly, the Isolute column was washed with buffer (3 ml), followed by water (3 
ml) before elution of the adducts with methanol (containing 5%, v/v, ammonia). 
Eluates were dried under vacuum or under a stream of nitrogen.
6.2,4 Preliminary in vivo studies
The aim of these studies was to establish whether the administration of IQ to rats 
leads to the formation of DNA adducts that can be detected and quantified using the 
procedures described above.
6.2.4.1 Detection o f DNA adducts following administration o f a high dose ofIQ  
Initially, a study was undertaken where rats were treated with a high dose of IQ in 
order to ensure detection of IQ-DNA adducts. Male Wistar albino rats (200-250 g) 
were gavaged daily for 3 days with IQ (50 mg kg”*, in com oil), then killed by 
cervical dislocation 24 hours after the final dose. Hepatic DNA was extracted, 
digested, postlabelled with ^^ P, and analysed for the presence of IQ-DNA adducts 
as described above.
6.2.4.2 Effect o f time after IQ administration on DNA adduct detection
The next objective was to ascertain the effect of time following administration of IQ 
on the detection of IQ-DNA adducts in rat liver. Rats were treated with a single 
dose of IQ (50 mg kg”*, in com oil) by gavage, and killed at various timepoints (2, 
4, 6, 16, and 24 hours) following administration. Following excision of the liver, 
hepatic DNA was extracted, digested, postlabelled with ^^ P, and analysed for the
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presence of IQ-DNA adducts as described above. DNA extracted from the liver of 
an untreated animal was also included as a negative control. Subsequently, the 16- 
hour timepoint was employed in succeeding investigations, adduct levels being 
greatest at this timepoint. In addition to the liver, the heart, kidneys, and lungs were 
also taken from animal #5 (i.e. the 24-hour timepoint).
6.2.4.3 Effect o f IQ dose on DNA adduct formation
In order to establish whether the formation of IQ-DNA adducts in the liver of the 
rat was dose-dependent, four animals were administered by gavage a single dose of 
IQ (in com oil) at 5, 10, 25, 50 mg kg”*, respectively, and were killed 16 hours after 
administration. Hepatic DNA was extracted, digested, postlabelled with and 
analysed for the presence of IQ-DNA adducts as described above. The heart, 
kidneys, lungs, and intestinal mucosa were also excised for DNA extraction and 
postlabelling analysis.
6.2.5 Effects o f  tea consumption on DNA adduct formation
Five groups, each of four rats, were used. The first group served as control, 
maintained on water, whilst groups two and three were maintained on aqueous 
extracts (2.5%, w/v) of decaffeinated black tea and whole black tea, respectively, 
for 4 weeks. Groups four and five were each maintained on an aqueous extract 
(2.5%, w/v) of green tea as the sole source of liquid for 4 weeks.
At the end of this period, all animals were treated with a single dose of IQ by 
gavage (50 mg kg”*, in com oil). However, 24 hours prior to IQ administration, 
green tea was withdrawn from group five and replaced with water. All animals were 
killed 16 hours after administration of IQ, and the liver, heart, kidneys, intestinal 
mucosa, and lungs excised for determination of IQ-DNA adduct formation in these 
tissues. DNA was extracted, digested, postlabelled with ^^ P, and analysed by HPLC 
for the presence of IQ-DNA adducts as described above.
170
Chapter 6 : Formation o f DNA adducts
6.2,6 Analysis o f  results
Chromatogram peak integration was performed in Borwin Winflow radiochemical 
HPLC software, with peak areas presented as counts per minute (c.p.m.). The 
degree of postlabelling was determined by calculating the relative adduct labelling 
(RAL), i.e. the proportion of labelling attributed to nucleotide adducts expressed as 
a fraction of the total labelling of all nucleotides. RAL was calculated as follows:
RAL= peak area of adducts (c.p.m.) 
total peak area (c.p.m.)
6.3 Results
6.3.1 Formation o f  IQ-DNA adducts in vitro and evaluation o f  enrichment 
techniques
Figure 6.3 shows that photoactivated azido-IQ forms three major adducts with calf 
thymus DNA in vitro, with retention times of 30-35 minutes. Using this system, 
various enrichment procedures were evaluated in order to optimise detection and 
maximise the sensitivity of the system. The results of the procedures investigated 
are summarised in Table 6.1. Clearly, none of the enrichment procedures evaluated 
in the present study improved the detection of IQ-DNA adducts, hence the use of 
such a procedure was not pursued any further.
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Figure 6.3 Radiochemical HPLC chromatogram of IQ-DNA adducts formed in vitro. Calf 
thymus DNA was incubated with azido-IQ, photoactivated by irradiating at 360 nm. Following 
digestion of the DNA, nucleotides were ^^P-postlabelled in the absence of any enrichment procedure.
6.3.2 Detection o f IQ-DNA adducts in vivo
Figure 6.4 shows the presence of four distinct DNA adducts, one of which is clearly 
predominant, detected in the livers of rats treated with three daily doses of IQ. 
Based on retention times, three of these adducts appear to be the same as those 
generated in vitro by the photoactivation of azido-IQ in the presence of calf thymus 
DNA (see Figure 6.3). No adducts were detected in the livers of control animals, 
treated with com oil only (data not shown).
6.3.3 Time-dependency o f IQ-DNA adduct formation in the rat.
From Figure 6.5 it can be seen that adducts were evident as early as 2 hours after the 
administration of IQ, with levels of adduct formation increasing with time. Of the 
timepoints investigated, a maximum level of adduct formation was reached 16 hours 
after IQ administration. This timepoint was employed in all subsequent 
investigations.
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Table 6.1 Effect of various enrichment procedures on the determination of IQ-DNA adducts.
Results are presented as the average of two determinations, deviating from the average by not more 
than 25%.
Enrichment procedure Relative adduct labelling (xlO^)
no enrichment 44.2
butanol extraction 1 1 . 6
SPE Cl8 columns 4.1
SPE mixed-mode 15.0
columns (C18-SO3)
1500
32.88
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34.10
30.07 32.27
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Retention time (minutes)
Figure 6.4 Formation of hepatic IQ-DNA adducts in the rat. Rats received a single, daily dose of 
IQ for 3 days (50 mg kg"') and were killed 24 hours after the last dose. Adduct formation was 
determined in the absence of any enrichment procedure. The retention times o f the major peaks are 
indicated.
173
Chapter 6 : Formation o f DNA adducts
12
' b  10 
E 8
Î
-  6
4
2
0
2 4 6 8 10 12 14 16 18 20 22 24
Time after administration of IQ (hours)
Figure 6.5 Tim e-dependent form ation of hepatic IQ-DNA adducts in the rat. Rats were treated 
with a single dose of IQ (50 mg k g ') by gavage, and were killed at various time intervals following 
administration (2, 4, 6, 16, and 24 hours). Adduct formation was determined in the absence o f any 
enrichment procedure, and is presented as a single determination at each timepoint.
6.3.4 Dose-dependency o f IQ-DNA adduct formation in the rat
Rats were administered a single oral dose of IQ at either 5, 10, 25, or 50 mg kg ' in 
order to establish a suitable dose to use in the principal investigation of the present 
study. Adducts were detectable at all doses of IQ administered, with the exception 
of 5 mg kg"', the level of adduct formation increasing with the dose (see Figure 
6.6).
From the results shown in Figure 6.6, it was decided to administer IQ at 50 mg kg"' 
to the animals in the principal investigation, that pertaining to the effect of tea 
consumption on IQ-DNA adduct formation.
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Figure 6.6 Effect of dose on the concentration of DNA adducts formed in the livers of rats 
treated with IQ. Rats were treated with a single oral dose o f IQ at either 5, 10, 25, or 50 mg kg ', 
respectively, and killed 16 hours after administration. Adduct formation was determined in the 
absence o f any enrichment procedure, and is presented as a single determination at each dose o f IQ.
6.3.5 Extrahepatic formation o f  IQ-DNA adducts in the rat
Extrahepatic tissues from rats treated with IQ at 50 mg kg ' and killed 16 hours 
after administration of IQ were analysed for the formation of IQ-DNA adducts. 
Although the most extensive adduct formation occurred in the liver, adducts were 
also detected in the heart and kidneys, but not in the lungs or the gut (Table 6.2). 
Figure 6.7 shows HPLC ehromatograms of DNA extracts from the heart and 
kidneys, demonstrating the presence of the adduct peaks.
Table 6.2 Formation of IQ—DNA adducts in rat tissues.
Rats received a single dose o f IQ (50 mg kg ', in com oil) by gavage, and were killed 16 hours 
following administration of IQ. ‘Rats received a single dose o f IQ daily for 3 days (50 mg kg ') and 
were killed 24 hours after the last dose. Adduct formation was determined in the absence o f any 
enrichment procedure.
Tissue Relative adduct labelling (xlO^)
liver* 8.44
liver 7.39
heart 3.64
kidney 2.06
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Figure 6.7 Form ation of extrahepatic IQ-DNA adducts. Rats were treated with a single dose of 
IQ by gavage (50 mg kg”*, in com oil), and were killed 16 hours after dosing. IQ-DNA adduct 
formation was determined in the absence of any enrichment. A. Heart, and B. Kidney. Retention 
times of the adduct peaks are indicated. Adduct formation was determined in the absence o f any 
enrichment procedure.
6.3.6 Effect o f  tea consumption on the formation o f IQ-DNA adducts in the rat
The wet weights of all tissues were noted and the mean, as a percentage of body 
weight, of each group was compared with the mean of the control group. There was
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no significant variation in any of the extrahepatic tissues, but the mean wet weights 
of the livers from groups four and five — the green tea-treated groups — were 13% 
and 15% {P < 0.05), respectively, greater than that of the control (group one). There 
was little difference from the control group in the liver weights of either of the 
groups consuming black tea.
6.3.6.1 Modulation o f hepatic IQ-DNA adduct formation — results from initial 
analyses
Treatment with both decaffeinated black tea and whole black tea increased the 
number of IQ-DNA adducts, but was only significant in the former case {P < 0.05, 
Figure 6.8). However, neither of the green tea treatments influenced DNA adduct 
formation.
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Figure 6.8 Effect of tea consumption on the formation of hepatic IQ-DNA adducts in the rat.
Group 1 served as control, maintained on water for 4 weeks; Groups 2 and 3, animals were 
maintained on aqueous extracts o f decaffeinated black tea and whole black tea (2.5%, w/v), 
respectively; Groups 4 and 5, animals were maintained aqueous green tea extract (2.5%, w/v) for 4 
weeks as their sole drinking liquid. At the end o f this period, all animals received, by gavage, a 
single dose of IQ (50 mg kg ', in com oil). However, 24 hours prior to IQ administration, the green 
tea was withdrawn from Group 5 and replaced with water. All animals were killed 16 hours after IQ 
administration. IQ—DNA adduct formation was determined in the absence o f any enrichment 
procedure. Results are presented as the mean ± S.D. for 4 animals. *P < 0.05.
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6.3.6.2 Modulation o f IQ—DNA adduct formation in vivo — further analyses and 
method development
At this stage of the study, safety concerns over the manual injection of samples into 
the HPLC necessitated the use of an autosampler (AS 1000, ThermoSeparation 
Products). Therefore, minor modifications to the procedure were necessaiy. 
Primarily, this involved increasing the volume of the DNA digest for injection from 
80 pi to 106 pi (actual injection volume was 100 pi). This volume was determined 
following optimisation of the autosampler and evaluation of various sample 
volumes with the aim of maximising reproducibility and minimising sample loss; 
some loss of sample was, however, unavoidable due to the mechanism of injection 
by the autosampler.
Subsequent analyses performed with this system resulted in a failure to detect any 
adducts in either kidney or heart DNA samples. Although, at first, adducts appeared 
to have been detected in the kidney DNA sample (data not shown), this was later 
attributed to the presence of ‘artefact peaks’, i.e. adduct peaks retained on the 
column following analysis of the IQ-DNA positive control sample owing to the 
veiy high levels of such adducts in this sample, which were then eluted during 
subsequent analyses. Following the lack of detection of adducts in the kidney DNA 
samples, it was decided to repeat the measurement of selected liver DNA samples in 
order to confirm the previous results with the modified system. Repeat analysis of 
liver DNA samples, as well as certain heart DNA samples, with an increased 
amount of DNA and of ATP also met without success. Consequently, the 
preparations of liver DNA were re-assessed and the concentrations confirmed.
In previous analyses, only 5 pg DNA were used; increasing the amount of DNA 
used would increase the amount of adducted DNA. Hence an increasing quantity of 
liver DNA (5-15 pg) was investigated, with a concomitant increase in [y-^^ P] ATP. 
In addition, the DNA digestion time was increased (4 hours with MN, overnight 
with SPD). These modifications appeared to be successful, and Figure 6.9 shows the 
increasing adduct peak detected with increasing DNA (confirmed by reference to 
blank DNA).
77^
Chapter 6 : Formation o f DNA adducts
15.0 
17.5
110.0 
115.0
25.0 27.5 30.0 32.5 35.0 37 .5
Retention time (minutes)
40 .0 42 .5 45.0
Figure 6.9 Effect of increasing DNA quantity on detection of IQ-DNA adducts. Adduct 
formation in hepatic DNA from a control group animal, killed 16 hours after administration of a 
single, oral dose of IQ (50 mg kg % in com oil), was determined in an increasing quantity o f DNA 
(5.0, 7.5, 10.0, and 15.0 pg), and in the absence of any enrichment.
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Figure 6.10 Effect of increasing ATP content on detection of IQ-DNA adducts. Adduct 
formation in hepatic DNA (7.5 pg) from a control group animal, killed 16 hours after administration 
of a single, oral dose of IQ (50 mg kg'", in com oil), was determined with either a low (7.5 pi) or 
high (11.25 pi) level o f ATP, and in the absence of any enrichment. There was little difference 
between the RAL values in each case (2.82 and 2.78 x 10^ for low and high ATP, respectively).
Continuing from this achievement, DNA (7.5 p-g) from the same liver sample was 
analysed with ‘normal’ and ‘elevated’ amounts of ATP. The ‘normal’ amount of 
ATP, that previously used for 5 pg DNA, represented a relative decrease in the 
amount of ATP used. The ‘elevated’ amount of ATP represented a concomitant 
increase in ATP with the increased amount of DNA used. In addition, the 
postlabelling incubation was increased from 30 minutes to 40 minutes. The relative
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levels of MN and SPD were maintained. Although there was an apparent increase in 
the adduct peaks with the higher level of ATP (see Figure 6.10), the RAL in each 
case was approximately equal.
These successful modifications were employed to repeat the analysis of all liver 
DNA samples. Unfortunately, satisfactory detection of adducts was not achieved. 
Furthermore, at this point, the supply of the present scintillation cocktail (‘Optifiow 
Safe 1 ) was exhausted, and no further supply was available for the foreseeable 
future.
6.3.6.3 Effect o f varying HPLC solvent system on detection ofIQ-DNA adducts
With the arrival of the new scintillation cocktail (Ultima-Flo AF), it was decided to 
experiment with different HPLC gradients. In an attempt to improve the sensitivity 
of the system, instead of separating the adduct peaks from each other, various 
gradients were evaluated with the aim of ‘compressing’ the adduct peaks into a 
single, bigger peak; since the aim of the investigation was simply to quantify all 
adducts formed, it seemed unnecessary to separate the peaks, thus reducing the 
likelihood of their detection.
However, evaluation and optimisation of the new scintillant was first necessary. 
This scintillant was developed specifically for use with ammonium formate-based 
mobile phases, and possessed a greater capacity for mixing with the mobile phase. 
Therefore, a variety of mobile phase:scintillant ratios and scintillant flow rates were 
investigated before experimenting with a series of new gradients. These evaluations 
were performed with IQ-DNA only.
Figure 6.11 shows IQ-DNA analysed under the new conditions and with the new 
scintillant. There is one major peak and one minor peak, in contrast to the four 
peaks previously detected (Figure 6.3), the minor peak proving difficult to 
‘compress’ into the major peak. The gradient employed here, and for subsequent 
analyses, is described below (Table 6.3). The scintillant flow rate was 1 ml min.“’.
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Figure 6.11 Radiochemical HPLC chromatogram of IQ-DNA adducts formed in vitro —  
evaluation of new gradient. Calf thymus DNA was incubated with azido-IQ, photoactivated by 
irradiating at 360 nm. Following digestion of the DNA, nucleotides were ^^P-postlabelled in the 
absence o f any enrichment procedure. Separation of normal and adducted nucleotides was achieved 
using a modified elution gradient.
The digestion of DNA with MN and SPD was returned to 2 hours with each 
enzyme. Further experimenting with liver DNA samples indicated that the modified 
system was now suitable for analysis of samples. In addition, these experiments 
revealed that artefact peaks were still being retained, and therefore the system was 
extensively washed following any analysis of IQ-DNA. The repeat analysis of all 
liver samples was carried out under the new conditions, and although sufficient 
detection was achieved (see Figure 6.12), the system was not as sensitive as with the 
previous measurements (Figure 6.8).
Selected heart, kidney, lung, and gut samples (together with repeat assays of certain 
liver samples which appeared not to work well initially) were also analysed under 
the new conditions, but no adducts were detected in the extrahepatic tissues. 
Following these results, the postlabelling-FlPLC procedure was no longer pursued, 
and the present study was terminated at this point.
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Figure 6.12 Effect of tea consumption on the formation of hepatic IQ-DNA adducts in the rat 
determined with alternative HPLC solvent system. Group 1 served as control, maintained on 
water for 4 weeks; Groups 2 and 3, animals were maintained on aqueous extracts o f decaffeinated 
black tea and whole black tea (2.5%, w/v), respectively; Groups 4 and 5, animals were maintained on 
aqueous green tea extract (2.5%, w/v) for 4 weeks as their sole drinking liquid. At the end o f this 
period, all animals received, by gavage, a single dose of IQ (50 mg kg"% in com oil). However, 24 
hours prior to IQ administration, the green tea was withdrawn from Group 5 and replaced with water. 
All animals were killed 16 hours after IQ administration. IQ-DNA adduct formation was determined 
in the absence of any enrichment procedure. Results are presented as the mean ± S.D. for 4 animals. 
No statistically-significant differences were observed.
Table 6.3 Revised HPLC elution gradient.
This gradient was employed in order to ‘compress’ the adduct peaks together whilst maintaining 
adequate separation from the normal nucleotide peaks. Solvent A, 1 M ammonium formate, pH 4.5, 
and Solvent B, 20% acetonitrile in I M ammonium formate, pH 4.5.
Time (min.) Solvent A (%) Solvent B (%)
0 100 0
21 47.5 52.5
27 47.5 52.5
28 0 100
45 0 100
50 100 0
60 100 0
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6.4 Discussion
6.4A Formation o f  IQ-DNA adducts in vitro and evaluation o f  enrichment 
techniques
Before embarking on the in vivo studies, it was considered pertinent to study the 
formation of IQ-DNA adducts in vitro to enable the identification of such adducts 
following administration of the carcinogen to the rats. In addition, the resulting 
adduct-containing DNA (see Figure 6.3) served as an ideal positive control in the in 
vivo postlabelling studies.
From Table 6.1, it can be seen that none of the enrichment procedures evaluated in 
the present study improved the detection of IQ-DNA adducts. Indeed, lower RAL 
values were observed, indicating considerable loss of adducts during the enrichment 
procedures. Enrichment using nuclease PI was also evaluated, but unsatisfactory 
results were obtained, and no further investigation was earried out. However, it 
should be pointed out that these procedures were originally developed for the 
identification of DNA adducts formed with PAH (Gupta, 1985; Gupta & Earley, 
1988), and appear to be inapplicable to IQ, and possibly other HAA. In support of 
the current findings, butanol extraction has been reported as unsuitable for the study 
of HAA-DNA adducts (Hall et ah, 1990), although others have used this technique 
with HAA (Wohlin et a/., 1996).
Subsequently, the postlabelling procedure known as ‘adduct intensification’ was 
utilised. This variation of the original procedure exploits the fact that the 
phosphorylation of nucleotides at the 5'-position occurs more readily in modified 
nucleotides compared with normal nueleotides (Randerath et a l, 1985). 
Consequently, when the DNA digest is treated with deficient amounts of [y-^ ^P] 
ATP, the modified nucleotides are preferentially labelled. As a result of using this 
procedure, adduct labelling is erroneously high (Randerath et al, 1985), and should 
true RAL values be required, the determination of ‘intensification factors’ is 
necessary. This is achieved by measuring the ‘true’ RAL of a given sample, i.e. in 
the presence of excess [y-^ ^P] ATP, and calculating the ratio of the RAL values 
determined by each method, then applying this ratio to the RAL values obtained by
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the intensification method to correct these to true RAL values (Hall et a l, 1990; 
Sehut et a l, 1988).
6.4,2 Preliminary investigations into formation o f  IQ-DNA adducts in vivo
6.4.2.1 Formation ofhepaticIQ-DNA adducts
Oral administration of IQ to rats resulted in the formation of up to four adducts in 
the liver, one of which was clearly the most abundant (see Figure 6.4). The 
formation of these adducts appeared to be dose-dependent (Figure 6.6), and the 
adducts were detectable as early as 2 hours after the administration of the 
carcinogen (Figure 6.5). Similar findings in mice treated with IQ also revealed a 
dose-dependent effect, with three to five hepatic DNA adducts detected, while six 
IQ-DNA adducts have been observed in human mammaiy epithelial cells 
(Carmiehael et a l, 1996; Nerurkar et a l, 1995; Zu & Schut, 1991).
6.4.2.2 Formation o f extrahepatic IQ-DNA adducts
The aim of these investigations was to determine whether adducts were generated in 
rat tissues other than the liver following treatment with IQ, and if such adducts were 
different from those generated in the liver. In addition to the liver, adducts were also 
detected in the heart and kidneys (see Figure 6.7), whereas no adducts were evident 
at this dose in either the lungs or the gut. The liver displayed the highest level of 
IQ-DNA adducts in the present study (Table 6.2), as well as in previous studies in 
the rat, mouse, and cynomolgus monkey (Nerurkar et a l, 1995; Snyderwine g/ al, 
1992a; Turesky et a l, 1996b; Zu & Schut, 1991). However, using the TLC 
procedure, the same workers demonstrated the presence of adducts in a number of 
tissues, including the heart, kidneys, colon, stomach, pancreas, and the urinary 
bladder.
Purely on the basis of retention times in the present study, the same adducts appear 
to have been formed in all tissues displaying adduct formation, and indicate that the 
same ultimate metabolites of IQ are reacting with DNA in vivo. Given the 
surprisingly high level of adducts in the heart compared with the liver, it is a
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possibility that reactive intermediates generated in the liver may be transported to 
the heart where they can interact with DNA in situ, thus forming the observed 
adducts.
The two major IQ—DNA adducts have already been chemically characterised, 
namely dG-C8-IQ, the more abundant adduct, and dG-A^-IQ (see Figure 6.2), each 
formed as a result of the interaction of the ultimate IQ metabolite with either the C- 
8 or N^ atoms, respectively, of a guanine base (Schut & Snyderwine, 1999; 
Snyderwine et al, 1993). However, dG-A^-IQ may not be detectable when labelling 
is performed under intensification conditions (Turesky & Markovic, 1995 — see 
Wohlin et a l, 1996), It is possible that the IQ metabolite may interact with other 
bases (Snyderwine et a l, 1993), and it may be cautiously inferred that the other 
peaks in the chromatogram represent as yet undefined IQ-DNA adducts. However, 
it is also possible that these peaks may represent radiolabelled di- or 
oligonucleotides containing an IQ-guanine adduct as a consequence of incomplete 
digestion (Pfau et a l, 1994). Such multiple adducts have been converted to one 
major IQ-DNA adduct by further digestion of DNA with nuclease PI or 
phosphodiesterase (Turesky et al, 1996a).
6.4.3 Effects o f  tea consumption on the formation o f  IQ-DNA adducts
It is interesting to note that the mean wet weights of the livers from groups four and 
five, the green tea-treated groups, were 13% and 15%, respectively, greater than that 
of the control group, whereas there was little difference from the control group in 
the mean wet liver weights of the groups consuming black tea (two and three). Liver 
weights were expressed as a percentage of body weight, and this value for each of 
the test groups was compared with the control group. Body weight was independent 
of the type of drinking fluid. This is in agreement with a previous study in this 
laboratory (Bu-Abbas et al, 1999), which, although the values obtained were not 
statistically significant, also reported an increase in the liver weight of rats drinking 
green tea compared with the control group, whereas the weights of livers from rats 
eonsuming whole or decaffeinated black tea were not markedly different from the 
control group. In the present study, the values obtained from both groups drinking 
green tea were significant {P < 0.05). This observation suggests that components of
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green tea only caused this relative weight gain of the liver, and that such 
components appear to be absent from black tea.
6.4.3.1 Modulation o f hepatic IQ-DNA adduct formation — results from initial 
analyses
DNA adduct formation in rats administered a single dose of IQ was not impaired by 
consumption of tea. Perhaps surprisingly, treatment with black tea, whole or 
decaffeinated, led to an increase in the number of adducts. Although treatment with 
black tea increased the formation of hepatic IQ-DNA adducts, significantly in the 
case of decaffeinated black tea (Figure 6.8), there was marked variation seen in each 
group, an observation also noted by other workers (Liew et a l, 1995; Schut & Yao, 
2000), and perhaps a fondamental limitation of the technique, especially when 
assessing HAA-DNA adduct formation.
These results suggest that, under the conditions employed in the present study, 
consumption of tea did not suppress the binding of IQ to DNA. Therefore, in 
contrast to in vitro observations (Bu-Abbas et a l, 1994a, 1996), it may be inferred 
that tea neither inhibits the bioactivation of IQ nor scavenges the reactive 
intermediates. Similarly, the reported increase in UGT levels (Bu-Abbas et al, 
1995, 1998) following consumption of similar preparations of tea does not appear to 
have influenced the balance between activation and deactivation of IQ.
6.4.3.2 Modulation o f hepatic IQ-DNA adduct formation —further analyses
There were no significant effects of tea consumption on hepatic DNA adduct 
formation (Figure 6.12), and again, wide variation was observed within the groups. 
Decaffeinated black tea appeared to increase the formation of adducts, as seen in the 
previous analyses (Figure 6.8). In contrast to the previous results, however, whole 
black tea, and one of the green tea treatments, appeared to reduce the formation of 
adducts, with the other green tea treatment having no apparent effect. If such a 
pattern is a reflection of the true situation, then it may be speculated that these 
results could have been expected, given the results of a similar study by McArdle et 
al (1999). In this study, consumption of green tea and whole black tea, but not
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decaffeinated black tea, reduced the urinary excretion of mutagens and promutagens 
following a single, oral dose of IQ. If these observations can be explained in terms 
of the relative activation and deactivation of IQ, then by extrapolation to the present 
study, it may be expected that consumption of green tea and whole black tea, but 
not decaffeinated black tea, would reduce the formation of IQ-DNA adducts. 
However, as the results in the present study were not statistically significant, no 
modulation of adduct formation can be inferred, and this suggestion is merely 
speculative.
Both sets of data fi*om the present study appear to contrast with previous reports that 
tea consumption suppressed the formation of ACF and DNA adducts in rats (Xu et 
al, 1996). However, in keeping with the present study, these authors also found that 
black tea, but not green tea, increased the formation of IQ-DNA adducts up to 8 
hours after administration of IQ, but that adduct formation was suppressed by both 
treatments 24-48 hours after IQ administration. Decaffeinated black tea was not 
investigated by Xu et al (1996). In the present study, only one timepoint was 
employed, namely 16 hours, where adduct formation appeared to be maximal in 
preliminary in vivo studies (see Figure 6.5). It is therefore conceivable that the level 
of IQ binding to DNA at other timepoints may indeed have been suppressed by the 
consumption of tea. For example, Uehara et al (1996) reported a reduction in the 
formation of IQ-DNA adducts by p-carotene and a-tocopherol only when the 
number of adducts was measured 48 hours after administration of the carcinogen. 
Schut & Yao (2000) found that inhibition of DNA adduct formation, in this case 
with PhIP, by both green tea and black tea was not only organ-specific, but also 
time-dependent. Therefore, in future studies of this nature, it may be prudent to 
employ multiple time-points in order to account for this observation, and to acquire 
a more accurate representation of the true situation.
6.4.3.3 Modifications to the ^^P-postlabelling procedure
There were two major factors in the postlabelling procedure that required changing, 
and together, these changes had considerable influence over the sensitivity of the 
procedure. These were the use of an autosampler in the HPLC analysis of the 
samples, and secondly, the sudden and long-term unavailability of the HPLC
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scintillation cocktail that had been employed initially. The inherent dangers of using 
mean that safety must be paramount in any experiment or procedure involving 
this isotope, and consequently, the procedure and the safety precautions employed 
were under constant scrutiny. Thus, due to the hazards involved in manually 
injecting samples containing ^^ P into the HPLC system becoming unacceptable, the 
use of the autosampler was necessary, which in turn necessitated changes to the 
procedure. The increased injection volume required, although optimised to 
minimise loss of sample, may have adversely affected the analysis, for example, due 
to the greater dilution of the sample.
Subsequently, after adapting the procedure to allow for the use of the autosampler, 
the HPLC scintillation cocktail that had been used previously (‘Optiflow Safe V) 
became unavailable from the supplier (EG&G Berthold), who was unable to supply 
this scintillant for the foreseeable future. Therefore, an alternative scintillant was 
sought (‘Ultima-Flo AF’ from Packard), and the necessary evaluation and 
alterations to the procedure carried out. Together, these changes substantially 
affected the analysis, and the results obtained. It would appear from the analyses of 
the liver DNA samples that the changes made reduced the efficacy of the procedure, 
which, combined with the innate relative lack of sensitivity of the ^^P-HPLC 
procedure compared with TLC methods (Moller et a l, 1993), rendered the current 
procedure unviable for the detection of IQ-DNA adducts formed in vivo, despite 
attempts to improve the sensitivity of the system. Previous studies have detected, by 
TLC and autoradiography, at least five IQ-DNA adducts in vivo (Schut et a l, 
1988), whereas no more than four were detectable in the present study.
It may have been expected that the new scintillant would actually improve 
detection, having been specifically developed by the manufacturers for use with 
ammonium formate-based mobile phases in applications of this kind. However, 
perhaps due in greater part to the use of the autosampler rather than the new 
scintillant, this was unfortunately not the case. Since nuclease PI has been 
employed in the ^^P-HPLC analysis of HAA-DNA adducts (Wohlin et al, 1996), it 
may be worthwhile re-evaluating this step for use in future studies, particularly as 
this step has been shown to concentrate multiple adduct peaks into a single peak 
(with PhIP) or into fewer peaks (with diMelQx) (Wohlin et a l, 1996). This would
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have the effect of increasing sensitivity in a manner similar to that attempted by 
‘compressing’ the multiple adduct peaks observed in the present study.
It therefore seems inevitable that future efforts to investigate the effects of tea 
consumption on the formation of DNA adducts in vivo either be restricted to PAH, 
which lend themselves more favourably to the use of HPLC analysis, or must 
employ a TLC method followed by autoradiography, the greater sensitivity of which 
would be more likely to enable detection of HAA-DNA adducts.
CHAPTER 7 
GENERAL DISCUSSION
Chapter 7 : General discussion
7.1 Does tea possess antigenotoxic properties?
Tea is one of the most promising naturally-occurring chemopreventive agents 
studied, and its anticarcinogenic properties have been repeatedly demonstrated in 
animal models (see Ahmad et al, 1998). However, the results of epidemiological 
studies are mixed and often inconclusive (Yang & Wang, 1993), but the beneficial 
effects of tea and various components of tea have been discussed already in Chapter 
1. Indeed, the results of the present study imply that the overall antigenotoxic 
potential of tea may reflect the effect of ‘the whole being greater than the sum of the 
parts’, with no single component able to account for the reported properties of 
whole tea.
7.2 What are the components of tea responsible for the 
antigenotoxic properties?
The results from the present study indicate that the component that appears to be 
largely responsible for the observed in vitro antigenotoxic effects of tea, namely 
EGCG, differs from that responsible for the observed in vivo effects, i.e. caffeine. 
These data imply that the in vitro antimutagenic properties of green tea are due, at 
least in part, to EGCG, and are manifested by the inhibition of bioactivation, of IQ 
in particular, by CYPIA enzymes. This would appear to be in contrast to further 
data from the present study, from which it may be inferred that the in vivo 
antigenotoxicity of tea is mediated primarily by caffeine, and that this effect is 
manifested by induction of, and consequently an increase in the activity of, 
CYP1A2 (Ayalogu et al, 1995; Bu-Abbas et a l, 1994a, 1999a; Sohn et a l, 1994). 
The same authors have also demonstrated an increase in UGT activity, but whether 
this is relevant to the antigenotoxic effect of tea is questionable, since constitutive 
levels of UGT are unlikely to be saturated by levels of putative carcinogens 
undergoing glucuronidation. However, IQ is by no means representative of all types 
of carcinogen, and it should be borne in mind that disparate component(s) of tea 
may be involved in the suppression of genotoxic or carcinogenic responses to such 
influences. Indeed, tea has been shown to act at both the pre- and post-initiation 
stages of carcinogenesis against a variety of carcinogens (Ahmad et a l, 1997;
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Record & Dreosti, 1998; Saeki et a l, 1999; Shih et a l, 2000; Weisburger et al, 
1996).
Clearly, the two situations do not appear to be comparable. The key points 
regarding the antimutagenicity of EGCG are [1] the striking correlation of the 
antimutagenicity of green tea with a single green tea fraction (F6), the major 
component of which was EGCG, and [2] treatment of this fraction with degallase 
enzyme abolished (though not entirely) the inhibition of MROD activity observed 
with the untreated fraction (see Figures 4.11 and 4.12). Similar inhibition of MROD 
activity by whole green tea and EGCG was also abolished following degallation. 
The role of EGCG in the antimutagenicity of green tea is currently under further 
investigation in this laboratory; the effect on the antimutagenicity of whole green 
tea following treatment with degallase is being examined. Whether the present 
results regarding EGCG can be substantiated remains to be seen, but recent reports 
on the modulation by green tea of IQ metabolism in the rat (Embola et a l, 2001a, 
2001b) appear to support the in vivo data from the present study with regard to the 
excretion of urinary mutagens {vide infra). It is worth noting at this point that 
caffeine has itself demonstrated antimutagenic effects, notably against IQ, among 
other mutagens (Alldrick & Rowland, 1988).
Another question regarding the role of tea components is posed by the present data, 
namely, Ts caffeine likely to be the agent responsible for the increase in relative 
liver weight in animals consuming green tea?’ In agreement with a previous study 
(Bu-Abbas et a l, 1999a), results from the present study (Chapter 6) indicated an 
increase in relative liver weight in animals consuming green tea, an effect not 
observed following consumption of a mixture of green tea catechins (GTC) in the 
diet (Hirose et al, 2001). This may be because the dietary GTC were not equivalent 
to the consumption of such GTC in the aqueous GTE used in the present study, but 
the most obvious difference was the lack of caffeine in the dietary GTC mixture. 
However, in the present study, a similar effect was not observed following 
consumption of black tea, either whole or decaffeinated, suggesting that some 
component of green tea other than caffeine, or indeed any of the GTC, is 
responsible for this effect.
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The many studies that have focused on the polyphenol content of green tea (i.e. the 
catechins) use isolated compounds, or mixtures of such compounds to simulate 
whole tea. Significantly, such mixtures of catechins tend to omit caffeine, which the 
results from the present study indicate may be the most significant factor in vivo, 
with regard to tea consumption. However, such an approach may be misleading. In 
the present study, following the fractionation by HPLC of green tea with the aim of 
isolating a fraction responsible for the observed in vitro antimutagenic properties of 
green tea, EGCG appeared to be the most likely component responsible, based on 
the evidence from the present study described above. Indications from preliminary 
LC-MS data from this fraction were consistent with EGCG, plus a mixture of 
several minor components, mainly proanthocyanidins (data not shown).
However, as discussed in Chapter 4, the belief that the polyphenolic content of 
grapefruit juice, based on the large presence of these compounds, was responsible 
for the observed biological effects of the juice proved to be mistaken, with the 
identification of a minor, furanocoumarin derivative(s) (Mohri & Uesawa, 2001; 
Tassaneeyakul et al, 2000), which was shown to be responsible for virtually all of 
the P450-inhibitory activity of grapefruit juice. The precise identity of this 
component(s) is not clear, but the above studies suggest that bergamottin, or some 
furanocoumarin dimer(s), are the most likely candidates. This remains a salutary 
lesson when considering individual components for investigation into the 
anticarcinogenic properties of tea.
7.3 How does tea modulate IQ-induced genotoxicity?
7.3.1 Effect o f tea consumption on the metabolism o f IQ
The metabolism of IQ has been widely studied in vivo, with animal models 
including rats, mice, and primates (Luks et al, 1989; Snyderwine et al, 1992b; 
Turesky et al, 1986). In addition, the study of the modulation of IQ metabolism, 
particularly with respect to detoxication, is important since dietary sources of HAA, 
such as IQ, are so widely consumed (Embola et al, 2001a). The pathways of IQ 
metabolism are illustrated in Figure 1.2.
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However, a recent study by Embola et al (2001a) has since addressed this question, 
though only the effect of green tea on the metabolism of IQ was investigated. It was 
found that urinary levels of the sulphate and glucuronide 0-conjugates of 5-hydroxy 
IQ were greatly increased, while levels of the sulphamate and the parent compound 
were decreased. These findings appear to support those from the present study, and 
as discussed in Chapter 5, the increased levels of 5-0-conjugates appear to account 
for the reduced levels of urinary mutagenicity observed in rats consuming green tea 
prior to treatment with IQ. This would also explain the lack of effect on urinary 
mutagenicity observed following treatment of the urine with deconjugating enzymes 
(McArdle et al, 1999); in keeping with reports that ling-hydroxylated metabolites 
of other aromatic amines are not further metabolised to mutagenic species 
(loannides et al, 1989; Tong et al, 1986), 5-hydroxy IQ also appears to be non- 
mutagenic.
Embola et al (2001a) also suggested that the resulting increased UGT activity 
following green tea consumption (Bu-Abbas et al, 1995, 1998; Sohn et al, 1994) 
provides the likely mechanism for the increased excretion of the glucuronides 
observed. However, as the level of the A-glucuronide excreted is only slightly 
increased, and the level of 0-sulphate is increased by a similar degree to the O- 
glucuronide, the contribution of increased UGT activity may only be minor, with 
the increase in 5-hydroxylation seemingly the more significant factor; it follows that 
increased formation of 5-0-conjugates must ipso facto be preceded by increased 5- 
hydroxylation. It is important to note that the overall fraction of the dose of IQ 
excreted in the urine was not affected by consumption of tea, compared with the 
control animals maintained on water.
Xu et al (1996) suggested that although CYP1A2 is primarily responsible for the 
activation of IQ to A-OH IQ, the detoxicating 5-hydroxylation is catalysed by 
CYPIAI. Therefore, the observed induction of CYPlAl over CYP1A2 by I3C is a 
potential protective mechanism against IQ, and might be expected to increase the 
amounts of 5-0-conjugates relative to IQ sulphamate, consistent with the pattern of 
urinary metabolites and excreted mutagens in rats given I3C. However, since 
caffeine is a known inducer of CYP1A2 (Ayalogu et a l, 1995), and such an 
observation is supported by CYP1A2 induction following consumption of green tea
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and whole black tea, but not decaffeinated black tea (Bu-Abbas et a l, 1999a), the 
explanation proposed by Xu et al (1996) seems an unlikely scenario. Further doubt 
is cast upon this explanation by the increase in 5-0-conjugates of IQ observed in the 
urine following consumption of green tea (Embola et a l, 2001a, 2001b). Indeed, 
induction of CYP1A2 by 3-methylcholanthrene has been shown to result in 
decreased formation of hepatic and extrahepatic DNA adducts following treatment 
of rats with IQ (Snyderwine et al, 1993a). This observation is compatible with the 
present results, indicating that induction of this isoform does, in actual fact, lead to 
overall deactivation of IQ, despite the fact that CYP1A2 catalyses the N- 
hydroxylation of IQ, as well as the 5-hydroxylation.
Moreover, a similar study investigating the effect of green tea on the metabolism of 
IQ (Embola et a l, 2001b), found that green tea consumption also increased the 
urinary excretion of the A-glucuronide of A-hydroxy IQ (A-OH-A-GlcA). This 
metabolite was not considered in the previous study by the same authors (Embola et 
al, 2001a), but again, it was suggested that this observation was due to the increase 
in UGT activity associated with green tea consumption. However, once again, this 
observation may be primarily a consequence of elevated phase I activity, in this 
case, A-hydroxylation rather than 5-hydroxylation of IQ. The increase in 5- 
hydroxylation, and A-hydroxylation, of IQ may be mediated by the induction of 
CYP1A2 observed following consumption of tea (Bu-Abbas et al, 1994a, 1999a).
What remains unclear, however, is why the balance of metabolism under these 
conditions should favour deactivation to the 5-hydroxy rather than activation to the 
A-hydroxy derivative. The haem prosthetic is central to P450-catalysed mono­
oxygenation reactions. Computer modelling studies have indicated that when IQ is 
located in the active site of CYP1A2, the orientation adopted for 5-hydroxylation 
results in this position being in closer proximity to the haem moiety of the enzyme 
(0.3148 nm) than the A-hydroxylation position (0.3452 nm) in the equivalent 
orientation, and this may, at least in part, explain why induction of CYP1A2 results 
in elevated levels of 5-0-conjugates (personal communication. Dr D. Lewis, 
University of Surrey). Finally, regarding this work, further studies are required to 
examine the effects of black tea and decaffeinated black tea to verify the role of 
caffeine in particular, and to establish whether the similar effects observed in vivo
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with black tea are manifested by a similar pattern of modulation of the metabolism 
of IQ.
It may be speculated that the increase in CYP1A2 results in increases in both 5- and 
A-hydroxy IQ, thus accounting for the decrease in the sulphamate and the parent 
compound. The concomitant increase in UGT, resulting in elevated levels of urinary 
5-0-GlcA and A-OH-IQ-A-GlcA, aiding detoxication, would render the increased 
level of A-OH IQ unavailable for further activation to the ultimate mutagen. This 
implies that A-OH-IQ-A-GlcA is either resistant to the ^-glucuronidase used in the 
present study (Chapter 5), or is (virtually) entirely degraded in the urine/urinary 
bladder. It is pertinent to point out that A-glucuronides of aromatic amines are poor 
substrates for P-glucuronidase, yet are quite acid-labile, and may therefore be 
subject to non-enzymatic hydrolysis in acidic urine (Zensner et al, 1999). Hence, 
degradation of A-OH-IQ-A-GIcA may account for the ‘direct-acting’ mutagenicity 
observed, but the question arises, ‘should the elevated level of A-OH-IQ-A-GlcA 
(and subsequent degradation) result in increased urinary mutagenicity, or is this 
metabolite stable?’
Therefore, to summarise, induction by tea increases the CYPlA2-mediated 
hydroxylation of IQ at the 5-position and at the exocyclic amino position. The 
elevated level of A-OH IQ is stabilised by conjugation with GlcA, whereas the 
elevated level of 5-OH IQ is detoxified by conjugation with GlcA and sulphate. 
Whether either pathway is influenced by the induced level of UGT is not clear, 
since the level of 5-0-sulphate is elevated by a similar degree to the glucuronide; 
the constitutive UGT activity is unlikely to be saturated at such a level of IQ, from 
which it may be inferred that induction of UGT would have little effect.
7.3.2 Effect o f tea consumption on IQ-DNA adduct formation
Unfortunately, conclusive results regarding the modulation of DNA adduct 
formation by tea were not achieved by the present study, hence it is only possible to 
speculate as to the significance of the data obtained. In Chapter 6, it was noted that 
future investigations into the effect of tea on DNA adduct formation should include 
multiple timepoints in order to realise fully the extent of any such effect. One
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possibility not previously discussed herein is the effect of tea on DNA repair, in this 
context, the removal of adducts. Schut & Yao (2000) investigated the formation of 
PhlP-DNA adducts in rats immediately following, and 8 days after cessation of, 
treatment with PhIP. Whilst there was an overall reduction in adduct levels on the 
eighth day relative to the first, the reduction was not influenced by tea. This 
observation suggests a pre-initiation stage mechanism of action in the antigenotoxic 
effects of tea. IQ-DNA adducts, particularly dG-A^-IQ, appear to persist in some 
tissues, but this persistence was not related to the susceptibility of the tissue(s) to 
the carcinogenic effects of IQ (Turesky et al, 1996a).
In the present study, a rather high level of DNA adducts in the heart was observed, 
in keeping with previously-reported formation of adducts in extrahepatic tissues. 
Rather than in situ metabolism, unlikely in metabolically incompetent organs, the 
formation of these adducts may be due to the transport of activated IQ, stabilised in 
the form of A-OH-IQ-A-GlcA, and subsequent hydrolysis by endogenous 
glucuronidases to A-OH IQ, before undergoing further activation (i.e. N-0- 
sulphation or acétylation and subsequent dissociation — see Figure 1.2) to the 
ultimate genotoxic species. Since A-OH-IQ-A-GlcA has been observed in the urine 
of animals treated with IQ (Embola et al, 2001b; Snyderwine et al, 1997; Turesky 
et al, 1993), this metabolite is clearly stable enough to undergo at least a certain 
degree of transport. Indeed, perhaps surprisingly, the A-hydroxy derivative may 
itself be sufficiently stable to undergo transport. A study by Kaderlik et al (1994) 
demonstrated high levels of DNA adduct formation in the rat in all of the 
extrahepatic tissues examined following i.v. administration of A-OH PhIP.
This evidence indicates that A-OH PhIP, believed to be primarily formed in the 
liver, is sufficiently stable to be transported throughout the circulation and undergo 
further metabolism to a DNA-reactive species in extrahepatic tissues. Such stability 
may also be applicable to the structurally-related A-OH IQ, and in addition to 
explaining the formation of DNA adducts in extrahepatic tissues, offers a likely 
source of ‘direct-acting’ urinary mutagenicity.
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7.4 Future work
There are several avenues of research to pursue in order to answer some of the 
questions posed by the results of the present study, or to validate the present 
findings. In addition, certain aspects of the present study require a different 
approach in order to obtain more meaningful data.
Perhaps the most important research in this respect is the further investigation into 
the effect of tea consumption on the excretion of IQ-derived urinary
metabolites. Embola et al (2001a, 2001b) have already conducted similar 
investigations into the effect of green tea on IQ metabolism in the rat, but with 
respect to the present study (McArdle et al, 1999; see also Chapter 5), the effects of 
black tea, both whole and decaffeinated, also require investigation. Such a study 
would lend support to, or discount, the role of caffeine. Indeed, it may be prudent to 
incorporate a ‘caffeine control’, similar to that employed in the investigation 
described in Chapter 3, to establish unequivocally the role of caffeine. Further 
related work could focus on the modulation by tea, and its components, of the 
various pathways of IQ metabolism in vitro, employing precision-cut liver slices, 
including human samples, as a model system (Steensma et a l, 1994).
Subsequently, the logical progression of such a study is to the human situation. The 
suppression of urinary IQ-derived mutagens and promutagens in rats following 
consumption of tea (McArdle et al, 1999) has, to a degree, been corroborated in 
humans by Sasaki et al (1996). As previously discussed in Chapter 5, these authors 
reported that the urine from volunteers consuming raw fish or cooked beef was less 
mutagenic in the Ames test in groups consuming Tochu tea, compared with the 
control group. However, Tochu tea is prepared from the leaves of a different plant 
species from that of ‘normal’ tea, and as such, these results may not be directly 
applicable to tea. Nevertheless, studies have been initiated in this laboratory to 
imitate in humans the previous study in rats (McArdle et a l, 1999). Volunteers will 
still be required to drink various preparations of tea prior to ingestion of the 
mutagenic material, but rather than receiving a dose of purified IQ, the volunteers 
will consume well-done beefburgers cooked by frying, thus ingesting a 
heterogeneous mixture of HAA and PAH. Whilst it is true to say that the data from
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such a study would be a valid human model, it is an artificial situation, and may still 
be some way from describing the actual situation. In addition, it may be of interest 
to investigate the induction of CYP1A2 following consumption of tea in the same 
human volunteer study, using caffeine as a probe. The use of caffeine clearance as 
an in vivo probe for CYP1A2 activity has been described (Carrillo et al, 2000, and 
references therein), and is based upon the determination of caffeine urinary 
metabolite ratios to evaluate the contribution of CYPIA2 to the metabolism of 
caffeine.
It was suggested in Chapter 5 that a possible explanation for the decreased excretion 
of IQ-derived urinary mutagenicity following consumption of tea, in the absence of 
any other quantitative data, may be an increase in binding to cellular 
macromolecules following enhanced activation of IQ, thus reducing excretion of IQ 
metabolites. In an attempt to investigate such a hypothesis, and to examine the 
effect of tea consumption on the formation of IQ-DNA adducts, the 
postlabelling assay followed by HPLC with in-line radiochemical detection were 
employed. However, technical difficulties prevented the acquisition of conclusive 
data.
Therefore, in the light of such information, it would seem logical to conduct a 
similar investigation, with appropriate modifications to the present postlabelling 
study. This could follow one of two potential lines of investigation. In order to 
retain IQ as the model genotoxic agent, following postlabelling, the normal and 
modified labelled nucleotides would be separated by TLC rather than HPLC. 
Detection and quantitation could then be achieved by autoradiography and either 
scintillation counting of the radiolabelled spots or by image analysis of the 
autoradiogram. Either way, the problem of lack of sensitivity experienced with 
HPLC radiochemical detection would be overcome, since exposure/counting time 
could be increased to allow for detection of low levels of radiolabelled material. 
Alternatively, to retain the convenience of HPLC analysis, another model mutagen 
could be used, such as a PAH, which lends itself more favourably to the HPLC 
method (Hall et al, 1990; Moller et al, 1993; Zeisig & Moller, 1997), owing to 
more effective application of enrichment procedures. In addition, the modulation of 
DNA adduct formation by tea, and its components, could be investigated in vitro.
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again employing precision-cut liver slices as a model system (Baumann et al, 1996, 
1999).
7.5 Conclusions
It is clear that the various components responsible for the observed in vitro and in 
vivo effects in the present study will have consequences on the relevance of these 
findings to the human population, e.g. the absence of EGCG from black tea, the 
increasing trend toward consumption of decaffeinated black tea, and indeed, 
whether the addition of milk to tea affects the aforementioned properties of tea, 
although it would appear that addition of milk does not impair the bioavailability of 
tea catechins (van het Hof et al, 1998). Some reports suggest that black tea may 
have similar properties to those of green tea, at least in vitro (Apostolides et al, 
1996), but the lack of caffeine in decaffeinated black tea, together with the relative 
paucity of studies on this type of tea, implies that consumption of this tea may not 
be as beneficial. However, in addition to reports demonstrating the antimutagenic 
effects of black tea polyphenols (Apostolides et al, 1996, 1997; Catterall et al, 
1998), results from the present study show that consumption of decaffeinated black 
tea suppressed the urinary excretion of IQ-derived mutagens in rats, albeit only 
modestly. Since this observation is unlikely to be attributable to the trace levels of 
caffeine present in this tea, it may be cautiously inferred that the black tea 
polyphenols, such as the thearubigins and theaflavins, are contributing to this effect.
The situation is too complex to ascribe to a single component of tea a particular 
mechanism of action in inhibiting any given type of cancer. The many variables 
involved in the complex process of carcinogenesis, such as dietary habits (including 
method of cooking food), genetic pre-disposition, environmental factors (such as 
dietary contaminants), are likely to prevent epidemiological evidence from being 
directly applicable to the human population as a whole. In addition, in tea­
consuming populations, the consumption of tea is likely to be ongoing, and 
therefore the anticarcinogenic effects of tea noted in epidemiological data may 
reflect the action of tea, or the numerous components of tea, continually working in 
concert at various stages of carcinogenesis. This multi-stage, multi-component 
mechanism may reflect the lack of anticarcinogenic epidemiology with respect to
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other caffeine-containing beverages, such as coffee, although this may be 
attributable to associated lifestyles and incidence of particular cancers in such 
populations.
From the results of the present study, it is proposed that the consumption of tea is 
likely to have beneficial effects with regard to the suppression of cancer in the 
human population, and this is most likely to occur at the initiation stage by 
inhibition of the bioactivation of carcinogens. However, also on the evidence of the 
present study, these benefits may be restricted to dietary carcinogens, in particular 
HAA, or at least to other substrates of CYP1A2 such as aromatic amines in general, 
which include certain occupational carcinogens (Zensner et ah, 1999). In addition, 
such a beneficial effect may only be manifested by reduced incidence of certain 
types of cancers, as suggested by epidemiological reports on Eastern populations 
(Fujiki et ah, 1996; Kuroda & Hara, 1999), which in turn, is a function of numerous 
factors, perhaps the most important of which is, in this case, the diet.
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I. Ingredients of CIO Diet
Ingredient g kg  ^diet
casein 100
maize starch 652
sucrose 100
maize oil 50
a-cellulose 50
mineral mix* 35
vitamin mix 8.636
Rovimix A 500 0.024
cholin chloride 1.34
D,L-methionine 3
♦Mineral mix
Ingredient g kg * mix
potassium citrate^O 290.1
magnesium sulphateJHiO 139.2
sodium chloride 37.3
calcium carbonate 241.6
calcium tetrahydrogen 275.9
diorthophosphate-H20
sodium metasilicate 5 H2O 5.3
trace mix** 10.6
**Trace mix
Ingredient g 100 g * mix
iron (III) citrate 57.23
manganous carbonate 28.54
zinc carbonate 3 H2O 5.79
nickel sulphate 3.71
copper (II) carbonate 3 H2O 2.62
tin (IV) chloride-5H20 0.78
sodium fluoride 0.61
ammonium metavanadate 0.30
chromic chloride-6H20 0.26
sodium selenite 0.09
potassium iodide 0.05
ammonium molybdate4H20 0.02
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II. Analysis of standard rat and mouse diet
Test Result (g lOOg *^) Test Result (g lOOg *^)
moisture 7.80 lead 0.14 mg kg“*
protein (Nx6.25) 19.7 phosphorus 0.81
fat 4.70 manganese 80.8 mg kg"*
crude fibre 2.40 magnesium 0.14
ash 5.20 zinc 103 mg kg"* 
20.7 mg kg"*potassium 0.74 copper
calcium 0.90 iron 160 mg kg"*
sodium 0.24 mercury <0.01 mg kg"*
chloride 0.44 selenium 0.38 mg kg"*
cadmium 0.02 mg kg"^ vitamin A (retinol) 12.4 i.u. g"* 
85.9 mg kg"*fluoride 23.8 vitamin E (D,L-a- 
tocopherol)
*Except where indicated otherwise
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